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Abstract 
Models and computational predictions are useful in identifying certain key 
parameters that play a central role in defining the overall behavior of the system, and 
thus lead to new and more informative experiments. In this thesis, in-silico models 
are developed over a range of individual biological scales (macroscopic, mesoscopic 
and microscopic) for a range of cellular phenomena (cellular interactions, migration 
and signalling pathways) in order to highlight the importance of combined in-vitro – 
in-silico investigations. It is widely accepted that Systems Biology aims to provide a 
simpler and more abstract framework to explain complex biological phenomena. 
However, integration of these models with experimental data is often underutilised. 
Incorporation of experimentally derived data sets into the mathematical framework 
of in-silico modelling results in reliable, well parameterised systems capable of 
replicating dynamical properties of the biological systems. Work in this thesis 
includes the development of a continuous macroscopic in-silico model to identify the 
key mechanisms of interaction between cells present within the gastric tumour 
microenvironment. This model of discovery is used in a predictive capacity to accept 
or reject hypotheses. Next, the construction of a discrete cell based model of 
fibroblast migration is used to determine the degree of bias fibroblast cells 
experience when migrating over different surface topologies. The key results from 
this model show that particular surface topographies can have an effect on migratory 
cell behaviour. Then, the parameterisation of a differential equation model is used 
to quantify the key mechanisms of Nrf2 regulation in the cytoplasm and nucleus. 
Validation with experimentally derived datasets results in the quantification of rate 
ratios important to the dynamics of this signalling pathway. Finally, a stochastic Petri-
net model capable of simulating the dynamical behaviour of functional cross-talk 
between the Nrf2 and NF-κB pathways is developed. This approach allows for the 
evaluation of a wide array of network responses, without the need for 
computationally expensive parameterisation. Together, these models exhibit how 
integration of in-silico models with in-vitro datasets can be used to generate new 
knowledge, or testable hypotheses.  
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Chapter 1: Introduction to Systems Biology 
and its Applications 
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1.1 Background 
In this thesis, systems biology is used to model and discover emergent properties 
over multiple individual scales in biological systems. This holistic approach provides 
a greater insight into the systems as a whole, while also allowing dynamic and 
quantitative conclusions to be drawn. One of the advantages of the work carried out 
in this thesis, upon which the novelty and importance is also highlighted, is that 
experimentally derived raw data is used as the basis for the creation of the 
mathematical models within. Utilising experimental data in this way allows for the 
depiction of more accurate and robust models. This distinction is important for 
drawing conclusions from the models, both qualitatively and quantitatively, and can 
provide the platform for the design of further experimentation for validation or in a 
predictive capacity. 
Systems biology is the computational and mathematical modelling of complex 
biological systems [1]. It is an interdisciplinary field of study that focuses on complex 
interactions within biological systems, using an integrated approach to biological 
research. Systems biology can be seen as an umbrella term which encompasses a 
variety of peripherally overlapping concepts, such as: applied mathematics [2], 
computational biology [3], quantitative systems pharmacology [4], integrative 
biology [5], systems biomedicine [6] and synthetic biology [7]. Almost two decades 
ago, the term was launched into the mainstream in correlation with the completion 
of the Human Genome Project (HGP) [8]. However, the origins of systems biology can 
be traced back even further, to the middle of the 20th century. For example, in 1973 
the theory of metabolic control was developed and as a result, metabolic flux was 
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recognised as a systemic property [9]. From the completion of the HGP, interest in 
systems biology has increased, as evidenced by the increasing number of papers 
published in the field each year (Figure 1-1). This emergence can be attributed to the 
development of new and increasingly powerful computational approaches. It is this 
improved computational power that drives the evolution of systems biology, as more 
complex and sophisticated systems are created. This development falls under 
Moore’s law [10] which states that the overall processing power of computers will 
double every two years. To put this into context, the HGP took 13 years to complete 
whereas, in the last few years, a full human genome can be sequenced in less than 
24 hours [11]. 
Biological systems consist of a large number of functionally diverse components, 
which can interact in highly specific and non-linear ways to produce phenomena such 
as cell migration, cell signalling and gene transcription. Typically, the models used in 
systems biology require iterative building and stepwise improvements based on 
comparison with experiments [1]. These models, once sufficiently refined, can then 
be used to predict the behaviour of the biological system under different 
perturbations that may be of interest or simply deemed unfeasible in an 
experimental setting. This is particularly beneficial when it comes to estimating rate 
constants on reactions that take place rapidly in-vitro. The various models used in 
systems biology can have significant differences depending on several factors, 
relating to the scope of the study, such as: the level of description in the model, 
limitations in the knowledge of the biological system or the ability to observe the 
phenomena of interest experimentally for validation. For example, this thesis focuses 
on the dynamic behaviours of cellular interactions at multiple individual biological 
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scales, i.e. the multicellular (tissue) level, cellular level and cell signalling networks at 
the subcellular (molecular) level. At each individual scale, different systems biology 
approaches are utilised in this thesis. 
 
 
Figure 1-1. Search results for systems biology on Pubmed [12]. The number of 
papers referencing “systems biology” in the Pubmed database are organised by 
year of publication (2000-2017). In 2017, there were 23,070 results compared 
with 3,773 results in 2000. 
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1.2 In-silico modelling motivation 
In the current age of technology, the high number and diversity of experimental data 
available has never been as easy to access [5]. The data available ranges from simple 
processes, such as enzymatic reactions, to the more complex, such as gene 
transcriptions in response to inflammatory stimuli of the cell. Regardless, 
representative models of these systems can be designed based on this empirical 
data. Thus, by combining raw experimental data with mathematical modelling, a 
more accurate model can be created, as it is designed with less theoretical 
assumptions and unknown parameter estimates. Another advantage when using an 
in-silico approach, rather than traditional biological techniques, is that the modelling 
algorithms can be reused many times and applied to differing biological systems. Not 
only does this provide a more cost-effective method, compared with organism-
dependent experiments, but also allows for the replacement, reduction and 
refinement of animal-based experiments [13]. Systems biology is a powerful tool that 
can aid in the understanding of the dynamics of disease mechanisms, ranging from 
cancer [14] to degenerative disease [15], and can also be utilised in drug discovery 
[16]. These approaches have already provided a deeper understanding of diverse 
biochemical processes from individual metabolic pathways [17], signalling networks 
[18] and genome-scale metabolic pathways. Therefore, the continued development 
of in-silico models is an important endeavour to facilitate and enhance our 
understanding of key biological processes.  
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1.3 Mathematical models 
All biological phenomena emerge from an intricate interconnection of multiple 
processes occurring at different levels of organisation. These levels include the tissue, 
cellular and molecular level which can be approximately connected to macroscopic 
(10-5 m), mesoscopic (10-6 m) and microscopic (10-7 m) scales, respectively [19,20]. 
The macroscopic scale typically corresponds to behaviours such as cell population 
dynamics and tissue mechanics. Adhesive interactions, between cells or between 
cells and the extracellular matrix (ECM), and mechanisms of cell motility are common 
phenomena observed at the mesoscopic scale. Finally, the microscopic scale refers 
to processes such as DNA signalling, activation of receptors and the transport of 
proteins (cell signalling networks) [21].  
An exhaustive in-silico model would incorporate all these levels in a multiscale 
fashion. However, a valuable approach in systems biology is to build a model as 
simply as possible, focused on a single scale and based on a minimal set of 
assumptions that can be derived from experimental observations. This is the 
approach selected for the work incorporated within this thesis. Each model is 
contained within a singular scale, so as to capture the dynamics of the critical 
components examined. Gradually, it is then possible to add more components and 
complexity to the model, after refining and validating against experimental results. 
In turn, this allows for a concise description of the essential features of the system of 
interest, whilst also providing the possibility of identifying the most relevant 
mechanisms and parameters.  
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1.3.1 Continuous vs discrete modelling 
There are many mathematical approaches to these problems which can broadly be 
defined into two main categories: continuous and discrete models. Additionally, 
there can be further classifications into deterministic or stochastic models, 
depending on whether they contain a degree of randomness. Continuous modelling 
can be described as the application of mathematics to continuous data, i.e., it 
generally doesn’t require data, just the use of continuous variables [22]. This 
approach is characteristic of a macroscopic point of view, as these methods 
represent populations of biological identities, such as e.g., epithelial cells, as 
densities. This modelling strategy includes using systems of ordinary differential 
equations (ODEs) and partial differential equations (PDEs) to solve for transient or 
steady state solutions [22]. Traditionally, systems of ODEs have been used to 
represent chemical reactions, using the law of mass action kinetics [23,24]. This law 
is defined as the rate of a chemical reaction being directly proportional to the 
concentration of the reactants [25]. In most cases, ODEs contain one or more 
functions of an independent, continuous variable and the derivatives of the functions 
with respect to that variable. These equations can be used to model dynamics over 
time. Whereas, PDEs typically contain multivariable functions and can be used to 
determine multidimensional patterns in the data and model dynamics over several 
independent variables, e.g., spatial variables in addition to time [22]. Conversely, 
discrete models can be used to represent biological individuals (e.g. focusing on the 
cellular level), as a set of discrete units with rules describing the interactions and 
movements of individual cells. Examples of these models are Cellular Automata (CA) 
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[26,27] and Individual Cell-Based Models (IBMs), also known as Agent-Based Models 
(ABMs) [28].  
Given the same parameters and initial conditions, deterministic models will produce 
the same result after each simulation, as there is no random element. While, 
stochastic models provide distributions of simulated outcomes as opposed to a single 
result [5]. Therefore, deterministic approaches are more suitable for modelling 
systems with large numbers of components, where the impact of small fluctuations 
is negligible. Stochastic approaches are more appropriate for modelling systems with 
a small number of components, where the impact of these small fluctuations is more 
relevant within the system. However, utilising both approaches is sometimes key for 
creating accurate models of large systems. One of the biggest challenges with these 
models is accurately obtaining parameter and rate constant values. These models 
form an iterative series of model building and simulation processes that are driven 
by hypotheses to understand how biological systems function as a network of 
biochemical reactions [29]. Linking models and data requires numerical values for all 
the mathematical parameters that describe the system of interest. A traditional 
approach to this challenge is to collect parameter values through a literature search. 
However, inferring the parameters from available experimental data would be a 
much more preferable method [30,31]. Optimisation-based approaches aim to 
reduce the discrepancy between the model predictions and experimental data by 
searching through parameter combinations [32]. Robustness and confidence in these 
optimised parameters presents a challenge also, as many parameter combinations 
could provide locally optimal fits [33]. Therefore, it is important to take measures to 
avoid over-fitting the data. Calibration with experimental data by fitting from initial 
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parameter estimates represents a routinely practiced method for obtaining these 
values. In general, in-silico model development can be broken down into the 
following initial steps [34]: 
1) Make initial assumptions of what is influencing the observed experimental 
behaviour based upon the data. 
2) Derive a system of differential equations (the model) to describe the dynamic 
events taking place. 
3) Parameterise the model 
4) Solve the model equations. 
5) Verify the results by comparing the model simulations to the data using 
various statistical tests. 
6) If the verification is unsuccessful, alter the model and repeat verification 
process. 
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1.4 Continuous modelling of multicellular interactions 
In multicellular organisms, there are evolutionary advantages conferred by the 
differentiation of cells into different types with specialised functions. Coordinated 
cell-cell interactions become vital in maintaining the organisation and function of 
tissues containing multiple cell types, both in development and in tissue repair. In 
the gastrointestinal (GI) tract, for example, interactions between epithelial cells and 
stromal cells control cell proliferation, differentiation and apoptosis. These 
interactions are disrupted in a variety of diseases including inflammatory conditions 
and cancer. Since inflammation is recognised as a driver of cancer progression [35], 
there has been a growing appreciation of the role that cellular microenvironments 
play in carcinogenesis. Amongst the various cells contributing to the tumour niche, 
myofibroblasts have been highlighted by many studies [36-38]. These cells normally 
play an important role in the maintenance of tissue architecture and wound healing 
[39-42]. Myofibroblasts are a rich source of growth factors, cytokines, chemokines, 
extracellular matrix (ECM) proteins, proteases and their inhibitors [43]. However, the 
functional role of myofibroblasts in many cancers is not well understood. One of the 
aims in this thesis is to investigate the effect that Barrett's adenocarcinoma cancer-
derived myofibroblasts (308 cells) have on gastro-adenocarcinoma cancer cells (AGS 
cells) and to develop a mechanistic model describing this interaction (Chapter 2). I 
begin by describing the environment that both these cell types reside within and how 
they behave in-vivo, i.e., their cellular phenotype and secretory profile. 
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1.4.1 Basic organisation of the gastrointestinal tract 
The upper gastrointestinal tract, which consists of the salivary glands, oesophagus, 
stomach and the small intestine, functions to aid food digestion and nutrient 
absorption. The wall of the gastrointestinal tract is divided into layers: an outer 
muscle layer; a mucosal layer consisting of epithelial cells that continuously line the 
luminal surface; and a stromal layer, the lamina propria, consisting of blood vessels, 
ECM, lymphatics, inflammatory cells, immune cells, fibroblasts and myofibroblasts 
[44]. 
There are five main regions in the stomach: i) the cardia; ii) the fundus; iii) the corpus; 
iv) the pyloric antrum; and v) the pyloric sphincter [45]. The epithelium, within the 
stomach, is folded into gastric glands (Figure 1-2). The glands found in the fundus and 
corpus are populated by histamine-secreting enterochromaffin-like (ECL) cells, acid-
secreting parietal cells and chief cells that release pepsinogen, whereas the glands 
found in the antrum are populated by gastrin-secreting G cells [46]. This antral 
hormone, gastrin, stimulates gastric acid secretion in parietal cells via the induction 
of histamine-secretion in ECL cells. Gastrin binds to cholecystokinin-2 (CCK-2) 
receptors expressed in ECL cells, inducing the synthesis and secretion of histamine. 
Then, histamine binds to its H2-receptor on the surface of the parietal cells resulting 
in the secretion of gastric acid [47]. 
The maintenance of the gastrointestinal tract epithelium is achieved through the 
proliferation and differentiation of epithelium stem cells. The cells exhibit 
bidirectional movement towards the surface or base of the glands [48]. Cells moving 
up to the pit region from the isthmus differentiate into mucus-secreting cells, 
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whereas cells moving towards the gland base region differentiate into parietal and 
chief cells [49,50]. There is a tight network of myofibroblasts around the gastric 
glands that are thought to determine organisation and function of the epithelial cells. 
 
Figure 1-2. Schematic diagram of a gastric gland. Diagram showing the different 
cell types present in a gastric gland: surface mucous cells, proliferating cells, 
mucous neck cells, chief cells, G cells and parietal cells. The bi-directional 
migration of the cells occurs from the isthmus region to the gastric pit and the 
fundus region generating the differentiated cell types. Adapted from [45]. 
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1.4.2 Myofibroblasts 
Myofibroblasts are activated fibroblasts. They are dynamic, spindle-like cells sharing 
the functional characteristics of both fibrocytes and smooth muscle cells [51]. They 
are rarely found in most tissues, but in the gastrointestinal tract they are relatively 
abundant, where they are localized in a sub-epithelial compartment. Myofibroblasts 
express alpha-smooth muscle actin (α-SMA) and vimentin, which are specific 
histopathological markers of these cells. A variety of different origins of these cells 
have been discussed by a number of authors, including: (a) rapid stimulation of local 
fibroblasts to differentiate into myofibroblasts [52]; (b) epithelial cell 
transdifferentiation into myofibroblasts via epithelial mesenchymal transition (EMT) 
[37,53]; (c) local or bone-marrow-derived mesenchymal stem cells (MSCs) 
transformation into myofibroblasts [54]. 
Myofibroblasts are rarely found in healthy tissue. However, as described previously, 
they are abundant in the gastrointestinal tract and are also found to increase during 
wound healing within the tract. The key events that characterise GI tract wound 
healing include restitution after tissue damage, inflammation, re-epithelisation and 
tissue remodelling [55]. Restitution is defined as an epithelial migratory response to 
superficial damage in the gut by which a protective layer of epithelial cells is formed 
over the injured site [56]. In damaged tissue, fibrin forms a provisional ECM [57,58] 
that embeds platelets which are an early source of growth factors and chemokines, 
required to further drive coordinated wound healing [59,60]. Myofibroblasts 
regulate this migration and proliferation through the secretion of transforming 
growth factor-beta 3 (TGF-β3), maintaining the integrity of the epithelium [61]. 
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Myofibroblasts that reside in the cancer niche exhibit changes to their phenotype; 
they are designated “cancer associated myofibroblasts” (CAMs) (Section 1.4.4) [62]. 
There is also a role for myofibroblasts identified in mucosal immunology. Intestinal 
myofibroblasts have been associated with innate immune responses through 
regulation and expression of toll-like receptors (TLRs) [63]. When stimulated with 
bacterial lipopolysaccharide or lipoteichoic acid, the expression of TLR-2, TLR-3, TLR-
4, TLR-6 and TLR-7 in intestinal myofibroblasts is increased, leading to the secretion 
of pro-inflammatory cytokines and chemotactic factors that recruit immune cells to 
sites of inflammation [63]. Furthermore, the expression of class II major 
histocompatibility complex (MHC) molecules in colonic myofibroblasts has been 
found, suggesting that these cells may function as antigen-presenting cells which 
activate CD4-positive T-cells during activation of adaptive immunity [64]. 
In addition, myofibroblasts have been shown to deposit ECM proteins (e.g. collagens, 
laminins and fibronectin) and secrete ECM-degrading proteases which regulate 
turnover of the ECM [65]. These proteases are classified into matrix 
metalloproteinases (MMPs); serine proteases, such as urokinase-like plasminogen 
activator (uPA) and tissue-type plasminogen activator (tPA); and cysteine proteases, 
such as collagen degrading cathepsins [66]. Fibrosis is the result of excessive 
deposition of ECM proteins, often with loss of some resident cell types, but increased 
numbers of myofibroblasts. Inefficient removal of scar matrix proteins leads to 
fibrosis [67]. Plasminogen activator inhibitor-1 (PAI-1) is an inhibitor of uPA and tPA. 
uPA regulates plasmin abundance, degradation of ECM proteins and also plays a role 
in activating MMPs [68]. The MMPs, which belong to a family of zinc-dependent 
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endopeptidases, are involved in physiological processes (e.g. embryonic 
development, wound healing) and cancer progression [69]. A total of 28 human 
MMPs has been identified, and they are classified into five main categories according 
to their substrate specificity, primary structures, and cellular localization, namely, the 
matrilysins (e.g. MMP7), collagenases (e.g. MMP1), stromelysins (e.g. MMP3), 
gelatinases (e.g. MMP2), and the membrane-type MMPs (e.g. MMP14) [70]. Other 
members of the metalloproteases include a disintegrin and metalloproteinases 
(ADAMs), which are transmembrane proteins, and ADAMs with thrombospondin 
motifs (ADAMTS), which are secreted and bound to ECM proteins [66].  
The MMPs are synthesised as inactive zymogens (i.e. pro-MMPs) and mostly become 
activated after proteolytic cleavage within the extracellular environment [71]. The 
activity of MMPs is low in the normal state, and can be induced in response to 
external stimuli. For example, proinflammatory cytokines stimulate the secretion of 
MMP1, MMP2 and MMP3 in colonic myofibroblasts [72,73]. In intestinal and gastric 
myofibroblasts, the expression of MMP1, MMP2 and MMP3 has also been identified, 
suggesting the importance of these MMPs [74]. Substrates for MMP1, such as 
perlecan and insulin-like growth factor binding protein-3 (IGFBP3), have been shown 
to increase the bioavailability of fibroblast growth factor (FGF) and insulin-like growth 
factor (IGF), respectively [75]. Additionally, studies have shown the proteolytic 
activation of transforming growth factor-beta (TGF-β) by MMP2, and the cleavage of 
E-cadherin, an epithelial adhesion molecule, by MMP3 [71].  
Matrilysin (i.e. MMP7), which is predominantly expressed in epithelium, is implicated 
in regulating myofibroblast function [74]. Gastro-epithelial cells secrete matrix 
metalloproteinase-7 which cleaves insulin-like growth factor binding protein-5 
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(IGFBP-5) secreted by myofibroblasts leading to release of IGF-II which stimulates 
both epithelial and myofibroblast proliferation [74].  
The gastrointestinal tract is normally exposed to many different potentially damaging 
agents including acid, ingested toxins, resident and ingested microbiota. In the upper 
gastrointestinal tract, failure of the normal protective mechanisms is a feature of 
several common conditions including pathology associated with gastric infection 
with Helicobacter-pylori, and reflux of gastroduodenal contents into the oesophagus. 
In both cases chronic inflammation is associated with increased risk of cancer. 
1.4.3 Basic description of cancer and the tumour microenvironment 
Cancer can be described as a wound that fails to heal, indicating that there is a 
correlation between the mechanisms of wound healing and tumour cell response to 
inflammation [76]. Moreover, it is well established that abnormal secretion of growth 
factors and cytokines, dysregulation of signalling pathways, and genetic alterations 
all play a role in the promotion and progression of tumour growth. Famously, 
Hanahan & Weinberg [77] proposed the six hallmarks of cancer that dictate cancer 
growth and malignancy. These hallmarks are as follows: 1) self-sufficiency in growth 
signals, 2) insensitivity to anti-growth signals, 3) tissue invasion and metastasis, 4) 
limitless replicative potential, 5) sustained angiogenesis and 6) evading apoptosis. 
However, in addition to these hallmarks, it is stressed that there is also a key 
contribution of genetic and epigenetic alterations in cancer cells. Epithelial cells are 
characterised by having tight cell-cell adhesions, forming a continuous sheet that 
functions as a barrier. However, for tumour epithelial cells to become invasive, these 
tight adhesions must be shed in favour of loose cell-cell contacts, obtaining 
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mesenchymal properties. This process is known as EMT and is a key process in wound 
healing, fibrosis and metastasis of cancer [78]. Tumour stromal cells, such as cancer-
associated myofibroblasts (CAMs), play a role in promoting tumour angiogenesis 
(formation of new blood vessels from previous vessels), cancer cell growth and 
invasion through ECM remodelling (Figure 1-3). These cells also activate cancer cell 
signalling pathways through the secretion of cytokines and growth factors [79]. 
 
Figure 1-3. Epithelial-stromal interactions in tumour formation and progression. 
In normal mucosa, myofibroblasts (NTMs) are involved in regulating epithelial cell 
function. Chronic inflammation contributes to the formation of cancer through 
genetic and epigenetic changes of epithelial and myofibroblast cells in pre-
neoplastic tissue. Paracrine signalling between cancer cells and CAMs result in cell 
growth and invasion. Myofibroblast populations are increased by bone marrow 
derived MSCs in cancerous tissue. This chemical environment supports EMT, 
metastasis and tumour growth. Adapted from [80]. 
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The tumour microenvironment consists of ECM, blood vessels, soluble paracrine 
factors and non-malignant stromal cells, such as CAMs, endothelial cells and 
inflammatory cells [81]. Malignancy of the tumour and suppression of the anti-
tumour immune response are products of the role these inflammatory cells have 
within the cancer niche [35]. Endothelial cells also contribute to this malignancy by 
maintaining normal physiology of the neoplastic blood vessels [82]. Non-malignant 
stromal cells, such as these, migrate into the tumour site from distant locations 
within the body. However, the cancer niche also depends on resident stromal cells 
from surrounding and neighbouring tissue, such as the myofibroblast. Stromal cells 
progressively increase in cancer either through inward migration, proliferation or 
transdifferentiation from other cell types [81]. In GI tumours, stromal cells constitute 
60-90% of the mass of the tumour, with CAMs showed to play a crucial role in tumour 
progression [83]. 
1.4.4 Cancer-associated myofibroblasts 
These cells undergo changes at the epigenetic level and a difference in gene 
expression [84] has been detected in CAMs from gastric cancer compared with 
“normal tissue myofibroblasts” (NTMs) [85]. This differential expression of genes 
relates to various cellular functions such as cancer cell proliferation, migration and 
invasion [79,86,87]. CAMs are phenotypically more migratory and proliferative 
compared to myofibroblasts from non-cancerous stroma [88,89]. The functional role 
of myofibroblasts in cancer cells is not well understood. However, they have been 
shown to influence proliferation and metastasis of cancer through disruption of 
autocrine and paracrine signalling pathways [43,90].  It has also been shown that 
cross-talk between CAMs and epithelial cancer cells, termed stromal-epithelial 
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interactions, promotes cancer cell growth and induces malignant transformation 
[79]. A decreased sensitivity to chemotherapy has also been demonstrated in CAMs, 
partly due to hypermethylation of CpG DNA and reduced expression of caspase and 
STAT-1 resulting in escape from apoptosis of cancer cells [91].  
1.4.5 Mechanisms of intercellular signalling 
Cell-cell signalling is mediated by various substances including hormones, growth 
factors, cytokines and chemokines [92,93]. In each case, a ligand activates receptors 
on target cells. Where ligands are released in close proximity to target cells the 
mechanisms are collectively known as paracrine signalling. Where they are carried in 
the blood stream to their targets the mechanisms are known as hormonal signalling 
[94]. In some cases, ligands may even act on their cell of origin, known as autocrine 
signalling [95]. Within a tissue, there are frequent interactions that are two-way. An 
example of this is epithelial-stromal cell interactions, where both cell types can be 
the source of signalling ligands and can respond to them by paracrine mechanisms 
(Figure 1-4). 
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Figure 1-4. Schematic diagram highlighting paracrine and autocrine signalling 
within the tumour microenvironment. Cytokines released by the cancer cell 
stimulate the myofibroblast cell to release MMPs and uPA. VEGF is also released 
by the cancer cells and promotes angiogenesis. MMPs released by the 
myofibroblast activate receptors in the cancer cell as well as the myofibroblast’s 
own receptors. The continued release of these compounds results in cell 
migration, ECM degradation and continued release of growth factors, cytokines 
and chemokines. Adapted from [96]. 
 
Gut hormones are shown to be involved in regulating gut secretion, motility and 
growth. The best characterised of these include gastrin, cholecystokinin (CCK), 
secretin and somatostatin (SST) [97]. Cancer cells, stromal cells and epithelial cells 
are all potential sources of growth factors. There are multiple classes of growth 
factors including the families of EGF, IGF, VEGF, TGF-β, HGF, FGF, PDGF, Wnt, 
Hedgehog and Notch [98-102]. Most of these growth factor families play a role in GI 
mucosal regeneration [103]. Many cytokines, which are small cell signalling 
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molecules, are upregulated in cancer. They stimulate growth, differentiation and 
activation of immune cells [104]. Thus, they can either be classified as 
immunoregulatory or pro-inflammatory [104]. Chemokines are defined as 
chemotactic cytokines [105]. They are involved in metastasis and are vital for the 
infiltration of immune cells into the tumour site. Typically, the chemokines expressed 
in cancer belong to the inflammatory group and are induced by pro-inflammatory 
stimuli [105].  
As previously described, in order for the cancer cells to invade normal tissue, they 
must undergo EMT. Therefore, loss of cell adhesions and removal from the primary 
site is necessary. A study has shown that E-cadherin was higher when cancer cells 
were co-cultured with fibroblasts as opposed to cancer cells that were cultured in 
isolation [106]. Contrastingly, when these cancer cells were co-cultured with CAMs, 
the expression of E-cadherin was downregulated, highlighting the possible role CAMs 
play in the EMT of epithelial cancer cells [106]. TGF-β is also a known inducer of EMT 
in epithelial cells and plays a crucial role in tumour progression by downregulating 
epithelial adhesion molecules [107]. TGF-β can be secreted by both cancer cells and 
CAMs within the primary tumour site. When secreted by cancer cells, TGF-β can also 
induce expression of MMP-9 in myofibroblasts. MMP-9, along with MMP-2, 
selectively degrades the components of the basement membrane, further 
contributing to the proliferation of the tumour [108]. Another well-known 
mechanism in cancer is that many neoplastic cells secrete VEGF, which plays a crucial 
role in angiogenesis, an essential mechanism for the development of tumour 
malignancy [109]. The role of CAMs in this process has not been clarified. However, 
many types of fibroblast have been shown to release VEGF in response to IL-6. It has 
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been demonstrated that myofibroblasts and CAMs secrete the same amounts of IL-
6 when stimulated with TNF-α, an inflammatory factor [110]. Therefore, it can be 
hypothesised that some cytokine released from the cancer cells promotes transition 
of myofibroblasts to CAMs, resulting in the secretion of IL-6. Reports show that IL-6 
plays an important role in cancer progression [108]. Finally, it is suggested that the 
CAMs use paracrine and autocrine signalling to increase the proliferation of cancer 
cells, as well as the continued activation of the CAMs themselves, through 
unregulated secretion of pro-inflammatory and pro-tumourogenic molecules. 
1.4.6 Mathematical models of the gastrointestinal tract 
Current mathematical models of the GI tract focus mainly on the electrical activity of 
the stomach wall, specifically, the electrical activity that organises motility of cells 
[111-114]. All these models incorporate a multiscale approach combining complex 
experimental findings with sophisticated systems biology techniques (i.e. such as 
biophysical models [115], channelopathy models [116,117], smooth muscle cell 
models [118] and gastric electrophysiology models [111]) to create a ‘Virtual 
Stomach’ [114]. The experiments focus on co-regulation of gastric waves from 
spontaneous depolarisations of interstitial cell of Cajal (ICC) membrane potentials 
and smooth muscle cells (SMC), ultimately generating GI motility [119]. Anatomically 
realistic models were generated using magnetic resonance images (MRI) and CT 
scans, creating over 60,000 data points [111]. Simulation of the electrical activity of 
the stomach was achieved by adapting an existing finite element (FE) derived finite 
difference (FD) continuum model used for solving cardiac activation problems [120]. 
This model has been shown to successfully replicate many of the electrical features 
of the stomach, by solving five ODEs, to include the coupling of ICC-ICCs, ICC-SMCs 
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and SMC-SMCs. These models are still in their infancy and further refinement and 
validation is needed for a wider application [111]. For a detailed review of these 
models and the Virtual Physiological Human (VPH) see [112] and [121]. Alternatively, 
there are also models of intestinal crypts [122,123], which are similar but not 
identical to gastric crypts. Meineke et al. [122] present a lattice-free model 
representing the spatial arrangement and migration of cells within the intestinal 
crypt based upon a scoring system. This model also include cell division, where 
daughter cells form at the bottom of the crypts and existing cells shift upwards. 
Similarly, the work of Van Leeuwen et al. [123] incorporates cell division and 
replacement of the cellular epithelium within the intestinal crypt structure. 
Furthermore, the model has been extended to multiple scales meaning that 
subcellular cell signalling events affect the mechanical cues of the cell migration. 
It is evident from reviewing the literature that there are currently no computational 
approaches dedicated to the relationship between gastric cancer cells and CAMs. 
However, there are many models of cancer present in the literature, such as those 
models which describe stochastic and deterministic models of structured 
populations [124-127]. There are several themes present in these models that can be 
applied to the biological problem our current model is trying to answer. The first is 
to assume a constant population size in the cell mass [124]. At a macroscopic scale, 
the number of cancer cells in a given area may be approximated by a continuous 
density. This can be given by PDEs and any random spatial movements by the cells 
can be approximated as diffusion [125]. Not only can PDEs model the dynamics of 
tumour cell density, they can also model the tumour cells dependence on other 
diffusive factors, such as chemokines [126]. More sophisticated models exist where 
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the position, movement and state of each individual cell can be represented. This 
type of model is known as CA [127]. The dynamics of the cells in CA models are 
governed by a set of rules taking into account interactions with neighbouring cells 
and stimuli. The advantage of having each cell explicitly modelled is outweighed by 
the computational cost in this instance, as the aim is to develop a model that will 
highlight the dynamic behaviour between the cell populations of the gastric cancer 
cells and the CAMs. 
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1.5 Discrete modelling of single cell migration 
1.5.1 Basic cell structure 
The basic mammalian eukaryotic cell comprises of a variety of membrane-bound 
structures, a cytoplasm and a nucleus. Through the advancement of microscopy 
techniques, the basic structure and function of these fundamental units of life 
unfolded. Working inwards, the cell membrane is the outer boundary of the cell 
consisting of a bilayer of phospholipids [128]. The polarity of this double layer helps 
to facilitate the cell membranes role of regulating the exchange of substances 
between the external and internal cellular environments. The membrane surrounds 
the cytoplasm, which comprises cytosol (gel-like substance) and the organelles [129]. 
The major organelles suspended within the cytosol are the mitochondria, 
endoplasmic reticulum (ER) and the Golgi apparatus [130].  The mitochondria is the 
powerhouse of the cell and generates energy through a process called oxidative 
phosphorylation [131]. The ER is a transport network and one of its main functions is 
to transport newly synthesised proteins to the Golgi apparatus. The Golgi apparatus 
then completes the process of synthesising the proteins by packaging them in 
vesicles ready for exocytosis [130]. Finally, the nucleus is a membrane bound 
organelle responsible for controlling gene expression and replicating DNA during the 
cell cycle [132]. A cytoskeleton is also present in all mammalian cells. The 
cytoskeleton acts to maintain cell shape, anchor organelles in place and provide 
mechanical resistance to deformation [133]. 
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1.5.2 Cytoskeleton 
There are three cytoskeletal systems in mammalian cells: the actin cytoskeleton, the 
intermediate filament network and microtubules; all of which are involved in the 
regulation of cell motility. All three networks are interconnected and they are 
anchored at cell-ECM adhesions and at cell-cell junctions, providing the cell body with 
mechanical support [134]. The complexity of the cytoskeleton and its associated 
proteins have become clear through the advancement of molecular techniques. For 
example, it is widely understood that the cytoskeleton provides a structural 
framework for the cell, determining cell shape and cytoplasmic organisation, as well 
as being responsible for cell movements and internal transportation of organelles 
and other structures within the cytoplasm (Figure 1-5) [129]. In addition, 
disorganisation of the cytoskeleton has been associated with many pathological 
conditions, including cancer and cardiovascular diseases [135].  
1.5.2.1 The actin cytoskeleton  
The actin monomer (G-actin) is the basic building block of the actin filament (F-actin) 
[136]. Dimers and trimers are formed, through a process called nucleation, and rapid 
elongation of the filament commences. This elongation is a function of the available 
G-actin, the most abundant cytoskeleton protein in the mammalian cell [136]. Put 
more simply, each G-actin has binding sites that facilitate head-to-tail binding with 
two other G-actin monomers, resulting in polymerisation to form the F-actin 
filament. F-actin is a polar polymer with a right-handed helical twist [137]. The 
polarity stems from the identical orientation of G-actin and is important for further 
F-actin assembly (elongation) and for establishing a unique direction of myosin 
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movement, relative to actin. This polarity also results in F-actin having two 
distinguishable ends, called the plus (barbed) and minus (pointed) ends [137]. There 
is simultaneous assembly and disassembly of G-actin at the plus end and minus end 
respectively. This process is known as ‘treadmilling’ and is coupled with ATP 
hydrolysis [138]. 
F-actin plays an important role in epithelial cell cohesion, maintaining the integrity of 
cellular layers by a ‘belt’ of actin filaments, and in cell migration, as they are found in 
the plasma membrane protrusion where they form a ‘mesh’ [139]. F-actin can also 
promote edge retraction at the trailing edge of motile cells by converting energy, 
formed by ATP hydrolysis into tensile force. ATP hydrolysis is used by actin-associated 
myosin motor proteins to exert force against the stress fibres during muscle 
contraction [138]. Actin is essential for the survival of most eukaryotic cells as their 
filaments provide internal mechanical support, and force to drive cell movements as 
well as providing tracks for movement of intracellular materials. 
1.5.2.2 The intermediate filament network 
Intermediate filaments (IFs) are composed of one or more members of a large family 
of mainly cytoskeletal proteins. These can be classified into five major types. The first 
four types (I-IV) are cytoplasmic whereas type V IFs are located within the nucleus 
[140]. Type I and II are found in epithelial cells and are typically formed from acidic 
and neutral-basic keratins. Type III IFs are composed of homopolymers of vimentin, 
typically found in fibroblasts, as well as other cytoskeletal proteins such as desmin, 
peripheran and glial fibrillary acid protein (GFAP) [141]. Type IV and V IFs are 
expressed in the nervous system and are comprised of internexins and nuclear 
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laminins respectively [140]. Vimentin IFs preserve mechanical integrity of the cell by 
contributing to cytoplasmic stiffness and enhancing the elastic properties of the cell, 
suggesting that IF networks can adapt to mechanical changes in their environment 
[142]. 
1.5.2.3 The microtubules 
The microtubule is a heterodimer of α- and β-tubulin dimers [143]. These tubulin 
dimers are assembled in a head-to-tail manner culminating in the formation of a 
protofilament. These protofilaments (typically 13) associate laterally and assemble 
into tubular microtubule structures [144]. As with the actin polymers, the 
microtubule is intrinsically polar, with a plus and minus end, due to the organisation 
of the tubulin dimers in the protofilament [145]. For both F-actin and the 
microtubule, the plus end grows more rapidly than the minus. The minus end of the 
microtubule is anchored close to the nucleus of the cell in structures called 
microtubule organising centres (MTOCs), this is known as a centrosome [143]. 
Microtubules are responsible for separating chromosomes and for the long-range 
transport of large particles. Each individual microtubule elongates and shrinks to fulfil 
a specific role (i.e. chromosome alignment). This phenomenon is termed “dynamic 
instability” [146]. 
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Figure 1-5. Schematic illustration of major cytoskeletal components in motile 
cells. The cross-hatched region represents the actin framework of the 
lamellipodia. F-actin is present throughout the cell. Aging focal adhesions in the 
rear are disassembled to allow retraction. Intermediate filaments surround the 
nucleus (N), some of which associate with focal adhesions in the lamellipodia. 
Microtubules are polarised along the direction of migration and accumulate 
toward the front of the cell. Adapted from [147]. 
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1.5.3 Role the cytoskeleton plays in cell migration 
The ability to migrate is one of the most remarkable properties of animal cells. To 
date the majority of the research carried out has been conducted on two-
dimensional (2-D) surfaces, mainly for experimental convenience [148]. This research 
has been pivotal in our understanding of how cells migrate. A large percentage of 
cells migrate primarily within the ECM: during development, specialised cells 
manoeuvre within the embryo to reach their correct orientation, and in disease, 
cancer cells migrate from the primary tumour to metastasise secondary sites [149]. 
Fibroblasts often play a crucial role in the cell migration, for example in wound 
healing by migrating to the wound site and secreting extracellular matrix (ECM) 
proteins, such as collagen, glycosaminoglycans and glycoproteins, to maintain the 
structural integrity of the connective tissue [150]. 
It is generally understood that there are four steps involved in the cycle of cell 
migration (Figure 1-6) [147]. The first step is the formation of a protrusion, called the 
lamellipodia, at the front of the cell in response to biochemical and mechanical 
stimuli. Next, formation of new focal adhesions at the leading edge strengthen the 
cells attachment to the ECM. Third, increased activity of the actomyosin increases to 
reduce retraction of the rear. Finally, focal adhesions within the cell rear are 
dissembled to facilitate the forward movement of the whole cell body [138,151,152]. 
The dynamic formation of lamellipodia is regulated by local actin filament assembly 
and disassembly. During migration, these formations push the cell membrane 
forward to explore the surrounding environment. Depending on the suitability of the 
surrounding environment, the cell will either extend further forward or retract. There 
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are two patterns of actin assembly in lamellipodia, branching and elongation, which 
promote the formation of the actin mesh [153]. Focal adhesions, which are a type of 
adhesive contact between the cell and ECM, are actively assembled and 
disassembled in the front and tail of the cell, respectively. At the site of focal 
adhesion, the extracellular domains of transmembrane integrins connect to the ECM 
whilst their intracellular tails form attachments to linker proteins, such as vinculin 
and talin, which in turn bind to the actin cytoskeleton [147]. This chain of connections 
allow the cell to crawl along the ECM during migration. Subsequently, the triggering 
of this focal adhesion assembly results in the recruitment of structural proteins (α-
actinin, talin, vinculin) and signalling proteins, including focal adhesion kinase (FAK) 
[154]. These structural proteins help to strengthen the attachment to the actin 
cytoskeleton and the signalling proteins promote further actin polymerisation and 
other pathways [155]. Further, after the connection between the ECM and actin 
cytoskeleton has been established, via focal adhesions, external signals induce stress 
fibre assembly. Stress fibres are contractile bundles containing both F-actin and 
myosin II filaments. The assembly of these stress fibres generates traction, via the 
activation of the actomyosin ATPase, propelling the cell forward [147,156]. 
IFs have been shown to physically interact with focal contacts in the lamellipodia, 
raising the possibility that they directly regulate focal adhesion dynamics, and thus 
cell migration. Cells which express high concentrations of vimentin have been shown 
to exhibit increased focal adhesion dynamics and destabilised desmosomes 
[157,158]. As IFs are widely distributed in the cytoplasm, they have also been shown 
to regulate cell contraction and nucleus rigidity. In most motile cells, microtubules 
do not enter the lamellipodia [159]. However, some pioneer cells can extend to the 
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protrusion sites. It is likely that microtubules promote the delivery of vesicles that 
are essential for cell protrusion [159]. They also promote the polarised delivery of 
integrins to the leading edge and facilitate the assembly and disassembly of mature 
focal adhesions within the cells rear, concluding that microtubules play a key role in 
cell protrusion and contraction [159]. 
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Figure 1-6 Schematic representation of the steps in 2D cell migration. 1. The 
extension of a lamellapodium. 2. The formation of a new adhesion. 3. The 
translocation of the cell body. 4. De-adhesion and retraction at the trailing edge. 
Adapted from [160]. 
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1.5.4 The role of mechanotransduction 
Mechanotransduction is a process whereby cells can sense their physical 
surroundings by converting mechanical stimuli into biochemical signals, via the 
activation of diverse intracellular signalling pathways [161]. This complex process is 
not yet fully understood. However, it is known that stretch-sensitive ion channels are 
key regulators of mechanotransduction [162]. The ECM of connective tissues bears a 
considerable physical load and provides protection to embedded cells from excessive 
mechanical forces [163]. Fibroblasts, which are abundant in connective tissues, firmly 
attach to the ECM, via focal adhesions. The link from ECM to the internal architecture 
of the cell, allows the propagation of mechanical forces in both directions. The 
opposing forces, felt internally and externally by the cell, cancel each other out in 
stationary cells [160]. However, an imbalance of force in either directions leads to 
cellular movement [164]. Due to these dynamic interactions, fibroblasts are able to 
use their adhesion contacts to sense the mechanical properties of the surrounding 
extracellular environment [165]. One of the ways in which fibroblasts gain 
information about the elasticity of the surrounding ECM is by pulling on an adhesion 
contact [160]. If there is resistance to the pulling of the fibroblast, this would indicate 
a stiff ECM and lead to the reinforcement of the focal adhesion site; conversely, any 
instability detected, via this mechanism, can result in the disassembly of focal 
adhesions and retraction of the cell [164,166]. Therefore, changes in a cells ability to 
respond to forces are associated with certain disease states, including; muscular 
dystrophies, cardiomyopathies, cancer progression and metastasis [161,167]. This 
process is the driver for the behaviour to be modelled in relation to fibroblasts 
reacting to their physical surroundings. By mimicking the ECM through patterned 
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surfaces, a model of the migrating cells can be built to predict how the fibroblast cells 
react to certain features. 
1.5.5 Replication of Extracellular Matrix (ECM) features 
The interaction between a cell and its environment is pivotal for many cellular 
behaviours such as migration, division, differentiation and proliferation. In-vivo, cells 
depend on an interaction with the ECM scaffold. In order to replicate this 
environment, significant research has focused on the development of cell substrates 
that mimic the features of the ECM [168-170]. This has largely been achieved by 
developing surfaces which have specifically designed features with defined 
geometries and sizes on a range of different materials. For example, surfaces 
patterned with micro- and nano-scale grooves [171], pillars [148] and pits [172] have 
been shown to influence cell adhesion [173] and migration [174] of a range of 
different cell types. 
Although many methods are available for creating and modifying the topography of 
patterned surfaces, the most widely used technique involves placing a template mask 
over the surface that is due to be processed, thereby leaving a predetermined 
pattern. Such an approach can be seen in lithography-based approaches including; 
electron beam lithography [172,175,176], photolithography [171,177,178] and X-ray 
lithography [170,179]. The advantages to using these methods are evident in the 
wide range of well-defined geometries that can be produced on the substrates. 
However, the equipment they utilise is often expensive and time-consuming. A more 
effective method in the creation of micro-patterned surfaces is laser processing. 
Laser processing is a quicker, direct-write and flexible process [169]. It is also capable 
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of processing relatively large areas by a single exposure. Finally, abrasive polishing 
methods, which have so far been largely overlooked, can also develop textured 
surfaces comparable to those produced by lithography-based methods whilst also 
being cost-effective. It has been shown that abrasive polishing can produce 
patterned polyurethane surfaces having ordered, or random, nanoscale features that 
can affect cell adhesion and migration [180]. Note that because of this utility and cost 
effectiveness, an abrasive polishing method was chosen to create patterned surfaces 
for the migration experiments in this thesis. 
Machine grinding was used for this purpose to generate the topographical patterns 
on the polyurethane surfaces. This method involves the micro-patterning of stainless 
steel, which can then be used to cast polymer substrates for observing the migration 
of fibroblasts [180]. An unprocessed plain polymer surface was used as a control and 
was labelled as ‘Flat’. Next, a pattern of parallel lines was cast on the polymer surface 
and was labelled as ‘Linear’. Finally, a pattern of random lines varying in direction 
was etched into the polymer surface and labelled appropriately as ‘Random’. 
Subsequently, a previous study has shown that these machine ground surfaces 
promote adhesion and migration in fibroblast cells compared to unprocessed, flat 
surfaces [180].  
1.5.6 Mathematical models of cellular movement 
In-silico simulation aims to model cellular movement through the use of complex 
numerically implemented mathematical methods, with the goal of facilitating better 
understanding of the phenomena and its role in wound healing, tumour growth and 
tissue formation [181-186]. As previously described in section 1.3.1, these models 
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can be classified as continuous or discrete. As continuous models can be used to 
describe the average of cell populations with continuum variables, cell movement 
can be defined in terms of cell density and average velocities. This method has been 
utilised in the description of adhesion [187], wound healing [188-191] and 
angiogenesis models [192]. For example, continuum models of wound healing have 
been used qualitatively, in a predictive capacity, to aid the understanding of the 
complex underlying mechanisms involved in wound contraction. Murray et al. [190] 
use a base model, with three simplified assumptions, to describe the wound 
contraction mechanism of wound healing only. Qualitatively, there were problems 
when the model output was compared to contraction curves. However, extensions 
of this model, through functional changes of the cell function, allowed incorporation 
of alternative mechanisms of contraction resulting in several scenarios that can be 
considered for further novel in-vitro wound healing assays. Additionally, Arciero et 
al. [188] proposed a two-dimensional continuum model were cell migration occurs 
collectively in a sheet, based on mechanical principles governing its motion [193], 
such as those described in Figure 1-6. This model was able to capture known 
quantitative and qualitative features of a migrating cell layer, with calibration to data 
from scratch wound assays. Although these methods are advantageous in terms of 
requiring less computational power, they require more assumptions than discrete 
models, the individual cell movement cannot be tracked and dynamical individual cell 
behaviour cannot be predicted. However, if cells are interpreted as discrete 
elements, then each cell can be defined as an individual, whose properties can be 
modelled in relation to its position within a cell population [194], the local chemical 
and mechanical environment [195-198], or any other external stimuli that could 
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regulate cell behaviour. This distinction is important for the creation of the cell 
movement model (Chapter 3) proposed as it takes into account the mechanical 
environment that surrounds the individual cells. 
It is clear that mathematical modelling of the movement of cells has great relevance 
in the field of biology. Again, there are many different forms of cell movement 
models. However, the most widely used are based on the extensions of simple 
random walk processes [199]. It is these models that I will base the model for Chapter 
3 upon, as they incorporate random movement or Brownian motion into their 
assumptions. Brownian motion can be described as the random movement of 
particles due to their collisions with other atoms and molecules. This concept is 
named after Scottish botanist Robert Brown, who in 1827, observed pollen grains 
moving randomly in the water [200]. However, he was unable to explain the 
phenomena he had observed and it remained undescribed until 1905, when Albert 
Einstein published a paper explaining that the fast-moving water molecules in the 
liquid moved the pollen [201]. The Weiner process is often used to model Brownian 
motion in cell migration models. The Weiner process is defined as a continuous-time 
stochastic process and is named in honour of Norbert Weiner. Brownian motion is 
considered a Gaussian-Markov process, it has normally distributed random variables 
over a continuous time constant and is considered a memoryless process [199]. 
These walks are uncorrelated and unbiased. Correlated random walks (CRWs) involve 
correlation between successive step orientations, which is termed as ‘persistence’. 
This creates a directional bias where the influence of the initial direction of motion 
gradually diminishes over time [202]. These types of models provide a lot of potential 
in terms of implementing a bias term and can apply to a lot of different situations. 
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For instance, a global directional bias can be introduced by making the likelihood of 
a cell migrating in a particular direction greater. This is most common in chemotaxis 
models where fixed external environmental factors are applied [203,204]. The goal 
is to utilise these models and modify the bias term so that it represents a mechanical 
gradient on the surface that the cells migrate upon. 
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1.6 In-silico approaches to protein signalling networks  
1.6.1 Structure and function of the Nrf2 protein 
The engulfment of aerobic mitochondria by our single cell ancestors, yielded higher 
energy through effective respiratory processes and facilitated the inception of more 
complex life forms. However, the cost of this ‘upgrade’ to the host cell was the 
requirement for an efficient detoxification system to deal with the constant 
production of reactive oxygen species (ROS), which are associated with normal 
mitochondrial activity [205]. More efficient respiration due to oxidative 
phosphorylation results in more ROS being produced. This symbiotic relationship 
significantly contributes to the process of aging and all age-related diseases. The 
aerobic cell defends itself by encoding sensor proteins that react to ROS by turning 
on a collection of cytoprotective antioxidant genes through transcription. The 
nuclear factor erythroid 2–related factor 2 (Nrf2) performs a central role in this 
process, regulating around 1% of human gene expression, many of which perform 
powerful protective functions [206]. Therefore, an increase in ROS leads to a higher 
production of Nrf2 and subsequently, an increase in the transcription of antioxidant 
genes. 
The Nrf2 coding sequence was first characterised by Yuet Wai Kan [207], who 
revealed that Nrf2 was able to bind activator protein-1 (AP-1) and the NEF-E2 tandem 
repeat consensus DNA sequence. The Nrf2 protein belongs to the Cap’n’Collar family 
of proteins (CNC) and to the subfamily of basic leucine zipper (bZIP) proteins 
[208,209]. The transcriptional activity of the Nrf2 protein requires the formation of a 
heterodimer complex with another member of the bZIP subfamily, the small MAF 
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(sMaf) proteins [210]. This interaction facilitates binding to a cis regulatory DNA 
element called the Antioxidant Response Element (ARE), which is contained within 
the promoters of Nrf2 target genes [209,211]. The key characteristic of this 
transcription factor is its very low basal activity and its stringent regulation, as the 
half-life of Nrf2 protein has been estimated to last only 10-30 minutes [212]. The 
stability of Nrf2 dramatically increases as a result of diverse stimuli including plant-
derived phytochemicals and intracellular and extracellular stress factors, such as 
ultraviolet (UV) and gamma (or ionising) radiation, electrophiles, pollution, 
inflammation and ROS [211,213]. Expression levels of the Nrf2 protein are primarily 
controlled at a post-transcriptional level, through an interaction with proteins that 
trigger proteasome mediated degradation [206,210].  
The best understood negative regulator of Nrf2 is the Kelch-like ECH-associated 
protein (Keap1), which is an actin-bound zinc metalloprotein that acts as an E3-ligase, 
facilitating the attachment of ubiquitin chain to Nrf2 [214]. Keap1 binds as a dimer 
to the Neh2 domain within Nrf2 forming bonds with the high affinity ETGE and low 
affinity DLG amino acid sequences. This interaction brings the Nrf2 protein into 
proximity with Cullin3 and Ring Box 1 (Rbx1), which then catalyse the process of 
ubiquitin attachment (Figure 1-7) [215]. Keap1 is located mainly in the cytosol where 
it constantly sequesters Nrf2, thereby restricting basal Nrf2 activity to very low levels. 
An unusually high number of reactive cysteine (Cys) residues are encoded within 
Keap1 (27 Cys residues), which makes it an extremely sensitive sensor of oxidative 
stress, with C151, C257, C273, C288 and C297 being especially sensitive to oxidation 
[211,216]. The oxidation of thiols within Cys residues leads to the formation of 
disulphide bridges between cysteines, resulting in a conformational change in Keap1 
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protein structure, which in turn prevents the effective ubiquitination and 
degradation of Nrf2 [215,217]. 
Newly formed Nrf2 proteins will still bind to free Keap1 dimers. However, as Keap1 
becomes saturated, free Nrf2 is then allowed to enter the nucleus, where it will 
subsequently heterodimerise with sMaf and bind to ARE containing promoter 
sequences (Figure 1-7) [215]. Therefore, antioxidant pathway activation will rely on 
Nrf2 protein synthesis to overcome the levels of Keap1, which are usually present in 
cells, at very low (near-saturated) levels [218]. The Keap1/Cull3/Rbx1 complex is 
extremely robust and efficient in restricting Nrf2 protein expression. However, 
several other negative regulators of Nrf2 protein expression have been described. 
Glycogen synthase kinase 3 (GSK-3) is a serine/threonine kinase and is encoded by 
two isoforms (GSK-3α and GSK-3β) [219]. GSK-3 is active basally and requires priming 
phosphorylation of its targets, which then prompts further attachment of a 
phosphate group onto a serine or threonine residue. In the presence of glucose, the 
insulin/Akt/PI3K pathway leads to GSK-3 phosphorylation at Ser9 (β isoform) and 
Ser21 (α isoform), which terminates its activity [219]. Nrf2 is also a target for GSK-3 
phosphorylation, on the Neh6 domain, facilitating docking of the β-TrCP E3 ubiquitin 
ligase and formation of the β-TrCP/Skp1/Cull1/Rbx1 complex, which like 
Keap1/Cull3/Rbx1 catalyses the ubiquitination of Nrf2 and subsequent degradation 
[220,221]. While Keap1 is thought to dominate the control of cytoplasmic Nrf2 levels, 
the GSK-3/β-TrCP axis is thought to be predominantly active in the nucleus, directing 
Nrf2 protein for nuclear proteasomal degradation [220]. Ultimately, Nrf2 controls the 
transcription of over 200 genes and depending on the tissue context, these genes 
have prominent roles in the maintenance of redox status and the generation of 
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reducing equivalents, protein folding and degradation, cell metabolism, calcium 
homeostasis and drug metabolism [222,223]. 
It is clear from the research described above that Nrf2 is a key transcriptional factor 
in the regulation of cellular response to oxidative stress. However, in most tissues, 
cells are not only exposed to frequent changes in levels of oxidative stress, but also 
inflammation [224]. The key transcriptional factor controlling cellular response to 
inflammation is nuclear factor-κB (NF-κB) and it has been shown, through 
pharmacological [225,226] and genetic [227,228] studies, that there exists a 
functional cross-talk between these two important regulators. 
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Figure 1-7. Keap1-dependent Nrf2 regulation. Schematic diagram of the Nrf2 
pathway. Nrf2 is sequestered by Keap1 under normal conditions and the complex 
closes allowing attachment of the ubiquitin chain. Keap1 is then recycled and 
binds to another Nrf2 molecule. During oxidative stress, there is a modification of 
cysteine residues on Keap1 by oxidation or attachment of electrophilic 
compounds. Keap1 is unable to form the closed complex and therefore catalyse 
the ubiquitin attachment. The newly made Nrf2 is then accumulated in the 
nuclear space and leads to the transcription of ARE genes. 
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1.6.2 Structure and function of the NF-κB protein 
The NF-κB transcription factor mediates immune responses to bacterial and viral 
infections, as well as initiating gene expression supporting inflammation, cell 
development, proliferation, anti-apoptotic pathways, oxidative metabolism and 
protection against UV radiation [229-231]. NF-κB is actually a family of transcription 
factors including RelA (p65), RelB, c-rel, p50 and p52 subunits, which act as homo- or 
hetero-dimers [232]. Only the p65, RelB and c-rel contain the transactivation domain 
required to drive transcription [233]. The p50 and p52 subunits are detected basally 
in the nucleus of unstimulated cells and are thought to have an inhibitory effect on 
gene expression, exerted by blocking DNA sequence availability [232,233]. A complex 
network of protein interactions usually initiated by an extracellular stimulus (e.g. 
stress, cytokines, free radicals, bacterial and viral antigens) mediates NF-κB signalling 
[234]. The NF-κB subunits form homo- and hetero-dimers through their Rel 
homology domains (RHD), which are also necessary for their dimerization, DNA 
binding and association with the IκBα inhibitor [232,234]. 
The p65/p50 (NF-κB) heterodimer is sequestered in the cytoplasm by association 
with IκBα, which obscures one out of two NLS and limits its nuclear entry 
[232,235,236]. Importantly, NF-kB gene transcription is inducible by variety of stress 
stimuli and over 150 different factors have been identified as activators of NF-kB 
mediated gene expression: e.g. LPS, exotoxin B, muramyl peptide, viruses e.g. 
Hepatitis B, Adenovirus, Herpex Simplex Virus-1, HIV, cytokines, but also physical 
stress, UV radiation, shear stress, ischemia oxidative stress and environmental 
hazards [237,238]. NF-κB plays a central role in the maintenance of the immune 
responses by initiating the genetic program designed to modulate the local 
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environment and to attract the immune cells to the site of infection or injury. It was 
found to mediate the expression of approximately 300 genes, including numerous 
cytokines and their receptors, anti-apoptotic genes and adhesion molecules 
[238,239]. 
TNFα is one of the best-studied cytokines and is a potent activator of NF-κB -
mediated gene expression, playing an important role in systemic inflammation and 
the induction of fever [240,241]. It has pleiotropic effects as it can induce a range of 
cellular responses such as proliferation, chemotaxis, apoptosis and inflammation, as 
its downstream signalling can trigger several molecular cascades [242]. Pro-
inflammatory cytokines such as TNFα and IL-1β activate the canonical signalling 
cascade by engaging their extracellular receptors and initiating a relay of intracellular 
phosphorylation events, which co-ordinate signalling and conditional cell responses 
[243]. Activation of the TNFR1 receptor initiates the TRADD/RIP signalling cascade, 
which removes the phosphate group from the IKK kinases complex, comprised of the 
IKKα and IKKβ catalytic subunits and IΚKγ (NF-κB essential modifier, NEMO) (Figure 
1-8). IKK activation results in the phosphorylation of IΚBα on Ser32 and Ser36 and 
parallel activation of several kinases, such as MAPK p38, JNK [232,234,242]. 
Phosphorylation primes IΚBα for interaction with the β-TrCP/Skp1/Cullin1 complex, 
which drives IΚBα ubiquitination and proteasomal degradation, finally releasing the 
NF-κB subunits to the nucleus [244].  
The entire signalling process from TNFR1 activation to κB transcription is very rapid, 
taking place within minutes [234]. The activation of inflammatory gene transcription 
also initiates multiple negative feedback loops, which prevents the inflammatory 
signalling uncontrollably increasing. The IΚBα protein is one of the earliest gene 
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targets of NF-κB signalling, in response to the TNFα cytokine. Shortly following 
translation, IκBα localises to the nucleus and removes p65 from the DNA, and 
sequesters it back into the cytoplasm [245]. In addition, NF-κB also transcribes the 
deubiquitinating enzyme (DUB) A20, which terminates the signalling cascade 
upstream of the IΚK complex by modification of the receptor interacting protein 
(RIP), which is essential for TNRF1 receptor signalling (Figure 1-8). The A20 protein 
removes Lys-63 chains from the RIP protein leading to Lys-48 ubiquitination and 
targeting for proteasomal degradation, leading to inactivation of the downstream 
phosphor-relay signalling [246,247]. Therefore, both IΚΒα and A20 create safety 
loops which can terminate the signalling from the inflammatory signalling. 
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Figure 1-8. The Canonical NF-kB Pathway. Schematic diagram of the NF-kB 
pathway. The canonical/classical pathway of NF-κB activation involves 
inflammation that triggers a downstream cascade of ubiquitination and 
phosphorylation events leading to nuclear occupancy of p65/p50 heterodimers. 
The p65/p50 dimer then translocates to the nucleus and mediates transcription 
of κB driven genes. 
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1.6.3 Molecular cross-talk between Nrf2 and NF-κB response pathways 
The initial insights to an existing functional cross-talk between the Nrf2 and NF-κB 
pathways came through the study of Nrf2 knockout (KO) mice, which exhibit a 
phenotype of neurodegeneration. This loss of Nrf2 results in enhanced NF-κB 
dependent inflammation via the augmentation of cytokines [227]. Moreover, further 
studies have shown comparable results of amplified cytokine production in mouse 
models lacking Nrf2, resulting in pronounced levels of NF-κB activity [228,248,249]. 
Additionally, pharmacological studies focusing on the application of Nrf2 activating 
phytochemicals, such as sulforaphane (SFP), or synthetic inducers of Nrf2, such as 2-
cyano-3,12 dioxooleana-1,9 dien-28-imidazolide (CDDO-Im). The result of these 
studies concluded that pre-stimulation of Nrf2 caused a dampening of inflammatory 
cytokines and therefore a decrease in NF-κB activity [225,250]. Furthermore, HO-1 is 
an Nrf2 target gene and is central to the Nrf2-mediated inhibition of the NF-κB 
response pathway [251]. Finally, another link between these two pathways is the 
Keap1 protein [252]. Aside from its regulatory role in the Nrf2-ARE pathway, Keap1 
has been found to inhibit the phosphorylation and degradation of IKKβ. This 
ultimately leads to the stabilisation of IKKα and the negative regulation of NF-κB 
[252]. Despite this evidence, many aspects of the cross-talk dynamics remain 
unknown. As such, many important features of co-regulation, feedback loops and 
competitive binding remain undefined. However, the importance of this cross-talk 
cannot be understated, as these pathways regulate the fine balance of cellular redox 
status and response to stress and inflammation. Deeper understanding of these 
cross-talk points can facilitate in the identification of therapeutic targets, as the anti-
inflammatory potential of the Nrf2 protein can be utilised in the treatment of many 
50 
 
neurodegenerative diseases, such as amytrophic lateral sclerosis (ALS), multiple 
sclerosis (MS) and Parkinson’s disease (PD) [253-255]. 
1.6.4 Mathematical models of NF-kB and Nrf2 
In a recent review, Quanstrom et al [256] discussed the current state of 
computational modelling of the NF-kB signalling pathway. There have been a number 
of computational models developed of the signalling pathway over the past two 
decades. It is increasingly appreciated that the robustness of various cellular 
processes (i.e. signalling pathways, regulatory mechanisms) is rooted in the dynamic 
interactions among the cell’s many constituents, such as proteins, DNA, RNA and 
small molecules [256]. A significant body of knowledge has been generated through 
wet-lab experimentation since the discovery of NF-κB in 1986. Recently, equation-
based and agent-based models have been used within a predictive capacity to 
generate hypotheses for testing through this supportive wet-lab experimentation 
[257-259]. The first model of NF-κB dynamics used mass action derived kinetics to 
focus on IκBα association and dissociation rates, along with IκBα and NF-κB nuclear 
import and export rates [260]. Hoffmann et al [261], then developed an ordinary 
differential equation (ODE)-based model that incorporated the wider NF-κB network, 
including the other IκB isoforms. This model also focuses on reactions that affect IκB 
dynamics, paying particular attention to the temporal control of NF-kB activation 
through the coordinated synthesis and degradation of IκB proteins. Other authors 
have since built on this deterministic ODE model by performing new wet-lab 
knockout experiments on IκB isoforms [262] and recalibrating the model with 
outputs from single cell analysis rather than population-based wet-lab experiments 
[263]. This approach yielded the first working model to show NF-κB oscillations at the 
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single cell level. In recent years, additional components of the pathway have been 
added by various authors, to include IKK, A20 and their subsequent feedback loops 
[264]. An alternative method is to model cells or molecules individually and assign 
probabilities to each possible interaction or state change through rule-based 
techniques. It may then be aggregated up to system-level dynamics, to be 
extrapolated in order to make predictions of the system-level behaviours in the real 
biology [265,266]. The first such agent-based model of NF-kB used the concept of 
communicating X-machines, which is a formalised version of an ABM, to represent 
the individual agents and their associated interactions [267]. An important aspect of 
communicating X-machines is that each agent has memory, which in this instance, 
holds the current physical location and current state to further instil stochasticity into 
the model. Graphical visualisation of the resulting reactions then allows us to view 
the dynamics of the system over time. However, it has been argued by several groups 
that the complexity of such models makes them too computationally expensive to 
run and also requires complicated analytic tools to make inferences from the 
simulated results. 
In contrast, computational models of the Nrf2 pathway are limited, with work mainly 
focusing on in-vivo and in-vitro models [268]. Khalil et al [269] developed a model 
describing the Nrf2-keap1-dependent mechanism of redox homeostasis regulation 
and Nrf2 signalling. This kinetic model of Nrf2 signalling comprises 16 ODEs with 
parameters that were chosen based on experimental data. The model they proposed 
captures the Keap1-dependent degradation of Nrf2, and gene regulation of the 
antioxidant system. This lack of published Nrf2 models is a consequence of the 
limited quantitative data available. Due to the lack of in-silico models available in the 
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literature, a minimalist approach was taken in the process of the model build i.e., 
only key components were included based on a review of the literature. Additionally, 
the parameter values from the Khalil et al. paper will be used as initial estimates for 
the parameter optimisation.  In this thesis, a quantitative model of the Nrf2 pathway 
(Chapter 4) combining mathematical assumptions with raw experimental data is 
proposed. This data will be used to inform and validate the model in the hope of 
extracting vital information regarding the dynamical interactions of the individual 
pathway components. This illustrates the novelty of the work being carried out in this 
study. In addition, a further petri-net (PN) model is to be developed, incorporating 
both the Nrf2 and NF-kB response pathways (Chapter 5), and highlighting the areas 
of cross-talk in an effort to draw conclusions on the cyclic behaviour of their 
interactions, based upon feedback loops of activation and inhibition. 
Although quantitative mathematical models are well established tools for modelling 
complex biological phenomena, they typically require an exhaustive set of kinetic 
parameters to be estimated for each reaction. This approach is manageable for 
smaller models that align to the dynamics of a few components. However, these 
models tend to suffer from limitations in accuracy as the scale and complexity of the 
model is increased to capture more realistic details at a system-level. As such, we 
utilise minimal modelling for the creation of the Nrf2 quantitative system, as they 
have been shown to replicate the majority of the phenomenological behaviours with 
the minimum number of equations possible [270-273]. An alternative approach is 
PNs. The classical PN is a directed bipartite graph [274]. The two types of nodes are 
called places and transitions. In a PN, places and transitions are connected via arcs. 
Places are graphically represented by circles, transitions by boxes or bars. Places can 
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store tokens, represented by black dots or numbers. A distribution of tokens on the 
places of a net is called a marking, and corresponds to the “state” of the PN [275]. A 
transition of a net is enabled at a marking if all its input places (the places from which 
some edge leads to it) contain at least one token. An enabled transition can fire: it 
removes one token from each of the input places, and adds one token to each of its 
output places. This is called the firing rule. This flow of tokens represents the 
dynamical behaviour of the model [276]. While such approaches somewhat relax the 
necessity for biologically exact kinetic parameters, current PN-based approaches still 
require the selection of weights and/or probability distributions for individual 
interactions in the model. As a result, selecting the values for PN parameters presents 
challenges similar to those encountered in ODE modelling. PNs have been extensively 
used for simulating the dynamics of signalling networks [277-280]. These PN models 
are constructed with the same framework as described above. Places represent the 
entities within the signalling pathway, such as proteins. Transitions represent 
processes such as enzymatic reactions and lead to new places which represent the 
outcome of the process i.e., binding of proteins. Token numbers are equivalent to 
the amount of protein present and can be weighted to specific reactions. For 
example, in the Nrf2 pathway two keap1 tokens would react with one token of Nrf2. 
In general, the following steps are followed in model design [279]: 
1. Identification of the key events in the selected pathway 
2. Identification of objects related to the key events that also need to be 
represented as places 
3. Identification of the interactions between the objects, which are then 
represented by transitions 
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1.7 Thesis outline 
In this thesis, there is a combination of experimental data with mathematical 
formulae to produce several in-silico models depicting cellular phenomena across a 
range of individual scales (macroscopic, mesoscopic and microscopic).  The 
advantage and novelty to creating mathematical models in this way, results from the 
higher accuracy achieved through the utilisation of experimental data. Furthermore, 
the models proposed in this thesis, require less theoretical assumptions or 
estimation of parameters.  
Chapter 2 describes a continuous macroscopic in-silico model of the tumour 
microenvironment of the gut. The model was reduced so that only the cancer and 
immune cells involved in the experiments are relevant in the model. This continuous 
model is used to determine the dynamic nature of the interactions between the cells 
and provide insight into the underlying mechanisms of cell-cell communication.  
Moving down a scale, Chapter 3 describes a discrete model of individual fibroblast 
migration. This model incorporates cell migration mechanics with surface 
topography to assess the effect of differing topographical features on cell speed and 
direction. Microscopy image data was uploaded into the model the simulated 
migration paths were compared to the experimental observations to determine 
which, if any, of the surface features resulted in more directed cell migration of the 
fibroblast cell.  
Continuing with the progression down biological scales, Chapter 4 describes a 
molecular quantitative model depicting the processes involved in the life cycle of the 
Nrf2 protein. These processes include the production, translocation, degradation and 
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decay of the protein. A minimal model was generated to describe these components 
based on ODEs. Parameterisation and fitting of the model resulted in quantitatively 
derived values for the kinetic rates in the equations. Subsequently, the model was 
able to provide kinetic rates describing the dynamics of the Nrf2 protein. 
Finally, staying on the microscopic scale, Chapter 5 describes the interaction of the 
Nrf2 protein with the NF-κB protein. The pathways of both these proteins are 
extensive with multiple cross-over points. Therefore, these pathways were reduced 
to their key functional components, through analysis of the relevant biological 
literature. As with Chapter 4, the model comprises the production, translocation, 
degradation and decay of the proteins. However, this model also includes activation 
and inhibition of the proteins as part of the mechanism of cross-talk between the 
pathways. This model was used to provide important insights into the dynamic 
properties of the cross-talk mechanisms that were not feasible through 
experimentation alone. 
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Chapter 2: Systems Biology of the Tumour 
Microenvironment 
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2.1 Introduction 
In this chapter, a continuous macroscopic in-silico model of the tumour 
microenvironment of the gut is introduced. More specifically, a model that aims to 
investigate the underlying mechanisms involved in the interaction between epithelial 
cancer cells (AGS) and stromal myofibroblasts (308/1). As previously mentioned in 
Section 1.4, both of these cell types reside in the gastrointestinal tract. Due to the 
harsh nature of this environment, continued maintenance and regulation of the 
gastrointestinal tract epithelium is essential. When this epithelial layer becomes 
compromised, through inflammation and cancer, myofibroblasts form a key part of 
the immune response. They are involved in many vital processes of wound healing, 
such as tissue remodelling [46] and re-epithelialisation [47]. Myofibroblasts regulate 
these processes through secretion of cytokines and other factors, such as TGF-β [52]. 
Again, as highlighted previously cancer can be considered as a wound that does not 
heal [66]. The inflammatory response from the presence of these cancer cells 
promotes the recruitment of myofibroblasts to the cancer site, where they can 
undergo phenotypic changes and become designated as CAMs [74]. The functional 
role of these CAMs and the underlying mechanism of the cell-cell signalling between 
them and the cancer cells is not very well understood. However, as it is abundantly 
clear that myofibroblasts release a plethora of chemicals in response to stress (i.e. as 
a result of injury caused by inflammation and cancer), this will form the basis of the 
investigation into the mechanism at play between the cells. In-silico models allow us 
to study dynamics of biological cells which cannot be easily defined using 
experimental approaches. The strength of the modelling in this chapter is based upon 
58 
 
the experimental data that is used in its design. To my knowledge, there are no 
existing models in the literature based upon the interaction between these cell types. 
The experimental approach to the problem in this chapter involves carrying out cell 
migration assays on both cell types simultaneously. Ordinarily with these types of 
experiments, a scratch wound assay is performed on a monolayer of the first cell type 
in the presence of complemented media from the second cell type [281]. However, 
in the experiments described in this chapter, there is a monolayer of both cell types. 
These monolayers are separated by a uniform gap, created through the use of a gel-
insert. This allows the interaction between the cells to be recorded via time-lapse 
microscopy, with the resulting data utilised to create and inform the model. The key 
hypothesis is to investigate whether a ‘chemical inhibitor’ produced by the 
myofibroblasts is the driver (i.e. main influencer) of the observed cell migrations. 
In summation, this chapter describes the evolution of a continuous model from a 
simple diffusion based approach to a system that incorporates chemotaxis and 
density-based diffusion. By using computational approaches to reproduce properties 
that the biological system displays, a better understanding of how the mechanism of 
interaction between the myofibroblast cells and the cancer cells can be discovered 
[282]. It is important to stress that the models in this chapter are semi-quantitative. 
In other words, the research is primarily explorative and the models are being used 
to gain an understanding of the underlying interactions between the different cell 
types. 
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2.1.1 Chapter aims 
1. To complete in-vitro experiments on AGS and 308/1 cells. 
2. To use in-vitro results to develop an in-silico model that best describes the 
phenomena captured by the experimental data. 
3. Compare simulated output to the experimental data to assess 
appropriateness of model design and refine if necessary. 
4. Explore the underlying mechanism of interaction. 
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2.2 Experimental Methods 
Cell culture materials, namely 0.25 % w/v trypsin-EDTA, Dulbecco's modified Eagle's medium 
(DMEM), L-glutamine, non-essential amino acids, antibiotic-antimycotic solution, penicillin-
streptomycin solution and phosphate buffered saline (PBS) were obtained from Sigma 
(Dorset, UK); RecoveryTM cell freezing medium came from Invitrogen (Paisley, UK). Foetal 
bovine serum (FBS) was purchased from Lonza. Ibidi cell culture inserts for migration assays 
was purchased from SLS (Nottingham, UK).  The gastro adenocarcinoma cancer cell line (AGS) 
were derived from fragments of a tumour resected from a patient who had received no prior 
therapy. AGS was obtained from American type culture collection, ATCC, VA, US. Human 
primary myofibroblasts were obtained from resected oesophageal cancers and adjacent 
non-cancerous tissue during surgery for removal of tumours at First Department of Surgery, 
University of Szeged, Szeged, Hungary. Myofibroblasts were prepared in the Department of 
Medicine, University of Szeged, Hungary as described in [74] and transported to the 
University of Liverpool in liquid nitrogen and cryopreserved until use. Myofibroblasts were 
derived from three Barrett's adenocarcinoma, recovered from the oesophagus and 
oesophagus/cardiac junction. From each patient, CAMs and ATMs were cultured.  
2.2.1 Tissue culture  
2.2.1.1 Human myofibroblasts.  
The myofibroblasts (referred to hereafter as "308/1” unless otherwise stated) were 
maintained in T-75 flasks in DMEM supplemented with 10% v/v FBS, 1% v/v penicillin-
streptomycin, 2% v/v antibiotic-antimycotic and 1% v/v non-essential amino acids. 
This is referred to as "full medium” (FM) unless otherwise stated. Cells were grown 
at 37oC in a 5% v/v CO2 atmosphere and the medium was changed every 48 h. For 
passaging, cells at 80% confluence or above were washed twice with PBS followed by 
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incubation for 5-8 min in 2 ml 0.25 % w/v trypsin-EDTA. Trypsinised single cell 
suspensions were then added to 8 ml of FM and cells were re-plated in T-75 flasks. 
Aliquots of 10 μl of cell suspensions were used for cell counting using a 
haemocytometer.  
2.2.1.2 Human gastro adenocarcinoma cancer cell line.  
Gastro adenocarcinoma cancer cell lines (referred to hereafter as “AGS”) were 
cultured in Ham’s F-12 Nutrient mixture supplemented with 10% v/v FBS, 1% v/v 
penicillin-streptomycin, 2% v/v L-glutamine. Cells were maintained at 37°C in a 5 % 
v/v CO2 atmosphere, and media was changed every 48-72 h. Confluent cells at 80% 
were washed twice with PBS, trypsinised using 0.25% w/v trypsin-EDTA and cells 
were added to 8 ml FM and re-plated in T-75 flasks.  
2.2.1.3 Cryopreservation of cell lines. 
Cells were trypsinised at 80% confluence, centrifuged at 800 x g for 7 min at 4oC and 
supernatants discarded. Pellets were resuspended in 1 ml recovery cell freezing 
medium and cell suspensions stored in 1.5 ml cryovials. These vials were placed in a 
plastic holder in a bath containing propane-1, 2,-diol and then transferred to a -80°C 
freezer overnight and then to liquid nitrogen for long-term storage. 
2.2.1.4 Recovering frozen cell lines.  
Cells were removed from liquid nitrogen, thawed by hand or in a water bath at 37oC 
and added to a T-75 culture flask with 19 ml FM and maintained 37oC in a 5 % v/v CO2 
atmosphere. 
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2.2.2 Migration assay 
Cells were grown to confluence in six-well dishes. In co-culture experiments, 100,000 
AGS and 50,000 308/1 cells were cultured in each well. The experiment was setup 
using an Ibidi chamber, which is a small gel insert containing two wells with the 
dimensions 7000 μm x 3250 μm. The two cell types were segregated into different 
parts of the well by applying them to either side of the Ibidi chamber. A monolayer 
of 100,000 AGS cells were added to the left well and a monolayer of 50,000 308/1 
cells were added to the right layer. Before removing the Ibidi chamber, cells were 
kept in an incubator for 24 h (in FM). Ibidi chambers were then removed, leaving a 
uniform gap of 500 μm between the cell populations (Figure 2-1), and each well 
underwent a double PBS wash before 800µl of 50/50 mixed DMEM and F12-Hams 
medium with 2% FCS was added to each well. The number of cells crossing a margin 
of 500 μm into an acellular area was recorded using time-lapse microscopy. Time-
lapse image series were analysed using Scion Image software (Scion, Frederick, MD), 
which is based on the National Institutes of Health Image. Cell tracking and frame-
by-frame recording of movements were used to calculate cell speed over 30-minute 
periods. Manual cell tracking was performed with Image J using the Manual Tracking 
plugin. Statistical analysis was performed in Microsoft Excel and MATLAB.  
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Figure 2-1. Diagram showing the dimensions of the cell populations in each well 
of the Ibidi chamber. Wells are 7000 μm x 3250 μm with a 500 μm gap. The left 
and right well contain a monolayer of approximately 100,000 AGS cells and 
50,000 308/1 cells respectively. The inner cell boundaries either side of the gap 
are referred to as the ‘proximal’ side of the cells, while the opposite outer 
boundaries are referred to as the ‘distal’ side. Red squares indicate the area 
recorded by time-lapse microscope. The red squares for the distal side of the AGS 
ce population have been excluded for readability. However, it is identical to the 
red squares visible for the distal side of the 308/1 population. 
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2.3 Mathematical modelling 
The cell migration assays were performed under a time-lapse microscope. Images of 
the assay were taken every 30 minutes over a period of 24 hours. Cell migration 
videos were manufactured by stitching these images together and later analysed 
using ImageJ software. In the first frame of the video (t=0), the area of the cell mass, 
visible in the frame, was measured for each cell type on both the proximal and distal 
side of the experiment. For each subsequent frame of the video, this initial cell area 
was subtracted from the new total area of the cells measured, to give the area of 
migration from the cell mass. Collectively, this data was used to produce a graph 
showing the average of the total cell migration of the two cell types over time (Figure 
2-2). The cells located on the proximal sides were labelled as ‘AGS proximal’ and 
‘308/1 proximal’. The cells located on the distal sides were used as a control and were 
labelled as ‘AGS distal’ and ‘308/1 distal’. To incorporate the total proximal edge of 
each cell population, 7 videos were recorded per experiment (Figure 2-1, red 
squares). Similarly, the distal edges had 3 videos recorded per experiment (Figure 2-
1, red squares). 
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Figure 2-2: AGS cells exhibit increased migration. Graph showing migration of 
AGS and 308/1 cells over time. The AGS and 308/1 proximal cells are represented 
by the blue and red lines respectively. The AGS and 308/1 distal cells are 
represented by the green and purple lines respectively. Error bars are also 
included for each of the cells. 
 
 
2.3.1 Increased cell migration in epithelial cancer cells (AGS) 
AGS cells exhibited loss of epithelial phenotype from t=0. That is, the cells underwent 
EMT and quickly began migration into the 500 micron space. The proximity of 
myofibroblasts had a pronounced effect on the speed of migration of the AGS 
proximal cells (Figure 2-2), as the divide between cell types narrows, the AGS cell 
progression on the proximal side decreases (approx. t=4h). Initially, the 308/1 
proximal cells maintain cellular phenotype and exhibit low amounts of cell migration. 
In subsequent modelling of the proximal AGS cells, it is assumed that the 308/1 cell 
population is non-migratory for simplicity. This is reasonable given the much lower 
migratory potential of the 308/1 cells vs the AGS cells displayed in the experiments 
but is something that could potentially be explored in the future. 
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At the moment of initial contact between the cell types, there is a decrease in cell 
migration of AGS cells and inversely, an increase in the cell migration of the 308/1 
proximal cells observed in the time-lapse videos. Significantly, an increase can be 
seen in cell migration between the proximal AGS cells and the distal AGS control cells. 
At t=18h, the AGS distal cells have migrated into an area 2.5 times larger than that of 
the AGS proximal cells. In contrast, there is also a larger increase in the area covered 
by the 308/1 distal cells than that of the 308/1 proximal cells, although on a much 
smaller scale. The AGS distal cells exhibit the biggest increase in cell migration. 
2.3.2 AGS cell migration appears directed 
Using manual tracking software on Image J, individual AGS cells were tracked from 
t=0 to t=18h, using images taken every 15 minutes from a time-lapse microscope 
(Figure 2-3). The data obtained from these tracks show a direct migration pattern 
away from the original colony of AGS cells. As shown in the migration assays, the AGS 
proximal cells migratory behaviour changes with increased proximity to the 308/1 
proximal cells. For example, in Figure 2-3A, the direction of migration by the cell 
denoted with a green track appears to be directed towards the 308/1 proximal cells 
but then switches to apparent random behaviour as it approaches the 308/1 
proximal cells. The cells appear to exhibit the characteristics of random motion once 
this degree of proximity to the 308/1 cells has been reached. The AGS distal cells 
exhibit a similar pattern of migration (Figure 2-3B). 
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Figure 2-3. Cell migration tracking data. Image showing the migration track patterns of individual AGS cells on the proximal side (A) and 
distal side (B). Initial migration appears directed. However, the trajectory of the paths tend towards a more random pattern as the AGS 
proximal cells approach the 308/1 cell mass (A, right hand side). AGS distal cells exhibit similar features. The directed migration trajectory 
appears to last longer with cells at the distal side. 
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2.3.3 Model I – Simple diffusion 
Subsequent cell migration simulations are used to inform and refine model equations 
and ultimately explore the underlying mechanisms of interaction present in the 
biological experiment. Diffusion occurs when particles spread. Fick’s law describes 
diffusion as the net movement of cells from a region of high concentration to a region 
of low concentration [283]. In particular, the diffusive flux versus the concentration 
gradient of the variable under the assumption is given by:  
 
𝐽 = −𝐷
𝜕𝑢
𝜕𝑥
, (2-1) 
in which J (mol/µm2/h) represents the particle flux and is proportional to the 
diffusion coefficient, D (µm2/h), and negative gradient of the concentration 
𝜕𝑢
𝜕𝑥
 
(mol/µm4). For the modelling, we assume that the 2D experiment can be sufficiently 
modelled in one dimension, i.e. it is assumed there is no significant variance in the y-
direction and that the dominant migration direction is in the x-direction. This is 
informed by the experimental observations. For simplicity, it is also initially 
hypothesised that any cell movement from the distal side of the cell populations can 
be attributed to the effects of diffusion only, although we later readdress this 
assumption. Therefore, the preliminary model of distal cell movement can be 
represented using the following partial differential equation (PDE): 
 
𝜕𝑢
𝜕𝑡
= −
𝜕𝐽
𝜕𝑥
= 𝐷
𝜕2𝑢
𝜕𝑥2
, (2-2) 
where cell density is represented by u (cells/μm2), the location of the cell is 
represented by x (μm) and D (μm2/h), is the diffusion coefficient. The diffusion 
coefficient can be derived from experimental data by taking the average cell 
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extension in the x-direction and substituting it into Einstein’s formula for Brownian 
motion, which is defined as relating the diffusion coefficient to the mean squared 
displacement of a Brownian particle. It can be defined as follows: 
 〈𝑥2〉 = 2𝐷𝑡. (2-3) 
This expresses the mean squared displacement 〈𝑥2〉 in terms of time-elapsed, ti and 
the diffusion coefficient, D. Therefore, the diffusion coefficient is the result of 
𝑥2
2𝑡
. For 
example, at t=18h, the mean squared displacement of the AGS proximal cells is 41157 
µm2, resulting in a diffusion coefficient of 1143.25 µm2 h-1. A further assumption 
made within the model is that there is a fixed cell density at the source mass of cells 
(𝑥 = 0). This is based on the assumption that there is a large enough supply within 
the monolayer population to maintain this density at the distal and proximal regions. 
The cell density is rescaled so that 𝑢𝜖[0,1] and u is equal to the maximum density 
(u=1) at the monolayer cell boundary. In relation to Figure 2-1, x=0 refers to the 
boundary of the cell monolayer (on either the distal or proximal sides, depending on 
the reference point-of-view for the chosen simulation). As time increases, the cells 
migrate outwards from the cell monolayer to a maximum value of L. Here, L 
represents either the gap (proximal side) or a sufficiently long, arbitrary distance 
away from the original cell population within the wells (distal side) in which the 
migration assay takes place, to give the following initial condition for the cells: 
 
𝑢(𝑥, 0) = {
1,                𝑥 = 0
0,       𝑒𝑙𝑠𝑒𝑤ℎ𝑒𝑟𝑒
 (2-4) 
 
 
with boundary conditions, 
70 
 
 
𝑢(0, 𝑡) = 1,
𝜕𝑢(𝐿, 𝑡)
𝜕𝑥
= 0. (2-5) 
The boundary conditions state that at x=0 the density is fixed at the maximal level 
and if x equals the right-hand boundary, L, there is zero flux. As flux can be defined 
as the action of flowing or movement, zero flux is the result of the cell migration 
ending. As mentioned above, on the proximal side of the cell monolayer, L represents 
the location of the boundary of the other cell mass (308/1 proximal).  
 
2.3.3.1 Analysis of the cell migration  
Figure 2-4 shows model simulations based on the experimental data for the AGS 
distal and 308/1 distal cells previously plotted in Figure 2-2. The experimental ‘area’ 
values were converted to migration distances so that there would be consistent 
output from the experiments and simulations. The simulated migration distance, 
“Xmean”, was matched to the experiments for the AGS and 308/1 distal cells by using 
Equation 2-3 to simulate migration distances for different values of D. For example, 
the Xmean for the AGS distal cells (Figure 2-4A, subplot)  and 308/1 distal cells (Figure 
2-4B, subplot) is approximately 225 and 90 µm at t=18h, respectively. This 
approximately relates to the distance the simulated cell front has migrated, using 
𝑢 = 0.5 as a reference cell density. Comparatively, the AGS distal cells (Figure 2-4A) 
migrated into 2.5 times more space than the 308/1 distal cells (Figure 2-4B) over the 
same time period (~600 µm vs ~225µm). Also, the AGS distal cells migrate into the 
space approximately seven times faster than the 308/1 distal cells when comparing 
the diffusion coefficients (1143.25 vs 174.79 µm2 h-1). 
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Figure 2-4. Distal cell population migration into space. Simulation of the distal side of the AGS cell population (A) and 308/1 cell population 
(B) into surrounding area, x. The green line represents the boundary of the cell  at t = 0 were cell density is 1 (normalised scale). The five blue 
lines represent the distance travelled by the cells for each subsequent time-point. The red line represents the final time-point (t = 18h). 
Subplot graphs show experimental data highlighting the x-mean over time. X-mean is equivalent to the distance travelled by 50% of the cell 
populations i.e., u = 0.5. The diffusion coefficient for each cell population is indicated below these subplots. 
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2.3.4 Model II – Density-dependent diffusion 
At x=L=500μm on the proximal side, the migrating AGS cells meet the 308/1 cells 
which they are unable to pass through, resulting in zero flux. As Equation 2-2 results 
in solutions that are non-compactly supported i.e., 𝑢 → 0 as 𝑥 → ∞, this made it 
difficult to estimate the true migration front in the simulations. Consequently, 
comparison of the simulations to the experiments also proved difficult. Therefore, 
Equation 2-6 is preferred as it has a clearly defined migration front: 
 𝜕𝑢
𝜕𝑡
= 𝐷
𝜕
𝜕𝑥
(𝑢𝑛
𝜕𝑢
𝜕𝑥
). (2-6) 
The effect of crowding due to the movement of cells based upon density is 
represented by 𝑛. This density-dependent diffusion model can be simulated by using 
Equation 2-6. The boundary conditions remain the same and the results from the 
simulation are plotted on Figure 2-5B.  
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2.3.5 Model III – Addition of inhibitory chemical to proximal cell migration 
Due to the observable differences between the proximal and distal cell movement 
characteristics (Figure 2-2), the third model makes the assumption that the proximal 
side of the AGS population are affected by some inhibitory chemical, I, produced by 
the 308/1 cell population, namely, 
 𝜕𝑢
𝜕𝑡
=
𝜕
𝜕𝑥
(𝑘𝑢𝑛
𝜕𝑢
𝜕𝑥
+ 𝛼𝑢
𝜕𝐼
𝜕𝑥
), (2-7) 
with inhibitor chemical dynamics, described by, 
 
𝜕𝐼
𝜕𝑡
= 𝐷𝐼
𝜕2𝐼
𝜕𝑥2
− σI, (2-8) 
and boundary conditions, 
 𝐼(𝐿) = 1, lim
x→−∞
𝐼 = 0. (2-9) 
The additional flux term, 𝛼𝑢 𝜕𝐼/𝜕𝑥 represents cells moving down a gradient of I at 
some rate, α. For simplicity, we assume that the concentration of inhibitor I 
equilibrates quickly as it is assumed to be a small rapidly diffusing chemical with 
dynamics that are much faster than that of the slowly moving cells. To solve for I, a 
steady state is assumed for Equation 2-8, to give: 
 𝑑2𝐼
𝑑𝑥2
−
𝜎
𝐷𝐼
𝐼 = 0. (2-10) 
This is a second order homogeneous differential equation and so we assume a 
solution of exponential form, namely: 
 𝐼 = 𝑒𝑚𝑥 ⇒ 𝐼′′ = 𝑚2𝑒𝑚𝑥, (2-11) 
where 𝑚 is a constant, to be determined, and prime represents derivative with 
respect to 𝑥. Substituting this into Equation 2-10 gives: 
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𝐼′′ −
𝜎
𝐷𝐼
𝐼 = 𝑒𝑚𝑥 (𝑚2 −
𝜎
𝐷𝐼
) = 0 ⇒ 𝑚 = ±√
𝜎
𝐷𝐼
. (2-12) 
 
This gives us a general solution for I as follows: 
 
𝐼 = 𝐴𝑒
√
𝜎
𝐷𝐼
𝑥
+ 𝐵𝑒
−√
𝜎
𝐷𝐼
𝑥
, (2-13) 
where 𝐴 and 𝐵 are constants defined by the boundary conditions. By applying the 
boundary conditions from Equation 2-9 to this formula for I, the following is 
obtained: 
 
𝐼(𝐿) = 𝐴𝑒
√
𝜎
𝐷𝐼
𝐿
+ 𝐵𝑒
−√
𝜎
𝐷𝐼
𝐿
= 1,    
⇒ 𝐴 = 𝑒
−√
𝜎
𝐷𝐼
𝐿
− 𝐵𝑒
−2√
𝜎
𝐷𝐼
𝐿
,        
(2-14) 
and 
 
lim
𝑥→−∞
(𝐴𝑒
√
𝜎
𝐷𝐼
𝑥
+ 𝐵𝑒
−√
𝜎
𝐷𝐼
𝑥
)  = 0. 
 
(2-15) 
To satisfy the second boundary condition (Equation 2-15), it must have B=0. 
Therefore, the solution for A and I is as follows: 
 
𝐴 = 𝑒
−√
𝜎
𝐷𝐼
𝐿
, (2-16) 
and therefore, 
 
𝐼 = 𝑒
√
𝜎
𝐷𝐼
(𝑥−𝐿)
. (2-17) 
Equations 2-7 and 2-17 are used to represent density-dependent diffusion with an 
inhibitory chemical substance, 𝐼, for the proximal side of the cells.  
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2.3.5.1 Addition of chemotaxis to the model 
The solution of this modified density-dependent diffusion model with inhibitory 
chemical is plotted in Figure 2-5C. Again, the model appears to give a good account 
of the qualitative dynamics observed in-vitro. However, comparison of the 3 model 
simulations to the experimental plots (Figure 2-6) suggests that the non-inhibition in-
silico simulations do not appear to fit the data for the proximal side very well. In 
particular, this graph shows that the simple diffusion model (blue trace) appears 
unable to describe the proximal AGS cell data.  The density-dependent model shows 
similar qualitative features and comparison to the data for the distal side as the 
diffusion data. But the best comparison to the data for the proximal side comes from 
the inhibitor density dependent model. These comparisons have been explored for a 
range of parameters producing the same key result i.e., proximal AGS cell migration 
is best described by a model with density dependence coupled with the effect of an 
inhibitory chemical. 
76 
 
 
Figure 2-5. Model simulations of migrating AGS cells. All graphs show AGS cells 
spatially extending into open space over time. Each blue trace represents a time 
point of three hours. The green trace represents t=0 and the red trace represents 
t=18. (A) Simple diffusion simulation of AGS distal cells. (B) Density-dependent 
diffusion model of AGS distal cells. (C) Density-dependent diffusion model with 
chemotaxis of AGS proximal cells. The magenta trace represents the amount of 
inhibitory chemical, I. 
 
 
A
B
C
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Figure 2-6. Comparison of the three simulated model results with the 
experimental data. AGS cell extension was plotted over time for the simple 
diffusion model (blue), density-dependent diffusion model (red) and the density-
dependent diffusion model with chemotaxis (black). These were compared to the 
experimental results of the AGS distal cells (red asterisk) and AGS proximal cells 
(black asterisk). 
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2.3.6 Model IV - Addition of the action of an inhibitory chemical to distal cells 
In order to model the effect of an inhibitor on the distal cells, the following equations 
are used, 
 
𝜕𝑢
𝜕𝑡
=
𝜕
𝜕𝑥
(𝑘𝑢𝑛
𝜕𝑢
𝜕𝑥
+ 𝛼𝑢
𝜕𝐼
𝜕𝑥
) (2-18) 
with inhibitor chemical dynamics, described by, 
 
𝜕𝐼
𝜕𝑡
= 𝐷𝐼
𝜕𝐼2
𝜕𝑥2
− σ𝐼, (2-19) 
and boundary conditions, 
 
𝐼(0) = 𝑒
√
𝜎
𝐷𝐼
(−3250−𝐿)
,   lim
𝑥→∞
𝐼 = 0. (2-20) 
where 3250 represents the width in μm of the AGS cell mass (Figure 2-1). Different 
boundary conditions are needed for this model as the distal side of the AGS cell mass 
is further away from the source of the inhibitory chemical (308/1 cells). Again, we 
can solve for 𝐼 by assuming a steady state and applying the boundary conditions 
(Equation 2-20) to give: 
 
𝐼 = 𝐴𝑒
√
𝜎
𝐷𝐼
𝑥
+ 𝐵𝑒
−√
𝜎
𝐷𝐼
𝑥
, (2-21) 
where 𝐴 and 𝐵 are constants. Now, we apply the boundary conditions from Equation 
2-20, namely: 
 
𝐼(0) = 𝐴 + 𝐵 = 𝑒
√
𝜎
𝐷𝐼
(−3250−𝐿)
 (2-22) 
 
⇒ 𝐴 = 𝑒
√
𝜎
𝐷𝐼
(−3250−𝐿)
− 𝐵 
 
(2-23) 
and   
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lim
𝑥→∞
(𝐴𝑒
√
𝜎
𝐷𝐼
𝑥
+ 𝐵𝑒
−√
𝜎
𝐷𝐼
𝑥
)  = 0. 
 
(2-24) 
In this instance, A=0 in order to satisfy the second boundary condition, resulting in 
the following solutions for B and 𝐼: 
 
𝐵 = 𝑒
√
𝜎
𝐷𝐼
(−3250−𝐿)
, (2-25) 
 
𝐼 = 𝑒
√
𝜎
𝐷𝐼
(−3250−𝐿−𝑥)
. 
 
(2-26) 
As with the proximal AGS cells model, it is assumed that the inhibiting chemical, 𝐼, 
has an effect on the distal AGS cells, which reduces as the cells migrate away from 
the source. Secondly, the parameters are the same as they were for the proximal AGS 
cell model, but the spatial reference is different and thus the model simulation is 
achieved through calculating new inhibitory dynamics and boundary conditions, 
using Equations 2-18, 2-19 and 2-20. The results for the density-dependent diffusion 
models with added inhibitory chemical effect are plotted in Figure 2-7. The inhibitory 
chemical,𝐼, decreases exponentially with distance relative to the normalised 
maximum chemical concentration at the source (u=1). On the distal side of the AGS 
cells (Figure 2-7A), the amount of chemical acting on these cells is smaller (8 orders 
of magnitude lower) when compared to the concentration of inhibitor at the 
proximal side of the AGS cells. Comparison of these simulations to the AGS 
experimental data (Figure 2-8) suggest that the inclusion of this inhibitor chemical 
doesn’t significantly alter the migration of the distal AGS cells. This is rather intuitive 
as the distal cells are a significant distance from the potential inhibitor source and so 
it effects would be relatively diminished.  
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In summary, there are four distinct models describing the in-vitro experiments. 
Model I attempts to describe the cell migration due to effects of simple diffusion only 
(Equation 2-2), whereas model II describes the experiment results as a density-
dependent diffusion model (Equation 2-6). Motivated by the experimental data, 
model III incorporates a chemical gradient of substance, I, into the density-
dependent diffusion model and is applied to the proximal side of the cell AGS cell 
mass only (Equation 2-7). Finally, model IV is adapted from model III and applied to 
the distal side of the cell mass (Equation 2-18). The key finding is that distal AGS cell 
movement appears to depend on the action of an inhibitor chemical produced by the 
308 cells. These results are inconclusive regarding the migration of the proximal cells, 
which are equally modelled well with either simple diffusion or density/inhibitor 
effects. 
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Figure 2-7. Effect of inhibition on dynamic profile of AGS cell migration. All 
graphs show AGS cells spatially extending into open space over time. Each blue 
trace represents a time point of three hours. The green trace represents t=0 and 
the red trace represents t=18h. Magenta traces represent amount of inhibitory 
chemical, I. (A) Density-dependent diffusion model with chemotaxis of AGS cells 
on the distal side. (B) Density-dependent diffusion model with chemotaxis of AGS 
cells on the proximal side.  
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Figure 2-8. Comparison of the inhibition model simulations with the 
experimental data.  Simulated AGS cell extension was plotted over time for the 
density-dependent diffusion model with added chemotaxis for the AGS distal cells 
(red) and the AGS proximal cells (black). These were compared to the 
experimental results for the AGS distal cells (red asterisk) and AGS proximal cells 
(black asterisk). 
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2.4 Chapter Discussion 
This chapter describes the evolution of a number of in-silico models in an effort to 
describe the migratory cellular phenomena observed during in-vitro cell migration 
assays. Furthermore, this approach was extended to include interaction between the 
AGS proximal cells and 308/1 proximal cells, through the addition of an inhibitory 
chemical. Initially, the migration of the AGS cells are described by a simple diffusion 
model. Upon comparison with corresponding traces from the experimental data 
(Figure 2-6), this model was deemed insufficient, in terms of describing the dynamic 
movement exhibited by the AGS cells on the distal side. Therefore, the model 
required updating to replicate the observations from the in-vitro experiments. Before 
the cell migration assay began, the AGS cells, which are epithelial cancer cells, were 
cultured in a monolayer. This means they were exhibiting an epithelial phenotype, 
tight cell-cell adhesions, before undergoing EMT. This cell-cell adhesion provided 
motivation for a density-dependent dispersal form of diffusion. Therefore, we 
modified the model to account for density-dependent diffusion (Model II). Model II 
appeared to better describe the dynamic characteristics exhibited by the migratory 
AGS cells. However, the expansion of these cells into the acellular space appeared 
too rapid. This observation provided the motivation to add the inhibiting chemical, I. 
The manual tracking data also suggests an inhibition model would be appropriate, as 
it clearly shows the direct migration of the AGS cells followed by a delayed inhibition. 
In Figure 2-6A, the tracked cells migrated in a direct, unidirectional manner and as 
the acellular space between the AGS and 308/1 cells decreased, so too did the direct 
migration pattern of the tracked cells. In contrast, the cessation of direct migration 
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by the tracked cells in Figure 2-6B was less obvious as there was no decrease in 
acellular space.  
Fick’s first law describes that the flux due to diffusion is proportional to the 
concentration gradient [283]. Qualitatively and quantitatively, the time lapse 
microscopy data can be used to observe and predict the cellular migration patterns 
of the cell types. This is where in-silico modelling approaches prove useful. For 
example, the diffusion coefficient, D, was calculated from the input of cellular 
density, u, and extension of the cells into the space, x, using Equation 2-3. The 
diffusion coefficient represents the driving force which arises from the differential 
surface energies in the system, i.e. the difference in surface energy between 
homotypic cells, heterotypic cells and between the cells and the external 
environment. The AGS cells on the distal side have a diffusion coefficient of 1143.25 
µm2 hr-1 and the AGS cells on the proximal side have a diffusion coefficient of 174.79 
µm2 hr-1. This greatly reduced diffusion coefficeint on the proximal side provides 
further support for the assumption that the 308/1 cells release an inhibitory 
chemical. Subsequently, to describe the proximal side of the AGS cell movement, 
further modification was again needed. As previously mentioned, 308/1 cells are 
CAMs and it has been shown that CAMs are involved in multiple cell signalling 
networks and express a range of growth factors, cytokines and chemokines. 
Therefore, their interaction with the AGS cells needs to be taken into account within 
the model, by incorporating an inhibitory chemical effect into model II.  The 
simulations of model II and III were also plotted against the experimental traces in 
Figure 2-6. Model III showed a better fit to the AGS proximal data from the 
experiments (black traces), than model I and II (red traces). Next, the effect of the 
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chemical, I, on the distal side of the AGS cells was tested, but the effect was found to 
be minimal, which is intuitive given the distance of these cells from the inhibitor 
source. However, future work for this project can clarify these assumptions through 
the addition of controls to the study. For example, the next logical experiment to be 
performed would be a cell migration assay containing two independent cell 
monolayers of AGS cells. The data obtained from observing these cells migrate in the 
absence of the 308/1 cells could indicate exactly the type of effect the 308/1 cells 
had on the AGS population i.e., attraction, inhibition or a combination of the two. 
Unfortunately, due to technical difficulties with the equipment and a change in 
institution, this work was prematurely ended. Additionally, further control 
experiments with just the CAM cell monolayers present would help to focus the 
direction of subsequent model building.  
The key result is that the inhibitor model appears to describe the dynamic profile 
exhibited in the in-vitro experiments better that the simple diffusion and density-
dependent diffusion models. However, it is still insufficient to describe the system 
fully. There is increasing evidence that the presence of CAMs contribute to tumour 
growth [284]. The mechanisms of homing and migration remain incompletely 
understood. Previous studies have reported that CAMs evoke a more aggressive 
phenotype in cancer cells compared with myofibroblasts derived from normal tissue 
environments [96]. This was observed from the experimental data where, initially, 
the AGS proximal cells migrated directly towards the 308/1 cells. Nevertheless, 
inhibition was also present between the cell types, as the experiments displayed a 
decrease in migration as the AGS cells encroached upon 308/1 cell monolayer. 
Potential theories as to why this happened include: (a) contact inhibition from the 
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decrease in acellular space for the AGS cells to migrate into [285]; (b) the release of 
a compound from the CAMs that directly inhibits the migration of the AGS cells, or; 
(c) the AGS cells slow down due to the energy spend required to remodel the 
extracellular network that has been laid down by the myofibroblasts [80]. Recently, 
an integrated multi-omics study [286] revealed for the first time that myofibroblasts 
derived from the site of gastric adenocarcinomas (CAMS) are epigenetically 
reprogrammed through DNA methylation and enhance the proliferation and 
migration of cancer cells. Therefore, this study provides motivation for further model 
refinement to include mechanisms of attraction in an attempt to define the 
underlying mechanism of interaction between these key cell types. 
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Chapter 3: Discrete Cell Based Model in 
Fibroblast Cell Migration 
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3.1 Introduction 
This chapter focuses on modelling cell movement at the mesoscopic scale. The 
internal architecture and mechanisms, described previously in section Error! 
Reference source not found., involved in the migration of an individual cell are not 
considered explicitly in this model. However, the role they play in 
mechanotransduction and polarised cell movement are reflected implicitly. For 
example, the cell is considered to sense its external environment and extend through 
a leading edge, by forming adhesions and assembling cytoskeletal machinery. Thus, 
it can be assumed that the cell will migrate in the direction of the leading edge. In 
other words, it is assumed that the cell is unlikely to make sudden 180° turns in its 
migration pathway and is much more likely to make smaller, smoother gradual 
movements as it senses the surrounding environment. Cell migration assays 
conducted on polyurethane surfaces containing varying topographical features were 
used to inform and validate the mathematical model. Using this model in 
combination with the experimental data, key question of whether surface topology 
affects the migratory cell path of fibroblasts can be addressed.  This work on 
mechanotransduction offers great potential into the possibility of controlling cell 
behaviour, using physical cues. Biofilm formation and the impact of implant 
integration are some of the key areas that may benefit from this control [287]. 
Biofilms are communities of adherent cells held together in a self-produced matrix 
of extracellular polymeric substances (EPS) [288]. The formation of biofilms during 
infection in wound sites and in inorganic materials such as catheters and stents can 
be detrimental as they exhibit increased protection from antibiotics [288,289]. 
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Therefore, understanding how to control cellular behaviour in such a system by 
altering its physical environment could provide the platform for a major 
breakthrough into tackling this complex problem. Also, it has been shown that 
increasing the surface roughness on the implants also increases the adhesive 
properties for fibroblast cells and suggests that there could be an improvement in 
wound healing, limiting the risk of capsular contracture [290].  
3.1.1 Mathematical modelling of cell migration 
Multiple mathematical models exist to describe the process of cell migration, as 
previously described in section 1.5.6. However, random walk models were 
determined to be the most appropriate for modelling the experimental observations 
in this chapter. These random walk models are based primarily on Brownian motion 
[199]. Brownian motion can be described as the random movement of particles due 
to their collisions with other atoms and molecules. A theoretical process describing 
Brownian motion is called the Weiner process [199]. The Weiner process is defined 
as a continuous-time stochastic process and is named in honour of Norbert Weiner 
[199]. Brownian motion is considered a Gaussian-Markov process, in that it has 
normally distributed random variables over a continuous time constant and is 
considered a memoryless process [199]. 
In this chapter, a stochastic mathematical model is proposed for the random motility 
and mechanotransduction of single cells and evaluate the migration paths on 
patterned surfaces. In the model, cell velocity is described as a persistent random 
walk using the Ornstein-Uhlenbeck (O-U) process [291].  
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3.1.1.1 Ornstein-Uhlenbeck process 
The advantage of using this model is that it allows the simulation of individual cell 
migration paths. The O-U process has previously been proposed to quantify 
individual cell random motility in a number of studies [291-294]. For example, by 
incorporating a discrete description of the O-U process, Dunn and Brown [295] were 
able to successfully demonstrate that the O-U process characterizes fibroblast 
random motility through use of the autocorrelation functions of cell displacements 
during discrete time intervals.  
In general terms, using the O-U process, the velocity of a cell can be described in 
terms of two processes: i) stochastic fluctuations in velocity and ii) deterministic 
resistance to the current velocity. The stochastic term represents all of the 
probabilistic processes that might affect cell velocity (e.g. response mechanisms to 
gradient of the cell surface features, etc). The deterministic term affects the 
persistence of motion mimicking e.g. surface friction, viscosity, etc. 
This approach was extended by Stokes et al. [291]: first by using a continuous version 
of the O-U process; and second, by adding a term to represent directional bias in 
response to the presence of a chemoattractant gradient. In the present work, the 
directional bias term is adapted to represent an environmental gradient (i.e. surface 
pattern) instead of a chemical gradient.  This is applied to an extended model to 
analyse the experimental data of migrating lung fibroblast (LL24) cells on three 
different surface types with varying topological features (Flat, Linear and Random). 
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This chapter begins with a description of the continuous version of the O-U process 
with the adapted directional bias extension. The standard O-U process is 
characterised by two parameters. These parameters are α (µm2/min4) and β (1/min) 
and these represent magnitudes of random fluctuations in velocity and velocity 
decay, respectively. The model’s applicability is validated for random fibroblast 
migration and provides relative estimates for α and β. Then, an additional parameter, 
𝜅 (µm/min2), is introduced to account for the directed motion of the fibroblast cell 
in response to the surface gradients. The 𝜅 -parameter could not be measured 
directly but it is shown how it can be estimated using model-generated cell paths. 
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3.1.2 Chapter aims 
1. To create an extended continuous O-U model to accurately describe random 
motility and surface bias. 
2. To use combined in-silico and in-vitro results to determine the mobility 
parameters α and β and the bias parameter 𝜅. 
3. To validate the in-silico output with the experimental data. 
4. Use the in-silico model outputs to predict how different surfaces (Flat, Linear, 
Random) can affect cell motility.  
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3.2 Materials and Methods 
The experiments performed in this chapter were completed in collaboration with Dr 
Mark Murphy’s lab in the General Engineering Research Institute (GERI) at Liverpool 
John Moores University (LJMU). The generation of the patterned surfaces were 
conducted by this lab and a summary of these methods are contained in Appendix A 
(Section 7.1). All the other experiments including cell culture, migration assays and 
mathematical modelling were performed by myself and are detailed below. 
3.2.1 Cell culture 
The cells described in this work are human lung fibroblast cells (LL24) which have 
been purchased from the European Collection of Animal Cell Cultures (ECACC) UK. 
Fibroblast cells were chosen because there is extensive evidence showing that 
fibroblast cells respond to changes in surface topography both in-vitro and in-vivo 
[180]. The LL24 cell line was chosen as it is a well characterised, stable, normal human 
diploid cell line [180]. All cell culture work was carried out under aseptic conditions 
in a grade II laminar flow cabinet (EBSCO). Cells were maintained at 37 °C in a 
humidified 5% CO2/95% air atmosphere in Dulbecco's Modified Eagles Medium 
(DMEM) (Sigma-Aldrich, D6429) supplemented with 10% foetal bovine serum 
(Sigma-Aldrich, 0804) and 1% penicillin-streptomycin. All experiments were carried 
out using cells at passage numbers 20–24. 
3.2.2 Cell migration assay 
To determine if the different surfaces affected cell migration, time-lapse imaging and 
subsequent cell tracking was performed over a four-hour period using a Zeiss LSM 
510 confocal microscope. Briefly, the polymer surfaces were sterilised in 70% 
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ethanol, washed in PBS then placed into 35 mm cell culture dishes. Next 100,000 
cell/cm2 were seeded onto the polymer surfaces and the dish was placed into a 
microscope environmental chamber (S-2, PeCon GmbH, Germany). The chamber was 
maintained at 37°C, 5% CO2 in a 60–70% humidified air atmosphere using a 
Temcontrol 37-2 and CTI-controller 3700 (PeCon GmbH, Germany). Images were 
taken every 10 min for 2.5 h using a 20× Plan-Apo/0.75 NA DIC objective lens, while 
scanning using a Helium- Neon (HeNe) laser at 543 nm. Images of the patterned 
surfaces without any seeded cells were also taken. This was done so that the specific 
features of each surface could be transferred to the in-silico model framework 
(Figure 3-2). 
3.2.3 Measurement of cell trajectories, mean squared displacement and 
tortuosity 
Cell movement tracks were analysed using ImageJ software (National Institute of 
Health, NIH) with a manual tracking plugin (Institute Curie, France) used to analyse 
the data produced from the time-lapse image series. The centroid of the cell area 
was used to represent the cell position. The time increment between image frames 
was ten minutes. This was long enough to discern cell movement without losing track 
of the cell’s position. The result was a series of migration distances vs time for each 
individual cell. The net displacement was calculated by the difference of the position 
at the beginning and end of each time step. The displacement, which is the measure 
of the cells position relative to its starting point over time, was calculated by 
subtracting the cells origin point from its current position. This was done for each cell 
at each time point. The mean of the square of the values was calculated to give the 
mean square displacement (D2) vs time.  D2 measures the deviation of the position 
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of a cell with respect to a reference position over time, and is useful in determining 
if the movement of a cell is solely down to diffusivity or if an external force is directing 
the motion. Tortuosity, τ, can be defined as the property of a curve being tortuous 
i.e. having many turns (a twisted path). Tortuosity can be estimated using the arc-
chord ratio (Figure 3-1): the ratio of the length of the curve (L) i.e. the actual path 
travelled by the cell to the straight-line distance between the ends of this path (C), 
namely: 
 
τ= 
L
C
. (3-1) 
L is the total curved-line distance and is measured by obtaining the total distance 
travelled by the fibroblast from t=0 to t=160. C is the straight-line distance travelled 
by the fibroblast and can be obtained by measuring the distance of the cell’s position 
at t=160 from its starting position at t=0. 
 
Figure 3-1. Schematic illustration of tortuosity calculation of cell migration 
path. Black line represents the migratory path taken by fibroblast cell from its 
origin (A) to its destination point (B). Using this example, L equals the length 
of the black line and C equals the length of the blue line.  
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Figure 3-2. Microscope images of the patterned surfaces. (A & B) These images 
show the linear and random patterned surfaces, respectively. The linear surface 
exhibits features in a ‘ploughed field’ pattern with straight lines etched from left 
to right. The random surface exhibits features producing a network of 
overlapping lines. (C & D) These are 3D schematic images of the linear patterned 
surface and random patterned surfaces, respectively.  The scale in the z-axis 
represents intensity which is subsequently used to represent feature 
depth/height in the in-silico simulations. 
  
A B
DC
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3.2.4 Mathematical model 
The cell motility is studied in terms of a stochastic O-U process which is used to 
describe a random cell motility model, updated via a Markov process. This means 
that only the current state of the cell is taken into account and the cell’s previous 
positions have no bearing on its future movements; i.e. there is no memory to the 
motion (white noise) [291]. Although this may seem oversimplified, Dunn and Brown 
[295] showed that this process is sufficient to describe random motility in fibroblast 
cells. Initially, this model is used to describe an unbiased random walk process (i.e., 
cells moving on a smooth surface). Then, through the addition of a haptotactic 
gradient term, it is extended to a biased random walk model. For this model, it is 
assumed that the cell responds to a spatial gradient of focal adhesions between the 
cellular membrane and the surface topography, although there are no assumptions 
made about the cell’s actual underlying mechanism of perception. It is also assumed 
that the fibroblast cell moves perpendicular to the gradient of the features of the 
surface i.e. the cell migrates along the surface grooves rather than up/down them.  
The details of the mathematical model are as follows: Equation 3-2 describes the 
velocity of a single cell as it evolves across an (𝑥, 𝑦) ∈ ℝ2 plane with time; a second 
equation (Equation 3-3) is then used to determine the cell’s (x, y) position from this 
velocity, producing a calculated trajectory for the cell; from this trajectory, the 
squared displacement and tortuosity can be calculated. Comparison of these 
predicted metrics to those obtained experimentally will allow us to: (1) examine the 
validity of the model and (2) determine values of the model parameters, appropriate 
for the fibroblast migration.  
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The rate of change of cell velocity is the sum of three components: the first two 
components represent the random motility behaviour, and the third represents the 
haptotactic, or directed, behaviour. For random motility, the first term describes the 
deterministic resistance to the cell's current velocity, and the second represents the 
random accelerations (or fluctuations) of this velocity. The third component that 
describes the haptotactic behaviour provides a directional bias in the presence of a 
patterned surface gradient. Mathematically, these three components are summed 
to give the following stochastic differential equation for the rate of change of the cell 
velocity, 𝑉: 
 
𝑑𝑉(t) =  −𝛽𝑉(𝑡)𝑑𝑡 +  √𝛼𝑑𝑊(𝑡) +  𝛹(𝑡)𝑑𝑡, (3-2) 
where α (µm2/min4) and β (1/min) are the motility parameters, t (min) is time, 𝑊 is 
the vector Weiner process (white noise), and 𝛹 is the haptotaxis function (see 
Equation 3-4), which describes the effect of the surface features on the velocity of 
the cell. The terms 𝑉, 𝛹and 𝑊 are vectors in ℝ2, capturing the x and y components 
of the cell velocity. As the velocity of the cell is a rate of change of the cell’s position, 
the position of the cell, 𝑥 ∈ ℝ2 can be obtained from the following: 
 𝑑𝑥
𝑑𝑡
 =  𝑉(t). (3-3) 
The parameter β can be viewed as the magnitude of resistance to motion, leading to 
a decrease in the persistence of velocity as β increases. The haptotactic term provides 
the directional bias in velocity caused by a cell reacting to the presence of surface 
topologies. As previously mentioned, it is assumed that the cell responds to a spatial 
gradient of focal adhesions between the surface of the cell and the surrounding 
environment. The gradient will be dependent on the steepness of the surrounding 
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pattern features, denoted by ∇𝑎, where 𝑎 is the height of the feature (see Figure 
3-2(D)) and ∇ is the spatial gradient. Let the haptotactic term be proportional to 
cos 𝜃, where θ is the angle between the direction of the cell and the direction of the 
surface pattern at the cells current position. Thus, introducing 𝜅 as the 
proportionality constant gives: 
 𝛹 =  𝜅∇𝑎 cos 𝜃. (3-4) 
Equations (3-2) and (3-4) provide a description of the velocity process of a single cell 
moving with the properties represented by the random motility parameters α and β 
and the haptotaxis parameter 𝜅 (µm/min2). Each cell described by equations (3-2 – 
3-4) with a given set of parameters, α, β and 𝜅, will have a different path or trajectory 
(owing to different realisations of the random noise process, 𝑊) but the same 
'degree' of randomness (described by α), velocity decay rate constant, and sensitivity 
to attractant gradients.  
For this framework to be meaningful, it must first be demonstrated that it is a valid 
description of the experimental cell trajectories. Before estimation of the haptotactic 
responsiveness (𝜅) can be accomplished, the polyurethane surface patterns and 
features need to be encoded in the model. A flow diagram depicting this process in 
available in Figure 3-3. This was achieved by taking the microscope image data, from 
Figure 3-2, saving it as an ASCII-delimited file and using the MATLAB function 
‘dlmread’ to convert it into a matrix. This matrix now contains numerical values which 
represent intensity values between 0 and 255 for each point of the image (0 = lowest 
height feature; 255 = tallest feature). These intensity values represent the depth and 
height of the surface features and were subsequently normalised to [0,1] and then 
converted into gradient values, using the Matlab function scatteredInterpolant, for 
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each x-y coordinate (denoted ∇𝑎). The ‘scatteredInterpolant’ creates an interpolant 
that fits a surface of the form 𝑣 = 𝐹(𝑥, 𝑦).  Vectors x and y specify the (𝑥, 𝑦) 
coordinates of the gradient values and 𝑣 contains the gradient values associated with 
the points (𝑥, 𝑦). This allowed the steepness of the topological features of the 
experimental polymers to be incorporated into the simulations. Firstly, experimental 
metrics were used to optimise the parameters α and β for the flat model simulation 
(𝜅 = 0). These α and β values were then fixed for all subsequent simulations on each 
of the patterned surfaces. In these subsequent simulations, cell velocity was updated 
using Equation 3-2 with 𝜅 ≠ 0. For Equation 3-4, θ is calculated using the dot product 
between the vector ∇𝑎 (i.e. describing the gradient of the surface topology at the cell 
position (x,y)) and the cell velocity vector 𝑉=(Vx, Vy), namely: 
 
𝜃 =  cos−1 (
𝑉. ∇𝑎
‖𝑉‖. ‖∇𝑎‖
), (3-5) 
 where θ is the angle between 𝑉 and ∇𝑎. 
The key aim of all these simulations is to obtain values for the parameters α, β and 
𝜅, which then provide a quantitative description of the characteristics of the actual 
cell's intrinsic motility properties on the different polyurethane surfaces from which 
predictions can be made about how the different patterned surfaces affect the cell 
movement. 
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Figure 3-3: Schematic of image conversion to code. Flow diagram shows basic 
steps involved to convert microscopic data into MATLAB code to have accurate 
gradient information for simulated cell to migrate upon. 
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3.3 Results 
3.3.1 Cell trajectories 
Several typical cell paths for fibroblast cell migration on the experimental polyurethane 
surfaces are shown in Figure 3-4. The paths reveal that fibroblast cells migrate with a 
combination of smooth and twisted trajectories. The persistence time in a given direction 
does not appear to be very long. The duration of all cell paths ranged from 140-160 minutes. 
The final measurement of the cell path is represented by the round head feature of the trace 
(—•), whereas the origin of the cell trajectory is represented by the tail like feature (—).  The 
cells that extended beyond the reach of the domain were ignored. The cell paths for fibroblast 
cell migration on the Linear and Random patterned surfaces are shown in Figure 3-4B and 
Figure 3-4C, respectively. These paths represent the movement of the centroid of the cell 
area. Qualitatively, directional changes in the cell paths appear smooth initially, before more 
frequent turns in trajectory. Certainly, initial inspection suggests that the fibroblast cells on 
the linear pattern (Figure 3-4B) travel a greater distance from their origin site compared to 
the cells on the other polyurethane surfaces.  
3.3.2 Experimental metrics  
Individual fibroblast cells were tracked using ImageJ (n=13 for flat and random, n=41 for 
linear), as previously described in section 3.2.3. Firstly, the multiple individual cell trajectories 
were averaged and the tortuosity was calculated for each of the three surfaces (Flat, Linear 
and Random).  These values are plotted with associated error bars indicating standard 
deviation in Figure 3-5A. The mean tortuosity measured for each surface was 3.4 ±2.12 (Flat), 
2.95 ±0.31 (Linear) and 2.96 ±1.62 (Random). For reference, if a cell were to have a tortuosity 
ratio equal to 1, that cell path would have a trajectory in a perfect straight line.  There is a 
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large variance in tortuosity on the flat and random surfaces, compared to that of the linear 
surface. This suggests that there is a greater persistence time in cell direction for fibroblast 
cells migrating on a surface with linear features. However, note that there is no statistical 
significance in tortuosity between the three surface types (Figure 3-4). What is apparent from 
the values outputted from these measurements is that the cells have a slightly more directed 
migration on the surfaces containing the linear and random nano-scratch features i.e. have a 
lower tortuosity value indicating greater straight line movement. Recall that the curved line 
distance is the total distance travelled by the cell and the straight-line distance is the distance 
the cell has travelled from its point of origin. For illustration, the means of both these metrics 
for the migration of the fibroblast cells on each surface were plotted in Figure 3-5B. The flat 
surface had a mean curved line distance of 76μm and straight-line distance of 25μm. Similarly, 
the mean curved line distance travelled by the cell population on the random surface was 
62μm with a straight-line distance of 23μm. Contrastingly, the distances travelled by the 
fibroblast cells on the linear surface were much greater. The mean curved line distance and 
straight-line distance measured for this surface was 134μm and 53μm, respectively. Again, as 
with the tortuosity measurements, there is a smaller variance in individual cell distance 
travelled along the linear surface compared to the other surfaces, particularly for the curved 
distance metric.  
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Figure 3-4. Tracking of cell migration on the polyurethane surfaces. Image showing the 
migratory paths of fibroblast cells on the flat surface (A), Linear surface (B) and Random 
surface (C). Scale in microns at bottom right corner.  
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Figure 3-5. Experimental metrics from cell migration experiments. Column chart showing 
the tortuosity (A) and distances travelled (B) by the fibroblast cells on each polyurethane 
surface.  (*) denotes P < 0.01. 
  
A
B
106 
 
A single factor ANOVA was conducted to compare the tortuosity, curved line and straight-line 
distance between the different surface types. There was no significant effect on tortuosity at 
the p<0.05 level for the three surfaces (p=0.53). However, there was a significant effect on 
the curved-line distance (p=4.4x10-6) and the straight-line distance (p=5x10-6) between the 
three surfaces. A Bonferroni correction test was utilised to counteract the problem of multiple 
comparisons and to reduce the chance of false positives. In other words, the confidence 
intervals are adjusted to compensate for the increase in number of hypotheses tested, using 
the following calculation 
𝑝
𝑛
. In this example, p=0.05 and n=3, to represent each surface type. 
Therefore, the Bonferroni correction now tests each individual hypothesis at p=0.0167. Post 
hoc comparisons using a Bonferroni corrected t-test indicated that the mean for the curved-
line distance for the flat surface was significantly different (p=7.5x10-4) than the linear surface. 
This was also true for comparison between the linear surface and the random surface 
(p=1.2x10-5). However, the flat surface mean did not significantly differ from the random 
surface mean (p=0.34). Similarly, this trend of significance was upheld for the straight-line 
distance means between the flat and linear (p=2.7x10-4), flat and random (p=0.79) and linear 
and  random (p=1.4x10-4) surfaces. Taken together, these results suggest that the linear 
surface has a statistically significant effect on the migration of the fibroblast cells, compared 
to migration on flat and random surfaces. 
In Figure 3-6, the mean squared displacement (D2), is plotted against time. The time course 
of the experiments varies between 130-160 minutes. This is due to the initial frames of some 
of the time-lapse videos having fibroblast cells still in the attachment phase of the 
experiment. For comparison of the D2 measurements, between the different surfaces, we 
focus on the D2 values at the end time of the experiments (i.e. at t = 160 min). These D2 values 
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were: for the flat surface 1076 μm2; the linear surface 2367 μm2; and the random surface 
1326 μm2. There is high variance in all 3 results leading to large error bars in the results, which 
is to be expected when taking the mean of multiple individual cell migration paths (n>10) 
from differing starting points on non-uniform surfaces i.e. different feature depths. Once 
more, it is clear that there is greater directionality of cell migration on the linear surface with 
approximately twice as much displacement compared with the flat and random surfaces. This 
is more clearly seen in Figure 3-6D. For the early time frames, the linear and random 
trajectories are almost identical, suggesting that the movement has a directional bias as the 
cells they attach to the pattern features. However, as time increases, the random trajectory 
more resembles the flat trajectory, which is more typical of random motility.  
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Figure 3-6. Experimental mean squared displacement results. Graphs showing experimental mean squared displacement (D2) as a function 
of the time increment for all the migrating cells on the flat (A), linear (B) and random (C) patterned surfaces. (D) All D2 measurements are 
plotted on the same graph with legend indicating which trace belongs to which surface. 
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3.3.3 Applicability of the model for migration on Flat surfaces 
The first level of validation of the model is to show that related average metrics produced by 
the in-silico model are the same as those produced by the real cells in the experiments. For 
the model, the related average metrics are the mean squared displacement of the cells, 
tortuosity, and curved and straight-line distances. Initially, only the flat surface is modelled 
using Equation 3-2, without the haptotactic part (𝛹), and Equation 3-3 to yield an actual cell 
path for the migrating in-silico cells.  
To initialise the model, the positional coordinates of the cells origin were set to (0, 0) and the 
initial cell velocity in the x and y directions was randomised to have any value ranging from -
10μm/min to 10μm/min. The time of the in-silico experiment, t, was set to match the 
experimental time (t = 160 min) with the time increments, dt, being as small as possible to 
ensure numerical accuracy (dt = 0.5). The two random motility parameters, α and β, were 
initially set as 73.6 and 0.22, respectively, to mimic the mean values obtained in a comparable 
O-U model designed by Stokes et al. [291]. Once initialised, the cells velocity and position 
were updated using Equations 3-2 and 3-3 for the duration of the time course.  A flow diagram 
depicting this process in available in Figure 3-7. These equations were solved using the Euler-
Maruyama and Euler method, respectively [296]. The Euler-Maruyama method is used to 
approximate numerical solutions for stochastic differential equations (SDE), adapted from the 
use on ODEs for the Euler method.  Using the Euler-Maruyama method, the next x-position 
can be updated if the current x-position is known. This allows for the velocity to be solved and 
for the positions to be updated with that velocity, using the Euler method. Example velocities 
and positions of the individual cells are plotted (Figure 3-8) as well as the simulated 
trajectories of these cells (Figure 3-9). Finally, relevant metrics (tortuosity, curved and 
straight-line distance) are produced and the mean squared displacement for these in-silico 
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simulations plotted. In Figure 3-8, the velocity changes in both axes are plotted. The influence 
of the α parameter is evident by the fluctuations observed in the traces. If this parameter 
were to be set to zero, the deterministic parameter, β, would produce traces showing the 
velocity reverting to zero over time. The cells were simulated separately in the model. 
Therefore, cell-cell interactions are not taken into account. 
 
 
 
 
Figure 3-7: Initialisation of Euler-Maruyama equations. Initial parameters were set as 
stated in the flow diagram (green code). The cell velocity and position is updated every 
iteration based on the Euler-Mayurama equations and the velocity and position of the 
previous iteration. The dW parameter represents the Weiner process and is a random 
number in each iteration.  
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Figure 3-8. Cell velocities (μm/min) and positions (μm) in x and y position over time. Graphs showing the simulated positions and velocities 
on both axes for 10 migratory model cells for the flat surface simulation.  Parameters for this simulation were as follows: α=73.6, β=0.22.
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Figure 3-9. Simulation of cell migration paths. This graph shows the 10 simulated cell 
paths for the flat surface described in Figure 3-8. The initial x and y position (μm) of each 
cell was (0, 0). The parameters were as those indicated in Figure 3-8. 
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3.3.4 Determination of random motility parameters 
Now that there is a working model of cell migration that visually aligns well with the 
experimental system, the parameters, α and β, can be optimised to find values that best 
describe the behaviour of the experimental system. The experimentally derived metrics from 
this system can be used for parameter (α and β) estimation and production of a value of best 
fit for the experimental data. To begin, we run the in-silico model, varying α and β between 
the values α = 0.1-1 and β = 0-1. The mean tortuosity, curved line distance, straight-line 
distance and D2 (end time) values are then calculated for each individual combination of these 
α and β values (see Figure 3-10). To aid comparison to the experiments, a contour plot was 
added to each graph (white curves). These contour plots represent the corresponding 
experimentally derived metrics from the fibroblast migration experiments on the flat surface. 
In other words, any α and β combination falling on these contours can be assumed to be an 
appropriate combination to describe the experiments.  
A more quantitative test for goodness of fit between the model and experiments is the sum 
of squared errors (SSE). The SSE is a measure of the discrepancy between the experimental 
data and estimation model. In other words, it is used in a test for goodness of fit of an 
observed set of data to a theoretical one. The SSE calculations for tortuosity, curved line 
distance, straight-line distance and mean squared displacement were calculated using 
Equation 3-6, namely; 
 
𝑆𝑆𝐸 =  ∑
(𝑆𝑖 − 𝐸𝑖)
2
𝐸𝑖
,
𝑛
𝑖=1
 (3-6) 
where Si is the simulated measurement of the metric (e.g. tortuosity, etc.) and Ei is the 
experimentally derived measurement of the same metric. A small SSE value indicates a tight 
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fit of the model to the data. Here, it is used as an optimality criterion in parameter selection. 
In the model, SSE values were calculated for each of the four flat surface metrics (tortuosity, 
curved line distance, straight line distance and mean squared displacement) and used to 
generate plots to help determine the optimal value of α and β (Figure 3-11).  
 
Figure 3-10. In-silico generated metrics. Plots show a range of α and β values (0 – 0.1) 
with tortuosity (A), curved line distance (B), straight line distance (C) and the end time 
mean squared displacement values (D), plotted on a colour scale with values indicated on 
the relevant colour bar. The white contours indicate the experimentally derived values for 
the metrics. 
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The SSE values for each of the metrics are plotted against the same range of α and β values 
(Figure 3-11). To find a combination of α and β values that will give a good fit (i.e. the 
minimum) of all four metrics simultaneously, their respective SSE values were totalled and 
plotted against α and β (Figure 3-3A). Figure 3-3B show the minimum SSE values from the 
respective plots in Figure 3-11 for the four metrics, i.e. contour plot of the minimum SSE for 
the α-β pairs. This plot shows that lower values of α and β appear to give the best fits for the 
experimental data. Therefore, the total SSE values were alternatively plotted as a colour 
projection against the range of α and β values (Figure 3-3C). The darker colours indicate a 
lower SSE value. Subsequently, it was found that a quadratic curve (Equation 3-7) maps well 
onto the minimum SSE values as indicated in (Figure 3-12C), suggesting (α,β) pairs given by 
this relationship predicted cell migration paths comparable to the experiments. The best fit 
polynomial given in Figure 3-11D is as follows: 
 𝛼 = 4.975𝛽2 + 0.002781. (3-7) 
 
 
116 
 
 
Figure 3-11. Sum of squared Errors (SSE) plots for metrics. Individual SSE- values are 
given in the colour bar for α versus β plots for the (A) tortuosity, (B) curved line distance, 
(C) straight line distance and (D)  end time mean squared displacement. 
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Figure 3-3. Sum of Squared Errors (SSE) plots. (A) Total SSE- values (i.e. SSEtotal = SSEtortuosity 
+ SSEcurved line + SSEstraight line + SSEmean squared displacement) are plotted on z-axis for α versus β 
plot. (B) Plots showing minimum values of the tortuosity (blue), curve-line (red), straight 
line (black) and D2 (green) SSE values on alpha versus beta plot. (C) Polynomial curve fitting 
plot for the minimum of the total SSE- values.  
118 
 
3.3.5 Determination of haptotactic responsiveness  
The experimental metrics for the patterned surfaces can be used along with the full version 
of Equation 3-2 (i.e., with 𝛹 = 0) to optimise and determine the haptotactic responsiveness 
parameter, 𝜅. The α and β values are fixed at 0.01 and 0.04, according to Equation 3-7. These 
low values of α and β are chosen to prevent the simulated cells from ‘exiting the boundary’ 
of the topographical space i.e., the data uploaded from the microscopic images in Figure 3-2. 
100 cells were simulated with a range of 1000 𝜅-values from 0.1 to 0.8 and the resulting mean 
values for tortuosity, curved distance, straight-line distance and the mean end-time squared 
displacement (D2t=160) were plotted against the range of 𝜅-values for the linear (Figure 3-4 – 
3-15) and random (Figure 3-7 – 3-18) surfaces. Figure 3-4 and 3-16 show the simulated 
predicted values with mean (black curves) and standard deviation (grey error bars) indicated. 
These simulated metric values, for the wide range of 𝜅-values inputted into the model, can 
be optimised using the experimentally derived metrics. Thus, the most appropriate 𝜅-value 
that best describes the in-vitro experiments can be determined. For the linear surface case, 
the experimental numbers were superimposed onto the plots (Figure 3-5 – red line) for 
tortuosity (2.95 μm), curved distance (134.26 μm), straight-line distance (53.60 μm) and the 
end time mean squared displacement (2367 μm2). Additionally, the SSE values were also 
calculated for these metrics, using Equation 3-6 and Figure 3-14, and the total SSE plotted 
against 𝜅 (Figure 3-6). Through comparison of these plots (in particular, see Figure 3-6), it can 
be observed that a 𝜅-value in the range 0.5-0.6 would be optimal to describe the linear 
experiments (i.e., minimise SSEtotal). Similarly, on Figure 3-8, the experimental values for the 
random surface were superimposed on the plots for tortuosity (2.94 μm), curved distance 
(62.62 μm), straight-line distance (23.62 μm) and the end time mean squared displacement 
(1326 μm2). Again, the most appropriate 𝜅-value can be derived from comparing the total SSE 
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values against 𝜅. In this case, it yields a much lower optimal 𝜅-value (i.e., min SSEtotal) in the 
range of 𝜅 = 0.01 − 0.07.  
 
Figure 3-4. Determining the haptotactic gradient for the linear surface. Graphs showing 
simulated mean metric values (black curves) with standard deviation (grey) for range of 
𝜅-values (0 – 0.8).  
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Figure 3-5. Optimisation of 𝜿 for the linear surface for individual metrics.  Experimentally 
derived values (red) superimposed over simulated mean values against 𝜅 (see Figure 3-
13). Optimal values of 𝜅 selected from points of crossover for each metric.  
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Figure 3-6. Optimisation of the haptotactic term for the linear surface. Total SSE-values 
(i.e. SSEtotal = SSEtortuosity + SSEcurved line + SSEstraight line + SSEmean squared displacement) of the four 
metrics plotted against 𝜅. Lower SSE-value indicates a stronger fit between the 
experimental data and the model. 
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Figure 3-7. Determining the chemotactic gradient for the random surface. Graphs 
showing simulated mean metric values (black curves) with standard deviation (grey) for 
range of 𝜅-values (0 – 0.15).  
 
  
123 
 
 
Figure 3-8. Optimisation of 𝜿 for the random surface for individual metrics.  
Experimentally derived values (red) superimposed over simulated mean values against 𝜅 
(see Figure 3-16). Optimal values of 𝜅 selected from points of crossover for each metric. 
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Figure 3-9. Optimisation of the haptotactic term for the random surface. Total SSE-values 
(i.e. SSEtotal = SSEtortuosity + SSEcurved line + SSEstraight line + SSEmean squared displacement) of the four 
metrics plotted against 𝜅. Lower SSE-values indicate a stronger fit between the 
experimental data and the model.  
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The in-silico model is now simulated using the fixed α =0.01 and β = 0.04 (satisfying Equation 
3-7) and 𝜅 values representing the linear (𝜅 = 0.5) and random (𝜅 = 0.02) patterned surface 
experiments. The resulting 10 model cell migration paths derived from these simulations are 
shown in Figure 3-10 and the corresponding mean squared displacement values were also 
plotted (Figure 3-20). Table 3-1 shows comparisons of the migration metrics (for tortuosity, 
curved line distance, straight line distance and mean squared displacement) for all three 
surfaces. The model parameters were those identified as being optimal in the above analysis 
for these surfaces. Significance levels are derived using a paired Z-test to calculate the 
difference between the observed means in the experimentally derived and simulated 
samples. There is an excellent comparison between the data in the flat surface with no 
significant difference shown for tortuosity (p=0.79), curved line distance (p=0.63), straight 
line distance (p=0.23) and mean squared displacement (p=0.58). Similarly, there is no 
significant difference between the experimentally derived and simulated means in the 
random surface for these metrics, respectively (p = 0.4, p=0.59, p=0.12 and p=0.98). However, 
there is an inconsistency in the curved line distance for the linear surface (p<0.0001). This 
outlier can be also be observed in Figure 3-14. This is likely an artefact of lowering the α-β 
values to prevent simulated cells from migrating off the simulated polyurethane surface. 
Subsequently, this significance is present between the tortuosity values (p<0.0001) for the 
linear surface. There is no significant difference between the means for the straight-line 
distance (p=0.12) and mean squared displacement (p=0.77) for the linear surface. Otherwise, 
the models show a good recreation of the key migratory features as observed in the 
experiments. 
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 Tortuosity Curved-line distance (μm) Straight-line distance (μm) Mean squared end-time 
displacement  (μm2) 
 Exp Sim Exp Sim Exp Sim Exp Sim 
Flat 3.4 ± 2.12 3.2 ± 1.55 
P=0.79 
75.89 ± 55.6 84.56 ± 14.2 
P=0.63 
24.81±15.9 32.22 ± 16.7 
P=0.23 
1075 ± 1196.4 1291 ± 406.4 
P=0.58 
Linear 2.95 ± 0.31 2.01 ± 0.8 
P<0.0001 
134.3 ± 21.8 86.09 ± 19.2 
P<0.0001 
53.6 ± 11.2 47.87 ± 17.5 
P=0.12 
2367 ± 2111 2566 ± 801.4 
P=0.77 
Random 2.96 ± 1.62 2.5 ± 0.73 
P=0.4 
62.62 ± 35.1 68.9 ± 14.9 
P=0.59 
23.62 ± 14.9 33.17 ± 17.3 
P=0.12 
1326 ± 1211.7 1318 ± 414.2 
P=0.98 
Table 3-1. Experimental and simulated values for the metric values. Table showing the mean and standard deviations for the in-vitro (Exp) 
and in-silico (Sim) results for tortuosity, curved-line distance, straight-line distance and the final mean squared end-time displacement on 
each of the three polyurethane surfaces (Flat, Linear and Random). P-values indicate significance between the in-vitro and in-silico results for 
each metric on each surface. 
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Figure 3-10. Simulation of cell migration paths. Example of 10 simulated cell 
paths for flat (A), linear (B) and random (C) surfaces. A magnified look at the cell 
paths across the features is included for the linear and random surfaces. All 
simulations had a starting point of (0, 0). The α and β values were fixed to 0.01 
and 0.04 for all simulations. The 𝜅 values were fixed to 0.5 and 0.02 for B and C, 
respectively. 
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Figure 3-20. Simulated mean squared displacement results. Examples of 
simulated mean squared displacement (D2) as a function of time increment for all 
the migrating cells on the Flat (A), Linear (B) and Random (C) patterned surfaces. 
Same parameters as Figure 3-19. 
A
B
C
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3.4 Chapter Discussion 
This chapter describes the development of an in-silico model for analysing the 
migration of fibroblast cells on polyurethane surfaces with varying nano-
topographical features, based on the stochastic O-U process introduced by Dunn and 
Brown (1987) [295]. In addition, we have extended this process to include a surface 
topology bias. In this model, random motility can be described as a mixture of 
random fluctuations and deterministic decay in cell velocity. These respective 
unknown quantitative parameters were optimised by comparing experimental 
results to the in-silico output. This permitted comparison of a large range of 
parameter values to be narrowed down to a specific subset of α-β pairs, which when 
inputted back into the simulation, results in an in-silico model that accurately 
describes the experimental cell migration patterns. A third term was added to the O-
U process to account for the effects of the surface gradient on the cells velocity. This 
term is proportional to the deviation of the current direction of the cell from the 
surface gradient. Again, this term was determined through a combination of 
experimental results and multiple model simulations, producing a range of values for 
each surface. Further simulations, with the parameters fixed to the predicted optimal 
values, resulted in in-silico models showing a good match to the in-vitro experiments. 
Therefore, the extended quantitative framework appears to be an appropriate 
description of the motility observed in the cell migration assays. 
Comparison of the metrics derived from the experiments (Figure 3-5) reveal that 
there was a significant difference between the flat and linear surfaces and the linear 
and random surfaces. There was no observable significant difference between the 
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flat and random surfaces for the curved-line distance (p=0.34) and straight-line 
distance (p=0.79) travelled by the fibroblast cells (Figure 3-5B) or for any of the 
tortuosity values generated (Figure 3-5A). An explanation for this lack of significance 
could be due to the orientation of the surface pattern features on the random 
polymer (Figure 3-2B). It is possible that the cells could be adhering and migrating 
along the pattern features while simultaneously exhibiting random motility, as 
observed on the flat surface, thanks in part to the criss-cross (random) nature of the 
pattern. However, the tortuosity for this experiment is almost identical to the 
tortuosity of the linear experiment (Figure 3-5A), suggesting that the motility in this 
experiment is more directed. Furthermore, observation of the mean squared 
displacement plot (Figure 3-6D) infers that, initially, the displacement of the cells on 
the random surface closely match that of the linear surface. However, as time 
increases, this trend changes and migration on the random surface more closely 
resembles the displacement of the fibroblast cells on the flat surface. Therefore, even 
though it is likely that the fibroblast cells on the random surface are influenced by 
the nano-features present on the polymer, it can’t be shown to have any significant 
effect on the cell migration pattern.  
As shown by the match of the O-U process to data for mean squared displacement 
(Table 3-1), the random motility parameters provide appropriate description of the 
fibroblast migration. This agreement strengthens the verification of the applicability 
of the model. While the actual mechanical and biochemical processes that α and β 
should represent are not presently defined, these parameters provide a direct means 
of relating observable quantities, such as cell speed, to basic motility mechanisms. 
These parameters are fixed for all subsequent simulations meaning the only 
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differences between the in-silico models for the different surfaces are the value of 
the haptotactic parameter 𝜅 and the surface gradients obtained from the 
microscopic data. By taking the SSE-values for the motility parameters, α and β, and 
fitting them to a polynomial curve (Figure 3-11D), a range of α-β pair values can be 
acquired. This suggests there is a quadratic relationship between the ratio of random 
fluctuations and velocity decay. Theoretically, any α-β value can be chosen as long as 
it satisfies this relationship. However, as alluded to in the results, smaller α-β values 
were chosen to prevent the simulated cells from leaving the simulated polymer 
surface. Experimentally, this isn’t a problem as the fibroblasts that migrated ‘out of 
frame’ in the time-lapse microscopy results were discounted. Nonetheless, when this 
event occurs in the model simulations it results in massive skewing of the data. 
Lowering the α-β pair values reduced the distance possible for the simulate cells to 
migrate into which allowed for simulated cells to remain within the boundary of the 
in-silico polymer space. A combination of this solution with each simulated cell having 
a starting origin in the middle of the polymer space (0,0) contributes towards the 
poor fit of between the experimentally derived mean curved-line and straight-line 
distance values and the simulated mean values for the linear (Figure 3-14) and 
random (Figure 3-17) polyurethane surfaces. However, for the purposes of 
optimising the haptotactic parameter, the ratio of these distances was more 
important than the values. Ultimately, the mean squared displacement plots were 
the biggest indicator of optimal 𝜅 values for the linear and random polyurethane 
surface.  
SSE-values for the haptotactic parameter were also utilised in the optimisation of 𝜅. 
The parameter 𝜅 represents the ability of the cells to respond to a perceived surface 
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gradient in its surrounding environment. A range of 0.5-0.6 for the 𝜅-parameter was 
predicted as optimal for the linear surface. For the random surface a much lower 𝜅-
value range of 0.01-0.07 was predicted. This lower value of 𝜅 suggests the random 
surface features have less effect on the migrating fibroblast cells compared to those 
features present on the linear surface, as 𝜅 represents a bias towards the surface 
gradient in the model. This result is in line with the statistical analysis as it was stated 
previously that there was no statistical significance between the flat and random 
surfaces (Figure 3-5). Ultimately, the lower 𝜅-value is needed on the random surface 
to generate the best fit to the experimental data. The higher 𝜅-value associated with 
the linear surface simulations would suggest that these features activate a more 
prolonged mechanism of sustained migration biologically within the fibroblast cells. 
Full simulation of the model, incorporating optimised derived values for α, β and 𝜅, 
result in the production of D2 plots (Figure 3-20) that accurately mimic what occurred 
in the in-vitro experiments (Figure 3-5).  
In summary, I have proposed a mathematical model of fibroblast migration and 
haptotaxis across varying polyurethane surfaces, containing nano-topographical 
features through abrasive polishing, which provides a quantitative framework in 
which to assess cell migration on these surfaces. The model has been shown to 
accurately replicate key migratory features observed in the in-vitro experiments and 
establishes a precise relationship between α and β values for fitting of the 
experimental data. The model was also able to provide distinct 𝜅-values for the linear 
and random surfaces. These values indicated the amount of bias shown by the cells 
to each particular surface. This information can be utilised in the design of smart 
materials to influence the adhesion and migration of cells.   
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Chapter 4: Mathematical modelling of 
Nrf2 dynamics 
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4.1 Introduction 
In this chapter, an in-silico model designed to highlight the subcellular machinations 
of the Nrf2 protein signalling pathway is introduced. As previously described in 
section Error! Reference source not found., the Nrf2 protein is a vital transcriptional 
regulator in response to oxidative stress. However, the key characteristic of this 
transcription factor is its very low basal activity and stringent regulation [212]. Some 
of the key questions the model aims to address involve the basic rates of interactions 
and translocations of Nrf2. These include production and decay rates, as well as the 
import-export rates across the nuclear membrane. To begin, the Nrf2 pathway is 
reduced to only include the essential components necessary to capture these rate 
profiles, based upon a review of the literature (section 1.6.1). For simplicity, within 
the cytoplasm, it is assumed that the Nrf2 protein undergoes the processes of 
production, decay, proteasomal degradation and nuclear translocation. Proteasomal 
degradation involves interactions with Keap1, the best understood negative 
regulator of Nrf2 [214]. For the model, it is assumed that Keap1 is constantly available 
to inhibit newly formed Nrf2, as it would under normal in-vivo conditions [211]. As 
such, there is no need to include the production or decay of Keap1 within the model. 
Instead, its involvement within the model includes binding to the Nrf2 protein and 
ubiquitously marking it for degradation. Within the nucleus, it is assumed the Nrf2 
has two pathways for decay and degradation. The simulated Nrf2 protein either 
undergoes a basal decay within the nucleus or it is exported back to the cytoplasm, 
to be degraded by the Keap1 protein.  This is explained in more depth in the methods 
(section 4.2.2 below). 
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A novel component of this work is the close interplay of the in-silico model with 
experimentally derived data. Note that the work in this chapter involves 
collaboration with Professor Chris Sanderson’s lab in the University of Liverpool. They 
provided experimental data sets for the validation of the Nrf2 signalling pathway 
model. These data sets contain experimental results of Nrf2 expression in wildtype 
cells and cells that have undergone various treatments to perturb the Nrf2 signalling 
system. A brief overview of the key information obtained from this experimental data 
is provided in section 4.2. Moreover, a detailed description of the experiments 
conducted by Dr Jo Wardyn (Sanderson lab) is included in Appendix B (section 7.2).  
4.1.1 Chapter aims 
1. To design an in-silico model to accurately describe the Nrf2 signalling 
pathway and capture the system dynamics based on a review of the literature. 
2. To parameterise the model using initial input values obtained from the Khalil 
et al. paper 
3. To validate the optimised in-silico output based upon agreement with the 
experimental data 
4. Use the in-silico model outputs to quantify the key mechanisms of Nrf2 
regulation in the cytoplasm and nucleus, proposed by Sanderson lab  
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4.2 Methods 
As mentioned above, this chapter was completed in collaboration with the University 
of Liverpool and all imaging experiments were performed by Dr Jo Wardyn 
(Sanderson lab). The raw data generated from these experiments were used as the 
basis for building the mathematical model. However, for completeness, a brief 
overview of the key information obtained from these experiments is provided below.  
4.2.1 Summary of wet lab experiments 
Real time imaging experiments were conducted on live cells with the aim of 
measuring Nrf2 expression via fluorescence. This was achieved by transfecting 
primary cells with fluorescent protein plasmids. Two cell types were used in these 
experiments with each cell type expressing a different fluorescent protein. BAC 
(bacterial artificial chromosome) cells stably expressed the Nrf2-Venus fluorescent 
protein, which exhibits a very low expression. These cells will be referred to as ‘BAC 
cells’ throughout the chapter. The photoswitchable fluorescent protein pDendra2 
was transiently expressed in SK-N-AS cells and will be referred to as ‘pDendra cells’ 
from this point forward. The pDendra2 emits naturally in a green light spectrum. 
However UV irradiation results in irreversible transition in emission to the bright and 
photostable red fluorescent protein (RFP) spectrum. The BAC cells were treated with 
MG132 (proteasome inhibitor) and CHX (translation inhibitor) to perturb the system 
and the results were recorded, containing nuclear fluorescence measurements only, 
which were then normalised to the initial value. These BAC cell data sets only contain 
nuclear fluorescent measurements, as Nrf2-Venus fluorescence is confirmed to be a 
nuclear fluorescent signal under lambda scanning [297]. Similarly, wildtype 
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experiments were conducted in the pDendra cells and measurements of green 
fluorescence were normalised to the initial fluorescence intensity. Note that the red 
data is normalised to the value after photoconversion. Experiments in these cells 
were also repeated with a knockdown of Keap1 (siKeap). Data obtained from the 
pDendra experiments provide distinct measurements for cytoplasm and nucleus. 
Therefore, there are four experimental data sets to validate the model, namely two 
data sets from the pDendra cells (wildtype and siKeap) and two data sets from the 
BAC cells (MG132 and CHX). 
4.2.2 Mathematical Model 
The starting point in the creation of the model involved the inclusion of the most 
important processes involved in the Nrf2-Keap1 interaction. These processes include 
the production, translocation, degradation and decay of the Nrf2 protein. The model, 
shown schematically in Figure 4-1, represents the regulation of Nrf2 within two 
compartments, the cell nucleus and the cytoplasm. Nrf2 is produced (at rate 𝑟4) in 
the cytoplasm and can translocate into the nucleus (rate 𝑟2). Due to the different 
transfection methods for pDendra cells and BAC cells, an additional parameter (𝑧) is 
required to modify the production rate of Nrf2 in the cytoplasm. That is the r4 
parameter is multiplied by the 𝑧 < 1 parameter to give a reduced basal synthesis 
rate for the BAC cell experiments. In the nucleus, the Nrf2 protein is either exported 
to the cytoplasm (rate 𝑟1) or decays within the nucleus (rate r5). Cytoplasmic Nrf2 can 
also bind with Keap1 whereupon it is targeted for proteasomal degradation (maximal 
rate 𝑟3). This Keap1-mediated removal of cytoplasmic Nrf2 protein is governed by a 
threshold (𝑟6). This simple description of Nrf2 dynamics in the cell is used for 
modelling the green fluorescent data. The red-Nrf2 system is modelled in the same 
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way as the green, but lacks the basal synthesis rate (𝑟4 = 0) as there are no newly 
synthesised Nrf2 proteins emitting red fluorescence by definition.  
The mathematical model, comprises two ordinary differential equations (ODEs) for 
each of the two cellular compartments (subscript c for cytoplasm and n for nucleus): 
 𝑑𝐺𝑐
𝑑𝑡
= 𝑟4 + 𝑟1𝐺𝑛
𝑉𝑛
𝑉𝑐
− 𝑟2𝐺𝑐 −
𝑟3𝐺𝑐
𝐺𝑐 + 𝑟6
, (4-1) 
 
 𝑑𝑅𝑐
𝑑𝑡
= 𝑟1𝑅𝑛
𝑉𝑛
𝑉𝑐
− 𝑟2𝑅𝑐 −
𝑟3𝑅𝑐
𝑅𝑐 + 𝑟6
, (4-2) 
 
 𝑑𝐺𝑛
𝑑𝑡
= 𝑟2𝐺𝑐
𝑉𝑐
𝑉𝑛
− 𝑟1𝐺𝑛 − 𝑟5𝐺𝑛, (4-3) 
 
 𝑑𝑅𝑛
𝑑𝑡
= 𝑟2𝑅𝑐
𝑉𝑐
𝑉𝑛
− 𝑟1𝑅𝑛 − 𝑟5𝑅𝑛, (4-4) 
 
where 𝐺𝑐 denotes the concentration of green-Nrf2 in the cytoplasm, 𝐺𝑛 represents 
the concentration in the nucleus, 𝑉𝑐 denotes the volume of the cytoplasm and 𝑉𝑛 
denotes the volume of the nucleus. The variables 𝑅𝑛 and 𝑅𝑐 represent the 
concentration of red-Nrf2 protein present in the nucleus and cytoplasm, respectively. 
All these dynamic processes are governed by parameters whose description and 
respective units are given in Table 4-1. 
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Figure 4-1. Minimal Mathematical Model. Schematic diagram showing the cycle 
of the Nrf2 protein within the cytoplasm and nucleus. In the cytoplasm, Nrf2 is 
produced and then sequestered by Keap1 and marked for degradation. The other 
elements of the minimal-model include nuclear import, nuclear decay and export 
of the nuclear Nrf2 protein to the cytoplasm. Rate descriptions included in Table 
4-1. 
 
 
 
Parameter Description [units] 
𝒓𝟏 Nuclear export rate [1/min] 
𝒓𝟐 Nuclear import rate [1/min] 
𝒓𝟑 Maximal Keap-mediated cytoplasmic removal rate 
[nM/min] 
𝒓𝟒 Basal synthesis rate of pDendra cells [nM/min] 
𝒓𝟓 Nuclear removal rate [1/min] 
𝒓𝟔 Keap-mediated cytoplasmic removal threshold [nM] 
z Modifier for BAC basal synthesis rate [dimensionless] 
Table 4-1. Description and units of the seven parameters. Table showing the 
seven parameters for the Nrf2 signalling processes included within the in-silico 
model design. A description of what each parameter represents and the 
respective units is also provided. 
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4.2.3 Parameterisation and Latin Hypercube sampling 
To initialise the model, the preliminary model uses values for the six parameters (𝑟1 
– 𝑟6) obtained from a publication by Khalil et al. [269]. A description of each of the 
parameters used in this study, the values of these parameters and how they 
correspond to the parameters outlined in the model above are given in Table 4-2. 
The value for the z parameter (0.01) was obtained experimentally from the 
Sanderson lab. Parameter optimisation was conducted in order to modify these 
initial parameter values and give the best possible fit between the model and the 
data. Latin hypercube sampling (LHS) was used to generate a distributed sample set 
of initial parameter estimates for this fitting. LHS is a way of generating random 
samples of parameter values [298]. The reasoning behind the use of LHS in the model 
is due to the computational power needed to optimise these parameters using 
general random sampling methods. In random sampling, the model would not take 
into account previously generated sample points when selecting new sample points, 
which has the potential to generate a poor spread of the data points. However, with 
LHS it can be decided how many sample points are needed and the sampling also 
accounts for which ranges of values have already been selected. Therefore, LHS 
sampling provides initial parameter estimates that incorporate the entire spread 
while remaining computationally efficient and preventing the model becoming 
trapped in local minima. A paper by Pan et al. [299] shows how LHS sampling can be 
used to improve the efficiency in terms of computational time and space-filling 
properties. LHS has also shown to optimally represent the multivariate distribution 
of input datasets better than other sampling methods [300].  
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Parameter Initial value [269]  Description and source [269]   
𝒓𝟏 0.1 min
-1 Rate of cytoplasmic/nucleus exchange of Nrf2 [269] 
𝒓𝟐 0.1 min
-1 Rate of cytoplasmic/nucleus exchange of Nrf2 [269] 
𝒓𝟑 0.1 µM
-1 min-1 Reaction rate of the binding of Nrf2 with Keap1 [269] 
𝒓𝟒 2x10
-2 µM/min Synthesis rate of Nrf2 [269] 
𝒓𝟓 5x10
-2 min-1 Degradation rate of Nrf2 [269] 
𝒓𝟔 5 nM Dissociation constant of Nrf2 with Keap1 [269] 
z 0.01  Modifier for BAC basal synthesis rate (Sanderson) 
𝑽𝒄 2.2x10
-12 L Cytoplasmic volume [301] 
𝑽𝒏 5x10
-13 L Nuclear volume [301] 
Table 4-2. Parameter values derived from literature. Table showing the initial 
values derived from Khalil et al. for the parameters 𝒓𝟏 – 𝒓𝟔.  These values are used 
for the initial parameterisation of the mathematical model. A description of what 
each parameter represents in the Khalil et al paper is also provided for clarity. 
Also included in this table are the other parameters used within the model. The 
𝒛 parameter was derived from the Sanderson lab (as described in the main text). 
The volume parameters were adapted from red blood cell volumes from the 
literature [301].  
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4.2.4 Fitting algorithm 
Optimised model parameter values were obtained by fitting the model to the 
experimental data, using the non-linear optimisation function (“fminsearch”) in 
Matlab. The fminsearch function finds the minimum of a scalar function of several 
variables, starting with the initial estimates. This is an unconstrained multivariable 
function using a derivative-free method based on the Nelder-Mead simplex method 
[302]. Simply, this function identifies parameter values that correspond to the 
minimum distance between the model output and the data. A limitation of this 
function is its tendency to only give local solutions if the initial parameter estimates 
do not fall near the global optimal solution. This is another benefit to using initial 
guesses from a spread of LHS generated samples as it provides a wide range of initial 
parameter estimates, diminishing the chances of the fminsearch algorithm becoming 
trapped within local minima. A range was taken for each parameter e.g. for 
parameter 𝑟1, the range generated was [𝑟1/10, 10𝑟1]. This range was then subdivided 
into 200 intervals, using a logarithmic scale, and then numbers were drawn from each 
of these 200 intervals using LHS. This gave a set of 200 randomly perturbed numbers 
from 𝑟1/10 to 10𝑟1. This was repeated for each parameter and each time the fitting 
was conducted, a random value was selected from these numbers for each 
parameter. Therefore, through the combination of LHS and fitting to the 
experimental data, 200 samples were optimised. This was further reduced to 98 
samples through further optimisation, described in the results section (4.3). From 
here further parameterisation was conducted, utilising experimental estimates, until 
the most appropriate parameter values for fitting the experimental data were 
identified. A flow diagram depicting this process in available in Figure 4-2.  
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Figure 4-2 Schematic of modelling strategy. This general schematic specifically 
highlights the simplified process implemented to optimise the model from 200 
potential samples to 3.  
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4.3 Results 
4.3.1 Nrf2 expression in cells using pDendra2 
pDendra2 is a green-to-red photoswitchable fluorescent protein. This fluorescent 
protein is fused with Nrf2 and irreversibly changes to emit red fluorescence when UV 
light is applied [303]. At the beginning of the experiment, all Nrf2 cells emit green 
fluorescence. When the pDendra2 is irradiated at time 4 minutes by UV light, 
approximately 50% of the Nrf2 cells switch to red fluorescence (Figure 4-3). This half 
maximal fluorescence change was deliberate by Sanderson’s lab to measure the 
equivalent import and export rates between nuclear and cytoplasmic compartments 
in their experiments. The fluorescence of the cells is measured in the cytoplasm and 
the nucleus to give two distinct measurements. The fluorescence scale is normalised, 
such that a value of 1 arbitrary unit (AU) corresponds to maximum fluorescence. 
There should be zero cells emitting red fluorescence before UV application. However, 
in Figure 4-3B, it can be seen that the initial red fluorescence measurement is 
approximately 0.2 AU. This is most likely due to background fluorescence in the 
experiment possibly due to e.g. autofluorescence, spectral overlap or undesirable 
antibody binding [304]. To allow comparison with the mathematical model, it is 
important to rescale this data (Figure 4-4) to remove any background signal that was 
measured in the experiment. This rescaling of the data was achieved by using 
equation 4-5 combined with the raw data values, namely: 
 
𝑥𝑁𝐸𝑊(𝑡) =
𝑥𝑅𝐴𝑊(𝑡) − 𝑥𝐵𝐴𝐶𝐾𝐺𝑅𝑂𝑈𝑁𝐷
1 − 𝑥𝐵𝐴𝐶𝐾𝐺𝑅𝑂𝑈𝑁𝐷
, (4-5) 
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where 𝑥𝑁𝐸𝑊 represents the rescaled pDendra2 fluorescence, 𝑥𝑅𝐴𝑊 represents the 
pDendra2 fluorescence from the raw data at time point t and 𝑥𝐵𝐴𝐶𝐾𝐺𝑅𝑂𝑈𝑁𝐷 
represents the observed background pDendra fluorescence at t=0 (approx. 0.2 AU). 
 
 
 
  
Figure 4-3. Green-Red pDendra-Nrf2 data. UV treatment is applied at t= 4 min 
and irreversibly switches pDendra-Nrf2 from green to red fluorescence. (A) Graph 
showing Green pDendra-Nrf2 fluorescence levels in the cytoplasm (dotted line) 
and in the nucleus (solid line). (B) Graph showing Red pDendra-Nrf2 fluorescence 
levels in the cytoplasm (dotted line) and in the nucleus (solid line). Green data 
normalised to initial fluorescence intensity and red data normalised to the value 
after photoconversion. 
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The photoconversion experiment was repeated with Nrf2 cells treated with siKeap1 
(Figure 4-5), which is a short interfering RNA (siRNA) that targets human Keap1 and 
silences the expression of this protein, which would be expected to lead to an 
increase in Nrf2 abundance. To achieve this in the model the parameter 𝑟3 was set 
to zero. One effect of silencing this protein appears to be a faster recovery of newly 
synthesised green pDendra-Nrf2 protein. At time point 40 minutes in Figure 4-3, the 
green pDendra-Nrf2 measurement is approximately 0.8 AU compared with a 
measurement of 0.9 AU at the same time point in Figure 4-5. This would suggest that 
overall production of Nrf2 is higher when Keap1 is silenced, which is what would be 
expected. Contrastingly, there is no comparative difference between the red 
pDendra-Nrf2 measurements at the same time point in Figure 4-4 and 4-5, which 
result in a measurement of approximately 0.3 AU. This would suggest that the rate 
of Nrf2 removal is unchanged. 
To measure the relative effect of proteasome-mediated degradation, an experiment 
was performed in stably expressed Nrf2-Venus cells imaged after treatment with 
10μM of MG132. MG132 is a proteasome inhibitor that blocks degradation. As a 
result, nuclear Nrf2 fluorescence increases twelve-fold over the duration of the 
experiment (Figure 4-6). The measurements in this experiment represent nuclear 
values only and are normalised based upon the initial fluorescence intensity in the 
nucleus. To mimic the inhibition of proteasomal degradation in the model, basal 
decay rates 𝑟3 and 𝑟5 are set to zero. Also, as these experiments were performed in 
BAC cells, parameter 𝑟4 is multiplied by parameter 𝑧 to represent the reduced Nrf2 
production in this cell type 
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Figure 4-4. Re-scaling of red data. The data is re-scaled to zero at t = 0 minutes 
to remove any background fluorescence and allow for model comparison. 
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Figure 4-5. Green-Red pDendra-Nrf2 experiment using siKeap-1. Green-Red experiments repeated with knockdown of Keap-1. UV 
treatment applied at t = 4 minutes.  (A) Graph showing Green pDendra-Nrf2 fluorescence levels in the cytoplasm (dotted line) and 
in the nucleus (solid line). (B) Graph showing Red pDendra-Nrf2 fluorescence levels in the cytoplasm (dotted line) and in the nucleus 
(solid line).
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Figure 4-6. Nrf2-Venus experiment using MG132. MG132 treatment was applied 
at t=0.4 hours. The experiment measures the Nrf2-Venus fluorescence levels in 
BAC cells. The data includes nuclear fluorescence measurements only and was 
normalised to the initial value. MG132 is a proteasome inhibitor. 
 
The relative nuclear fluorescence of green Nrf2-Venus is measured after treatment 
with 5ug/ml of CHX (Figure 4-7). CHX is an inhibitor of translation and effectively 
prevents the synthesis of Nrf2 proteins. This is clearly evident from the results in 
Figure 4-7. Previously, Nrf2 exhibited a distinct recovery pattern (Figure 4-3 & 4-5) 
which is absent in Figure 4-7. Instead, Nrf2 levels in Figure 4-7 decrease gradually 
until it reaches a steady state of approximately 0.2 AU (due to background 
fluorescence). As above, this data is rescaled to omit background fluorescence 
(compare Figure 4-7 and Figure 4-8). 
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Figure 4-7. Nrf2-Venus experiment using CHX. CHX treatment was applied at t = 
0.4 hours. The experiment measures the Nrf2-Venus fluorescence levels in BAC 
cells. The data includes nuclear fluorescence measurements only and was 
normalised to the initial value. CHX inhibits the synthesis of Nrf2. 
 
 
 
 
 
 
Figure 4-8. Re-scaling of CHX data. Data re-scaled to remove background signal. 
According to the structure of the model, Nrf2 should decay to zero with the 
addition of CHX. 
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4.3.2 Model optimisation through data fitting 
The model was run as described above (in section 4.2.3) using a range of initial 
parameter estimates centred on the values given in Khalil et al. [269]. The fitting 
routine was sensitive to the initial parameter estimates which motivates the use of 
Latin hypercube sampling (LHS) to supply a range of initial parameter estimates. Of 
the 200 initial parameter estimates, 98 samples produced a fit between the model 
and the data that gave R-squared (R2) values of 0.85 or higher. The model was fit to 
the different data sets simultaneously, with the appropriate scenario-dependant 
model terms omitted to represent the silencing of Keap1 (siKeap), inhibition of 
proteasomal degradation (MG132) and inhibition of translation (CHX). These 98 
optimised values were plotted against the corresponding initial parameters for each 
of the initial parameter sets, to identify trends in parameter sensitivity (Figure 4-9). 
Parameters are optimised using MATLAB function fminsearch to minimise the 
relative error, χ, for the 10 time-series (4 WT, 4 siKeap, 1 MG132 and 1 CHX):  
 
𝜒 =  ∑ ∑ (
𝑀𝑜𝑑𝑒𝑙𝑖(𝑡) −  𝐷𝑎𝑡𝑎𝑖(𝑡)
𝐷𝑎𝑡𝑎𝑖(𝑡)
)
2
𝑡
.
10
𝑖=1
 (4-6)  
 
The main result to be seen from this graph is the relatively small variability in 
optimised parameter values for the parameter sets 𝑟3 (Figure 4-9C), 𝑟4 (Figure 4-9D), 
𝑟6 (Figure 4-9F) and 𝑧 (Figure 4-9G). For these parameters, there are a wide range of 
initial parameter estimates imported into the model which produce a reasonably 
tight range of optimised parameter values. Compare that to the 𝑟1 (Figure 4-9A), 𝑟2 
(Figure 4-9B) and 𝑟5 (Figure 4-9E) parameter sets, where the range of optimised 
parameter values are much wider. Some clustering of optimised values can be 
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observed and becomes more apparent when the initial parameters are plotted 
against the optimised parameters (Figure 4-10). Red circles indicate possible 
clustering of the optimised parameter values for each of the seven sets. For example, 
for the 𝑟1 parameter, the initial estimate range of 0 to 10 results in an optimised 
range of 0 to 2 (Figure 4-10A). The initial estimate range for parameter 𝑟2 (Figure 
4-10B) is the same as parameter 𝑟1 but results in a much tighter optimised parameter 
range of 0.055 to 0.065. The optimal ranges for the other 5 parameter sets are 
produced at the low end of the initial ranges for 𝑟3 (Figure 4-10C), 𝑟4 (Figure 4-10D), 
𝑟5 (Figure 4-10E), 𝑟6 (Figure 4-10F) and 𝑧 (Figure 4-10G).  
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Figure 4-9. Goodness of fit estimates between initial and optimised parameters. Graphs showing initial parameter estimates against the 
optimised parameter values with R2≥0.85. CHI represents the relative error calculated using Equation 4-6. 
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Figure 4-10. Observed clustering of parameters. Graphs showing the initial 
parameter estimates against the optimised parameter values for 𝑟1, 𝑟2, 𝑟3, 𝑟4, 𝑟5, 
𝑟6 and 𝑧.  Red circles show clustering of optimised parameter values. 
 
Another way to display the distribution of data obtained from the parameter 
optimisation is to look at the median optimised values and the corresponding 
interquartile ranges (Figure 4-3). From this, the full range of variation and the average 
value (median) for each parameter set can be displayed. In Figure 4-3, parameters 1, 
2 and 5 have comparatively shorter ranges than the other 4 parameters. This trend 
suggests that these parameter sets are potentially sensitive to perturbations from 
the median value. 
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Figure 4-3. Box plots for each of the seven parameters. Box plots showing a range 
of parameter values with a R2 > 0.85. Parameters 1-7 correspond 𝑟1, 𝑟2, 𝑟3, 𝑟4, 𝑟5, 
𝑟6 and 𝑧 values respectively. The median and IQR values for each parameter set 
are given below the box plot. Outliers are denoted by crosses (+). 
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4.3.3 Further parameterisation of the model 
The next step is to narrow down the 98 (R2 > 0.85) samples and identify the most 
appropriate parameterisations for the model. One way of doing this is to exclude the 
samples that do not actually replicate features of the in-vivo system that the model 
is supposed to be simulating, e.g. the steady state concentration of nuclear Nrf2 
(estimated to be 2.8nM) and the cytoplasmic estimate (1.88nM) result in a 𝐺𝑛: 𝐺𝑐  
ratio of 1.5:1 (personalised communication, Sanderson). Figure 4-4 shows a plot of 
the 𝐺𝑛: 𝐺𝑐  steady state ratio for each of the 98 samples. The 𝐺𝑛: 𝐺𝑐  experimental 
steady state is represented by the horizontal blue line. Of the 98 optimised samples, 
3 were selected based upon the similarity of their 𝐺𝑛: 𝐺𝑐  ratios to the 1.5:1 
experimental estimate. The seven parameter values (𝑟1 to 𝑟6 and 𝑧) were then 
extracted from these three samples (#14, #27 and #53 out of the 98 parameter sets) 
and compared in Table 4-3 along with a value for 1/z and the 𝐺𝑛: 𝐺𝑐ratios. Note that 
1/z is equivalent to the ratio between pDendra2 and BAC Nrf2 expression. 
Parameters 𝑟1, 𝑟2 and 𝑟5 show the least percentage difference, which were calculated 
using Equation 4-7 and 4-8, across the three sample sets. Note that the parameter 
values in set #27 were used as reference values to calculate percentage differences: 
 
% 𝑑𝑖𝑓𝑓 1 = |2 ×
#14 − #27
#14 + #27
× 100| (4-7) 
 
% 𝑑𝑖𝑓𝑓 2 = |2 ×
#53 − #27
#53 + #27
× 100|. (4-8) 
 
These parameter sets are almost identical between samples #27 and #53. However, 
the other 4 parameter values show approximately 200% difference between the 
sample sets. In contrast, there is an approximately 90% difference between samples 
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#14 and #27 for parameters 𝑟4 and 𝑧. Sample #53 has a very large 1/z value compared 
to the other two samples and is too large to be considered to be biologically viable, 
which would suggest that samples #14 and #27 are more appropriate and 
representative. Parameter sensitivity analysis was then performed on the three 
samples and displayed in Figure 4-5. The seven parameters were plotted with their 
corresponding χ values (Figure 4-5, left hand panel) and R2 values (Figure 4-5, right 
hand panel) over a two-fold change (-2 to 2) in optimised values for each of the 
optimised sets #14, #27 and #53. Again, parameters 𝑟1, 𝑟2 and 𝑟5 exhibit the most 
sensitivity to variation as the change in χ was comparatively greater than for the 
others. Sample #14 show the least sensitivity for the other four parameter values, 
whereas samples #27 and #53 show increased χ values for 𝑟3, 𝑟4, 𝑟6 and 𝑧 as the fold 
change reached its upper and lower limit. Similarly, the behaviour was observed for 
the three parameter sets when also looking at the respective R2 values. For sample 
#14, parameters 𝑟1, 𝑟2 and 𝑟5drop below an R
2 value of 0.85 with only small changes 
in their respective parameter values. The R2 value for the other parameters remains 
relatively constant for parameter changes. This sensitivity analysis shows that 𝑟1, 𝑟2 
and 𝑟5 are the most sensitive, i.e. the model output varies significantly with only small 
variations in the parameters. These parameters are the most consistent across all 
three parameter sets. This indicates the values predicted for these parameters are 
most likely to be optimal. Subsequently, the sensitivity analysis also indicates less 
confidence in the other parameters. Now that optimised parameter sets have been 
identified, the in-silico results can be compared to the experimental results. For the 
point of illustration, the optimised parameter set #14 is used for the input values for 
the model.  
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Figure 4-4. Nuclear vs cytoplasm steady state ratios. Graph showing the 
nuclear/cytoplasm steady state ratios for each of the 98 parameter sets. Red line 
shows level of 1:1 ratio and blue line shows the level for 1.5:1 ratio. The 
parameter sets closest to the blue line are highlighted with red circles (#14, #27 
and #53). 
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Parameter Units #14 % diff 1 #27 % diff 2 #53 
𝒓𝟏 [1/min] 0.086 38.1 0.0585 2.8145 0.0601 
𝒓𝟐 [1/min] 0.696 21.2 0.0562 0.0248 0.0563 
𝒓𝟑 [nM/min] 0.0059 199.8 15.382 199.99 1.38x10
-5 
𝒓𝟒 [nM/min] 5.1345 89.4 1.9599 195.51 172.93 
𝒓𝟓 [1/min] 0.1089 0.1438 0.1087 1.1002 0.1099 
𝒓𝟔 [nM] 322.93 195.99 3.2x10
4 175.21 4.85x105 
𝒛 n.d 0.0135 90.4 0.0358 195.52 4.05x10-4 
𝟏/𝒛 n.d 74.07  27.96  2.47x103 
𝑮𝒏: 𝑮𝒄 ratio 1.57:1  1.48:1  1.46:1 
Table 4-3. Optimised parameter sets. The optimised values for the three samples 
#14, #27 and #53 are given in column 3, 5 and 7. % diff 1 and %diff2 refer to the 
percentage difference between parameter estimates for sets #14 and #27 and 
#27 and #53, respectively (calculated by equations 4-7 and 4-8).  
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Figure 4-5. Sensitivity analysis for each of the seven parameter (#14, #27 and 
#53). Box plots showing a range of parameter values with a R2 ≥ 0.85. Parameters 
1-7 correspond to 𝑟1, 𝑟2, 𝑟3, 𝑟4, 𝑟5, 𝑟6 and 𝑧 values respectively. Left hand panel 
shows the effect on the relative error χ as each parameter is varied from a -2 to 2 
fold change. Right hand panel shows corresponding effect on R2. 
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4.3.4 Fitting of the experimental data 
Figure 4-6 shows the green and red-Nrf2 results in the wild type pDendra-Nrf2 
experiments and simulations. The solid and dashed lines with circular markers 
represent the results from the wet lab experiments and the solid and dashed lines 
without markers represent the results from the in-silico simulation. The simulated 
results fit to the experimental results for both the green and red components giving 
confidence in the design of the model structure. Figure 4-7 shows the pDendra-Nrf2 
results that were treated with siKeap1. To achieve this knockdown effect in the 
model, the 𝑟3 parameter, representing the proteasomal degradation of cytoplasmic 
Nrf2 by Keap1, is set to zero. Again, the impact of these results adds weight to the 
reliability of the model. Figure 4-8 displays the Nrf2 dynamics after treatment with 
MG132. Comparison of the traces show another strong correlation of results. The 
final experiment involved the nuclear Nrf2 measurements in BAC cells in the 
presence of CHX. As CHX interferes with the synthesis of newly formed Nrf2 proteins, 
the basal synthesis parameter, 𝑟4, is set to zero for this simulation. The results are 
plotted in Figure 4-9. The fit between the experimental and simulated results is again 
encouraging. The overall outcome from these simulations shows that the optimised 
parameter set accurately depicts the dynamics of the Nrf2 system. The overall rate 
ratios for these three parameter sets are given in Table 4-4. These relative rates 
(nucleus influx/efflux and cytoplasmic vs nuclear decay) are of interest to biologists, 
and currently unknown from the experiments. Estimates of these rates can be 
calculated using the optimised parameters and taking steady state levels for 𝐺𝐶   and 
𝐺𝑁. From these calculations, the rate of influx is more than twice (2.26, 2.86) that of 
the rate of efflux across the nuclear membrane and that there is much less decay 
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(4.7x10-4, 0.0132) in the cytoplasm compared with the nucleus. Note that  set #53 is 
discounted because of the unrealistic 1/z value produced in Table 4-3. 
 
 
Figure 4-6. Wildtype experiment fitting. Nrf2 values are plotted in the graph for 
the cytoplasm (dashed line) and the nucleus (solid line). The experimental results 
are depicted by the traces with circular markers and the simulated results lack 
any markers. 
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Figure 4-7. siKeap experiment fitting. Nrf2 values are plotted in the graph for the 
cytoplasm (dashed line) and the nucleus (solid line). The experimental results are 
depicted by the traces with circular markers and the simulated results lack any 
markers. The 𝑟3 parameter value is set to zero for the simulated result to mimic 
the siKeap in the experiment. 
 
  
164 
 
 
Figure 4-8. MG132 experiment fitting. Nrf2 values are plotted in the graph for 
the cytoplasm (dashed line) and the nucleus (solid line). The experimental results 
are depicted by the traces with circular markers and the simulated results lack 
any markers. The 𝑟3 and 𝑟5 parameter values are set to zero for the simulated 
result to mimic the effect of MG132 in the experiment. 
165 
 
 
Figure 4-9. CHX experiment fitting. Nrf2 values are plotted in the graph for the 
cytoplasm (dashed line) and the nucleus (solid line). The experimental results are 
depicted by the traces with circular markers and the simulated results lack any 
markers. The 𝑟4 parameter value is set to zero for the simulated result to mimic 
the effect of CHX in the experiment. 
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Rate ratios Calculation #14 #27 #53 
Nucleus 
influx/efflux 𝑟2𝐺𝑐𝑉𝑐
𝑟1𝐺𝑛𝑉𝑛
 
2.2664 2.8597 2.8281 
Relative 
cytoplasm/ 
nuclear decay 𝑉𝑐𝑟3𝐺𝑐
(𝐺𝑐 + 𝑟6)(𝑉𝑛𝑟5𝐺𝑛)
 
BAC 
(stable) 
4.7x10-4 0.0132 7.83x10-10 
pDendra 
(transient) 
3.36x10-4 0.0131 7.75x10-10 
Table 4-4. Characterisation of the key mechanisms of Nrf2 regulation in the cytoplasm 
and nucleus. Table showing the relative rate ratios for the nuclear influx/efflux and 
cytoplasm/nuclear decay for the three optimal parameter sets #14, #27 and #53. The rates 
produced for each of the cell types (BAC and pDendra) are also given. 
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4.4  Discussion 
This chapter describes the development of an in-silico model of Nrf2-Keap1 
interaction in the subcellular cytoplasmic and nuclear compartments. This model is 
validated through parameterisation and fitting of experimentally-derived data sets 
to provide key insights on associated mechanistic rate profiles of the proteins. 
Normalised data sets of Nrf2 expression in untreated cells and cells treated with 
siKeap, the proteasome inhibitor MG132 and the translational inhibitor CHX were 
used to inform the model. In order to establish the model, initial parameter values 
were obtained from the literature [269]. By taking appropriate ranges of values 
around these initial estimates and fitting against the data, optimised values were 
obtained for the seven model parameters. A sub group of our initial parameter sets 
were determined to be a good fit through comparison of goodness of fit R2 values 
(R2>0.85). These sub samples (Figures 4-9 – 4-11) were further analysed by plotting 
the initial parameter estimates against the optimised values. A trend from these plots 
appeared to suggest that some parameters are more sensitive to variation. Outliers 
from these sub samples increased the range for parameters 𝑟3, 𝑟4, 𝑟6 and 𝑧 leading 
to the conclusion that these parameters are less sensitive to initial input values. This 
trend continued in subsequent analysis wherein the parameter sets were compared 
against data for steady-state cytoplasmic-nuclear concentration derived from 
experimental analysis (personal communication). The parameter values from these 
three sets were compared in Table 4-3. Interestingly, the percentage difference 
between parameters for 𝑟1 (nuclear export rate), 𝑟2 (nuclear import rate) and 𝑟5 
(nuclear removal rate) are much smaller than the percentage difference for the other 
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parameter values across the three sets. These sensitive parameters have the same 
unit of 1/min (Table 4-2) and do not rely on concentrations as the other parameters 
do. This may indicate one of the reasons why they are more sensitive to 
perturbations within the model, as the experimental data provided was measured in 
arbitrary units instead of concentration i.e., normalised data sets were provided. 
Therefore, to resolve this problem and increase reliability in the model, the 
experimental data for these concentration dependent parameters needs to be 
measured in non-normalised units.  However, the datasets provided were sufficient 
to answer the key rate questions (Table 4-4) proposed by the collaborators 
(Sanderson lab). Further comparison of Table 4-3 shows that one of the optimised 
parameter sets predicts a very large ratio of Nrf2 expression between the pDendra 
and BAC cells. It is unlikely that the Nrf2 expression would be 3 orders of magnitude 
greater from one cell type to the other. Therefore, the remaining two parameter sets 
were identified to be more appropriate. Simulation of the model results in a good fit 
to the data (Figure 4-6, 4-15, 4-16 & 4-17). However, Figure 4-14 and 4-15 exhibit a 
‘blip’ in the experimental measurements at t=68h. This artefact is also present at the 
same time point in Figure 4-3 and 4-5. The reason for the presence of this ‘blip’ 
remains unclear and is most likely a result of a technical malfunction in the 
fluorescence equipment towards the end of the experiment. In addition, the 
optimisation and identification of these three parameter sets allowed us to evaluate 
the key rate profiles addressed in the conception of the model (Table 4-4). That is, 
the motivation for creating an in-silico model of the Nrf2 signalling pathway was to 
establish and quantify the translocation and removal rates of the Nrf2 protein, as this 
is difficult to determine experimentally due to the rapid half-life of Nrf2. The rates 
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produced by the model for the influx/efflux are tightly regulated across the three 
parameter sets. This could again be attributed to the calculation requiring those rates 
(𝑟1 and 𝑟2) which were shown to be most sensitive to perturbations in the previous 
simulations and therefore have little variation across the three optimal parameter 
sets (Table 4-3). The relative rate ratio for the nuclear influx/efflux produced by the 
model shows that the rate of influx is over twice that of the efflux rate. A greater 
amount of Nrf2 is being imported into the nucleus than out meaning that Nrf2 
accumulates in the nucleus. The other key ratio established by the model is the 
relative cytoplasmic/nuclear decay rate. There are two results provided for each 
parameter set as a result of the differing transfection methods for the pDendra and 
BAC cells, meaning different background Nrf2 production rates in the simulation. 
Both cell types produce rates showing a higher decay in the nucleus, which is 
appropriate given the previous result regarding the influx of Nrf2.  
In summary, I have developed a novel in-silico model capable of simulating the Nrf2 
signalling pathway and producing results that provide key insights into the relative 
transport rates into and out of the nucleus, , based upon the experimental data sets 
provided . Reliability of the accuracy of the model can be improved through 
validation of the simulation output with the raw experimentally-derived data sets 
highlighting Nrf2 expression in differing cell types undergoing various treatments 
designed to perturb the system. 
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Chapter 5: Understanding Nrf2 and NF-κB 
cross-talk using in-silico modelling 
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5.1 Introduction 
5.1.1 Overview 
In this chapter, a stochastic Petri net (PN) model is developed to describe the 
dynamical cross-talk behaviour of the Nrf2 – NF-κB signalling pathways. In the 
previous chapter, an in-silico ODE model of the Nrf2 signalling pathway 
parameterised with experimentally-derived Nrf2 expression data was designed. 
Ideally, the same approach would be adopted for the creation of an extended Nrf2 
model and encompass the NF-κB pathway. However, there is a lack of experimental 
data available to parameterise this scale of ODE model for Nrf2 and NF-κB. Therefore, 
the framework of this model design is to be reduced to be less dependent on 
parameters and more reliant on the overall topology of the signalling pathways and 
their interactions. Following this approach, the key components of the pathways, as 
well as their points of interaction, can be compiled into a Petri net model. PNs have 
been extensively used for simulating the dynamics of signalling networks (such as 
MAPK and EGFR) [277-279].   
Both Nrf2 and NF-κB pathways have been previously described in depth in section 
Error! Reference source not found.. To recap, a brief description of the proteins and 
processes selected to represent the structure of this PN model from these pathways 
will be provided. For the Nrf2 pathway, the Keap1, cullin-3 and GSK-3β proteins are 
included. During steady state conditions, the Nrf2 protein is initially bound to Keap1 
in the cytoplasm before being marked for proteasomal degradation in combination 
with cullin-3 [215]. GSK-3β performs a similar process of proteasomal degradation of 
Nrf2 within the nucleus [220]. However, when the system is perturbed in the model, 
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phosphorylation events inhibit both the Keap1 and GSK-3β proteins allowing newly 
formed Nrf2 to translocate to the nucleus and transcribe cytoprotective genes (HO-
1). For the NF-κB pathway section of the PN model, the IKK and IκBα proteins are 
included. During steady state conditions, the NF-κB heterodimer is sequestered in 
the cytoplasm by association with IκBα [232,235,236]. Perturbation of the system 
results in phosphorylation of the IKKα catalytic subunit which results in further 
downstream phosphorylation of the IκBα protein, driving ubiquitination and 
proteasomal degradation, ultimately releasing NF-κB into the cytoplasm [244]. 
Subsequently, NF-κB translocates to the nucleus activating transcription of the pro-
inflammatory and anti-inflammatory genes. Within the PN model, it is assumed that 
NF-κB transcribes A20, IκBα and Nrf2. Therefore, this transcription provides several 
negative feedback loops in the NF-κB pathway branch of the PN model. It is also 
assumed that there are three points of interactions between the Nrf2 and NF-κB 
pathways within the PN. The first assumption is that the product of Nrf2 transcription 
(HO-1) modifies NF-κB, preventing it from translocating to the nucleus [224,251]. 
Secondly, it is assumed that NF-κB transcription results in increased Nrf2 production 
[224,305]. Finally, it is assumed that the IKK protein is inhibited by Keap1 [224,252].  
In the following section, simulations of the PN model are calibrated against 
experimentally-derived data of Nrf2 and NF-κB expression, again provided by the 
Sanderson lab. In these experiments, Nrf2-Venus and p65-dsRED fluorescence were 
measured in BAC cells for Nrf2 and NF-κB, respectively. Co-administration of CDDO 
and TNFα in these experiments initiate perturbations in the Nrf2 and NF-κB 
pathways, respectively. Note that CDDO is an activator of the Nrf2 pathway [224] 
whereas TNFα is a potent activator of NF-κB -mediated gene expression [240,241]. 
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Once calibrated, the model is used to determine key characteristics about the 
dynamics of the signalling pathway and their cross-talk interactions. Understanding 
of these mechanisms is important as Nrf2 and NF-κB have been shown to, for 
example, play a role in neurodegenerative disease. Nrf2 has been identified as a 
promising target in treating several neurodegenerative diseases, such as multiple 
sclerosis and Parkinson’s disease [253]. Also, a review has indicated that NF-κB plays 
a role in amyloid plaque accumulation in Alzheimer’s disease [306]. This highlights 
the importance in understanding the interaction between these pathways and 
utilising this information to develop potential therapeutic targets. 
5.1.2 Chapter aims 
1. To create a Petri net model that accurately replicates observed NF-κB 
dynamics and also includes the major Nrf2 pathway components with critical 
cross-over links. 
2. To calibrate the initial PN simulations with the experimental data. 
3. Use the PN model outputs to characterise the key mechanisms and dynamics 
of both signalling pathways and their cross-talk interactions. 
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5.2 Material & Methods 
This chapter was completed in collaboration with the University of Liverpool and all 
experiments were again performed by Dr Jo Wardyn (Sanderson lab). The raw data 
generated from these experiments were used as the basis for calibrating the PN 
model. The imaging experiments conducted in this chapter are the same as those 
conducted for the data used in the previous chapter (Appendix B). 
The Nrf2 and NF-κB pathways and their interactions are modelled using a stochastic 
PN model. PNs model signal flow as the pattern of token accumulation and 
dissipation within places (proteins) over time. Transitions in the network represent 
directed protein interactions; each transition models the effect of a source protein 
on a target protein, transfection, production and decay. Through transition firings, 
the source can influence the number of tokens assigned to the target, called the 
token-count, thereby modelling the way that signals propagate through protein 
interactions in cellular signalling networks. In order to overcome the issue of 
modelling reaction rates in the network, signalling dynamics are simulated by 
executing the signalling Petri net (SPN) for a set number of steps (called runs), each 
time beginning from some initial marking. For each step, the individual signalling 
rates are simulated via generation of random orders of transition firings (interaction 
occurrences). The results of multiple runs are then averaged together. Note that the 
tokenized activity-levels computed by the PN method should be taken as abstract 
quantities whose changes over time correlate to changes that occur in the amounts 
of active proteins present in the cell. It is worth noting that some of the most widely 
used experimental techniques for protein quantification—western blots and 
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microarrays—also yield results that are treated as indications, but not exact 
measurements, of protein activity-levels within the cell. Similarly, the PN method is 
designed to operate on tokenized models of signalling networks with the ultimate 
intent of predicting the activity-level changes of proteins in the underlying signalling 
network over time. In the next sections, the core design decisions underlying the PN 
method are discussed, such as the signalling PN, transition firing, constructing the 
initial marking for the model, and sampling signalling rates, followed by a discussion 
on how the PN approach can be used to predict the outcome of perturbation 
experiments. 
 
5.2.1 Stochastic Petri Net model 
In Figure 5-1, the PN for the Nrf2-NF-κB model (described in overview above) is 
depicted. The PN model was built using a unifying PN tool called Snoopy [307]. The 
classical PN is a directed bipartite graph [274]. The two types of nodes are called 
places and transitions. In a PN, places and transitions are connected via arcs. Places 
are graphically represented by circles, transitions by boxes or bars. Places can store 
tokens, represented by black dots or numbers. A distribution of tokens on the places 
of a net is called a marking, and corresponds to the “state” of the PN (mt is used to 
denote the marking of a PN at time t). A transition of a net is enabled at a marking if 
all its input places (the places from which some arc leads to it) contain at least one 
token. An enabled transition can fire: it then removes one token from each of the 
input places, and then adds one token to each of its output places. This is called the 
firing rule. For example, when a signalling interaction A→B (A activates B) occurs, it 
has the effect of changing the activity level of A and/or B. Thus the associated 
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transition will fire at time, t, and produce a marking mt+1 from m. When this transition 
fires, some number of tokens are moved from place A to place B via an arc. In a single 
time block every enabled transition fires once exactly. The order of the firing 
sequence is chosen randomly and changes for each time block. Therefore, within 
each time block all transitions are evaluated once, though not necessarily in the same 
order [308]. Since the rate parameters are not known, many simulation runs are 
executed to sample the space of possible outcomes and markings returned by these 
runs are averaged. The initial marking for the system is constructed on the 
assumption that the system is in an initial basal state until acted upon by an external 
stimulus. The basal initial state is a distribution of activation levels when the cell has 
no impulses propagating through it. For this reason, the model is run to a steady state 
before perturbations are executed. Assigning the correct number of tokens to each 
place as an initial condition to get to this basal state was the main challenge of 
constructing the model. Tests were performed to assess the effect of differing token 
values for each place (protein), ranging from 1-100 tokens. It was found that 10-20 
tokens, for Nrf2, Keap1, Cullin-3, GSK-3β, pFyn, IKK and IκB, were sufficient to 
replicate the results observed in-vitro. The accuracy and performance of the method 
was tested by simulating the activation of NF-κB and Nrf2 simultaneously, and 
compared the outputs to the experimentally derived data provided by the Sanderson 
lab.  
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Figure 5-1. The Petri Net model. Schematic outlay of the PN model. The model contains the Nrf2 and NF-κB pathways and the interactions 
between both indicated by red circles (nNF-κB/Nrf2, Keap1/IKK, HO-1/NF-κB). 
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5.3 Results 
To simulate the effects of TNFα and CDDO in the PN model, the firing of two time 
delayed places (both shown on the signalling network in Figure 5-1 in shaded 
squares) were used. These perturbations are set to occur 50 time units (AU) in order 
to allow the simulated system to reach a steady state before the perturbation takes 
place. The PN model has been minimised to only include functional parts, i.e. 
downstream proteins that do not provide feedback or alter the overall outcome of 
the pathway activation are omitted for clarity. The inclusion and omission of pathway 
components was decided through reading literature detailing the workings of both 
pathways. For further readability, Figure 5-2 shows the PN model as a simplified 
schematic diagram of both the Nrf2 (green) and NF-κB (red) pathways with some 
minor components removed, such as pFyn and intermediary states of 
activated/inactivated proteins. Three points were chosen to demonstrate the cross-
talk between both pathways. These three components are: 1) Nrf2 gene transcription 
modifies NF-κB preventing it from translocating into the nucleus [224,251], 2) NF-κB 
gene transcription of Nrf2 [224,305] and 3) Keap1 mediated inhibition of IKK 
[224,252]. In order to evaluate the accuracy of the stochastic model and these three 
cross points, the model simulation output was tested against the experimental data 
results (Figure 5-3).  
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Figure 5-2. Diagram showing key elements of the Petri Net model. Schematic outlay of the PN model. The minimal Nrf2 pathway is shown 
in green. Nrf2 is initially bound to Keap1 (Keap) and marked and degraded in combination with Cullin-3 (Cul 3). CDDO perturbs the system 
releasing Nrf2, where it translocates to the nucleus activating transcription. GSK-3β removes Nrf2 from the nucleus as the effects of CDDO 
decay. The NF-κB (p65/50) pathway is shown in red. NF-κB is initially inhibited by IκBα. Similarly, perturbation by TNFα releases NF-κB into 
the cytoplasm, where it translocates to the nucleus activating transcription. Phosphorylation events are indicated by P.
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5.3.1 Validation of PN model against experimental results 
CDDO activates the Nrf2 pathway and mimics the effect of the cells response to 
oxidative stress. The introduction of CDDO in-vitro results in an increased peak of 
Nrf2 activity followed by smaller damped oscillations before returning to a steady 
state level (Figure 5-3A). Mimicking this perturbation in the PN model, NF-κB activity 
increases, in response to the administration of TNFα, giving off a singular large peak 
followed by several smaller damped oscillations before returning to its original 
steady state level (Figure 5-3B). When a transition is fired in the model there is an 
increase in the activity of both NF-κB and Nrf2 levels followed by smaller peaks and 
a return to a base line level. It is known from the literature that these oscillations are 
present in the pathways, ultimately being used to control expression of the target 
genes [309]. This validation gives us confidence that the regulatory mechanisms 
encoded in the structure of the PN, informed by pathway information in the 
literature, are well suited to simulate the dynamics observed experimentally, 
consistent with expected oscillatory response of these signalling pathways. To add a 
quantitative element to the results, the time units were converted from arbitrary 
units to hours. This was achieved by matching the first peak of the NF-κB trace in 
Figure 5-3A with the subsequent peak in the simulated result (Figure 5-3B). The same 
conversion of time units in the PN is used in all subsequent simulations. The levels of 
NF-κB were altered in the PN model by changing the multiplicity on the relevant arcs 
(NF-κB → nNF-κB) to 2- and 4-fold the amount of tokens transferred. These changes 
were made to assess if the oscillatory behaviour shown by Nrf2 was driven by NF-κB. 
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All 3 Nrf2 runs were plotted on the same graph for comparison (Figure 5-4). The 
original values were plotted in blue, the 2-fold NF-κB increase was plotted in red and 
the 4-fold increase was plotted in yellow. The corresponding NF-κB traces are also 
shown in Figure 5-4B. In the original Nrf2 trace, the initial peak is approximately 9 
arbitrary units high. This initial peak then increases to approximately 16 and 25 
arbitrary units respectively when NF-κB is doubled and quadrupled, respectively. 
Increasing NF-κB results in larger and smoother oscillations in the Nrf2 trace, 
suggesting it could play a part in the overall oscillatory behaviour of the Nrf2 protein. 
It is expected that Nrf2 would increase as NF-κB increases, as NF-κB transcribes the 
Nrf2 protein.  
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Figure 5-3. Qualitative validation of the Petri net model through comparison of experimental vs simulated data. (A) Co-administration of 
CDDO and TNFα in BAC cells expressing p65-dsRED. Peaks in p65 (NF-κB) nuclear levels (red) induce subsequent Nrf2 (green) accumulation. 
(B) Co-stimulation of CDDO-Me and TNFα by the model produce peaks in NF-κB levels that also lead to Nrf2 accumulation. The PN qualitatively 
represents Nrf2/NF-κB dynamics. 
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Figure 5-4. High levels of NF-κB expression promote oscillatory behaviour in 
Nrf2. (A) Plot showing Nrf2 levels when NF-κB is background (blue), increased 2-
-fold (red) and increased 4-fold (yellow). (B) Plot showing NF-κB levels when NF-
κB is background (blue), increased 2-fold (red) and increased 4-fold (yellow). 
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5.3.2 Characterisation of the dynamics of the pathways 
One of the biggest limiting factors in the Nrf2 pathway is Keap1 [211]. Therefore, it 
is important to show the effect of Keap1 on the dynamics of the model. The initial 
level of Keap1 in the original simulation (Figure 5-3B) was 20 tokens. To showcase 
the effect of Keap1 on Nrf2 activity, the initial amount of Keap1 was altered across a 
3-fold range (0-3) and plotted against the resulting maximal peak of Nrf2 (Figure 5-5). 
The obvious trend shown from the results is that a decrease in Keap1 leads to an 
increase in Nrf2 and vice-versa. More specifically, a 2-fold increase in Keap1 causes 
an approximately 90% reduction in Nrf2 whereas half the initial amount of Keap1 
results in approximately 1.5 times more Nrf2 protein. 
Next, the model is modified to answer key questions about the mechanisms of the 
coupled signalling pathways. The key questions to be addressed are as follows: (1) 
what effect does an increase in Keap1 due to the CDDO have on Nrf2 and NF-κB? (2) 
What effect does an increase of Keap1 due to transcriptional activity have on Nrf2 
and NF-κB? (3) What effect does an increase in cullin-3 due to transcriptional activity 
have on Nrf2 and NF-κB? (4) What effect does decreasing A20 have on Nrf2 and NF-
κB? (5) Is there an upper threshold limit of Nrf2 concentration in the model? (6) What 
is the effect on Nrf2 if GSK-3β plays a role in nuclear decay or acts as a nuclear 
exporter? 
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Figure 5-5. Changing Keap1 levels alter network dynamics. Decrease in the 
representative peak number of Nrf2 tokens when initial Keap1 token levels are 
increased. 
 
Figure 5-6 shows the results of increasing Keap1 through varying CDDO activity. The 
goal in this simulation is to show how any dynamical changes in the system are 
affected by an external increase in Keap1. This result was achieved by adding an edge 
between Keap1 and CDDO, within the model, and increasing the multiplicity of 
tokens from one- to eight-fold. Biologically, this would represent increased 
transcription of Keap1. Figure 5-6A shows the Nrf2 trace as Keap1 is increased. As 
the amount of Keap1 increases, the overall level of Nrf2 activity decreases. At normal 
background Keap1 levels, the number of Nrf2 tokens at the maximal peak is 
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approximately 9 tokens compared with 5 tokens when Keap1 is at an eight-fold 
increase. Figure 5-6B displays the NF-κB trace for each fold increase of Keap1. There 
is very little difference in NF-κB activity as the Keap1 is increased, as expected.  
In contrast, when Keap1 is increased via transcription, rather than via CDDO, there is 
very little difference between the Nrf2 activity (Figure 5-7A) and NF-κB activity 
(Figure 5-7B) for any of the Keap1 fold increases. This result was achieved in a similar 
way to Figure 5-6, i.e. an extra arc was added from nuclear Nrf2 to Keap1 and the 
multiplicity changed from one-fold to eight-fold. Again, biologically this would 
represent increased transcription of the Keap1 protein. This corresponding Keap1 
trace is shown in Figure 5-7C. This result is again reiterated in Figure 5-8. When cullin-
3 levels are increased though the addition of an arc between nuclear Nrf2 and the 
cullin-3 place, there is very little change in the activity levels for Nrf2 (Figure 5-8A) 
and NF-κB (Figure 5-8B).  
A20 was decreased to observe the effect it has on the Nrf2 and NF-κB traces (Figure 
5-9). Again, this was achieved by altering the multiplicity on the arc (A20 → IKK) to 
50% and 25% of its initial value (Figure 5-9C). This decrease had relatively more effect 
on the Nrf2 trace (Figure 5-9A) than the NF-κB trace (Figure 5-9B). For example, when 
the amount of A20 was reduced to a quarter there was a subsequent decrease of 
~25% in the Nrf2 trace (Figure 5-9 – yellow). 
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Figure 5-6. Effect of CDDO-increased Keap1 on Nrf2 and NF-κB. (A) Simulated 
plot showing Nrf2 levels in response to the increasing fold change of CDDO on 
Keap1. (B) Simulated plot showing NF-κB levels in response to this change. (C) Plot 
showing Keap1 traces for each fold change. 
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Figure 5-7. Effect of transcribed Keap1 on Nrf2 and NF-κB. (A) Simulated plot 
showing Nrf2 levels in response to the increased fold change of transcriptionally 
produced Keap1. (B) Simulated plot showing NF-κB levels in response to this 
increase. (C) Plot showing Keap1 traces for each fold change. 
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Another key question that was proposed involves whether or not an upper limit 
exists for Nrf2 activity. As CDDO is used as an Nrf2 activator, the initial number of 
tokens in this place were increased up to 200-fold, representing an increase in the 
transcription of Nrf2 protein (Figure 5-10). The Nrf2 trace remains relatively 
unchanged when CDDO is increased up to ten-fold (Figure 5-10 – light blue, Figure 
5-10 – orange). However, for the twenty-fold trace (Figure 5-10 – yellow) the Nrf2 
token count for the maximal peak increases to 13 tokens from 9 tokens. This 
threshold is maintained for all the following fold changes in CDDO with only the time 
taken for each trace to return to steady state increasing.  
Another feature of the model is the delayed response of GSK-3β in the removal of 
Nrf2 from the nucleus. The model was designed to include the GSK-3β-mediated 
response as a nuclear exporter of Nrf2 (Figure 5-11 - blue) or as a decaying factor of 
Nrf2 (Figure 5-11 - red). The decay rate of both was plotted against the peak level of 
cytoplasmic Nrf2 (Figure 5-11). As an exporter, GSK-3β maintains an Nrf2 peak 
between 8 and 10 arbitrary units across a range of decay rates. In contrast, as an 
agent of decay, the GSK-3β maintains a lower threshold of Nrf2 activity (4 -6 AU). In 
Figure 5-11B, the corresponding nuclear Nrf2 levels were plotted. This plot shows 
that GSK-3β has a much greater effect on the nuclear Nrf2 levels than on cytoplasmic 
Nrf2. The level of Nrf2 increases in both circumstances, as the rate at which GSK-3β 
exports (Figure 5-11B –red) and decays (Figure 5-11B – blue) nuclear Nrf2 decreases. 
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At the lowest rate, the number of tokens has increased 5-fold for the export trace 
and 7-fold for the decay trace. 
 
Figure 5-8. Effect of transcribed cullin-3 on Nrf2 and NF-κB. (A) Simulated plot 
showing Nrf2 levels in response to the increase of the Nrf2-dependent 
transcription rate of cullin-3. (B) Simulated plot showing NF-κB levels in response 
to this increase. (C) Plot showing cullin-3 traces for each fold change. 
 
  
191 
 
 
 
 
 
Figure 5-9. Effect of decreased A20 on Nrf2 and NF-κB. (A) Simulated plot 
showing Nrf2 levels in response to a decrease in A20. (B) Simulated plot showing 
NF-κB levels in response to a decrease in A20. (C) Plot showing corresponding A20 
traces. 
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Figure 5-10. Upper limit of Nrf2. Plot showing Nrf2 activity against time for CDDO 
fold changes in the range x1 – x200. 
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Figure 5-11. Effect of GSK-3β-mediated nuclear export and nuclear decay. (A) 
Simulated plot showing cytoplasmic Nrf2 levels after the addition of nuclear 
export (blue) and decay (red). (B) Simulated plot showing nuclear Nrf2 levels after 
the addition of nuclear export (red) and decay (blue). 
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5.4 Discussion 
In this chapter, a Petri net-based method that qualitatively predicts the dynamics 
between the Nrf2 and NF-κB pathways is described. Once the scheduled transition 
fires in the model, representing the activation of the signalling pathway (Nrf2 and 
NF-κB), there is a rapid increase in Nrf2 before both Nrf2 and NF-κB display decayed 
oscillations that tend towards a steady state. This result mimics the outcome of the 
observed experimental behaviour (Figure 5-3). It has been noted that this oscillatory 
behaviour is a hallmark of the interaction of these pathways and it is suggested that 
this is driven by NF-κB [309]. Capturing this key known feature present in these 
pathways is important for showing the reliability of the model. However, the lack of 
replicates in the datasets provided introduces uncertainty in the results. Therefore, 
integration of the PN model with more datasets would be the next logical step in the 
progression of this work. Despite this, the PN model captures the dynamics we would 
expect to see in these pathways. Figure 5-4 shows the effect of increasing NF-κB 
levels on the system. It is clear to see that larger, smoother oscillations of Nrf2 are 
produced when NF-κB is elevated. For lower values of NF-κB, a singular peak is 
observed in the Nrf2 trace (Figure 5-4, blue). There are two and three peaks observed 
respectively when NF-κB is doubled (Figure 5-4, red) and quadrupled (Figure 5-4, 
yellow), respectively. Also, the ratio between both proteins (Nrf2: NF-κB) during 
these NF-κB changes is maintained. Therefore, the PN model adds weight to the 
hypothesis that NF-κB drives Nrf2 dynamics. The biggest limiting factor in the Nrf2 
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pathway is the presence of Keap1 [211]. Therefore, Keap1 levels were varied in the 
in-silico model to observe the effect on the Nrf2 levels (Figure 5-5). The simulations 
conclude that increasing Keap1 levels leads to a decrease in Nrf2 activity and, 
conversely, a decrease in Keap1 levels give rise to higher amounts of Nrf2. Thus, 
Keap1 is indeed crucial in the maintenance of Nrf2 levels and acts as the dominant 
mechanism of decay in this model. Additionally, Keap1 has a basal production and 
decay rate which maintains it at a constant level. It quickly reaches a steady state and 
only subsequently changes when CDDO perturbs the system and it becomes 
sequestered in an Nrf2 complex. In Figure 5-6 and 5-7, the model explores what 
would happen when there is an addition of an extra source of Keap1. In Figure 5-6, 
Keap1 levels are altered by varying the amount of CDDO added. This leads to modest 
decreases in cytoplasmic Nrf2 levels as Keap1 is more readily available, as shown in 
Figure 5-6C. However, in Figure 5-7, when instead Keap1 has an additional source via 
transcription, the overall levels of Nrf2 and Keap1 remain relatively unchanged. A 
possible explanation for this difference may be that, once CDDO perturbs the system, 
it becomes the dominant mechanism and overpowers any response from the 
transcription of Keap1, which is a much slower process. Similar conclusions can be 
drawn from the cullin-3 results (Figure 5-8), and again, a comparable trend can be 
observed in the traces of Nrf2 and NF-κB when changing A20 levels (Figure 5-9). This 
can be partially explained by the time delay of sending tokens through the 
transcription pathways. This time delay represents the period between gene 
activation and protein formation within the cell. As the rate of A20 is decreased, in 
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the PN model, the level of Nrf2 also slightly decreases. This change is not large 
enough to draw any conclusions from and is most likely due to noise of the system.  
The next question proposed to the model was whether or not it can replicate an 
upper limit of Nrf2. In Figure 5-10, it can be clearly seen that from a 20-fold to 200-
fold increase of CDDO activity the level of Nrf2 reaches an upper limit. It would 
therefore seem that the dynamical behaviour of the model does not allow for an 
unchecked increase of Nrf2 and that Nrf2 does indeed have an upper limit. Another 
consideration in the design of the PN model was whether to include a nuclear 
exporter or nuclear decay via the GSK-3β pathway. It has been shown in the literature 
that GSK-3β degrades the Nrf2 protein in the nucleus [310]. Therefore, this GSK-3β 
mediated decay (Figure 5-11A) results in the decrease of cytoplasmic Nrf2 levels. 
However, the level of Nrf2 remains constant as the amount of decay changes. This 
suggests that there is an upper limit on the amount of cytoplasmic Nrf2 that is 
susceptible to a decay pathway in the nucleus. The decay transition was then 
removed and GSK-3β-mediated nuclear export was introduced to the model. In 
Figure 5-11B, the same conditions were applied and the nuclear Nrf2 traces were 
plotted. These results showed that there is an increase in Nrf2 levels within the 
nucleus when the rate of GSK-3β activity is decreased. As with the cytoplasmic values, 
the export trace has a higher value than the decay trace. We observe that there is 
very little variability in Nrf2 activity upon the addition of an export transition. This 
suggests that the inclusion of the nuclear export is more appropriate as it upholds 
the network dynamics as observed experimentally (Figure 5-3).  
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Despite the complexity of the network dynamics, it was straightforward to find and 
integrate the connectivity information to build the model. However, although the 
information sources [210,224,232,236] provided information on existing pathways, 
little was offered in the way of biochemical or kinetic detail. Thus, it is difficult to use 
the evidence in the literature to assemble a parameterised ODE model. This further 
underlies the advantage of using the PN model as a way of quickly characterising the 
network dynamics of the pathways without the need for extensive model 
parameterisation.  
Although the predictions derived from the PN model may not be as quantitative as 
results returned from a parameterized ODE system, biologists using the PN method 
can derive information about a network’s qualitative dynamical behaviour without 
having to conduct extensive experimentation and computationally expensive 
parameter estimation. This novel capability offers scientists the exciting prospect of 
being able to test hypotheses regarding signal propagation in-silico. Furthermore, by 
using the PN method, researchers can evaluate a wide array of network responses in 
order to determine the most promising experiments before even entering the 
laboratory. 
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Chapter 6: Discussion  
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Systems Biology aims to provide a simpler and more tractable framework to explain 
complex biological phenomena. Most research labs focus on specific proteins and 
genes of interest or particular sections of a cell signalling pathway, with the goal of 
deriving as much information as possible about the structure, function, etc. of that 
particular protein. This has led to the availability of a wealth of experimentally 
derived data sets that can be integrated into in-silico models to generate testable 
hypotheses or allow the dynamical properties of the system to be deduced providing 
potential novel insights into the role and function of the system components [5]. 
Other potential benefits from designing robust predictive models include the 
identification of new biomarkers of disease, stratification of medicine, based on 
unique genetic patient profiles, and the targeting of drugs and other treatments, etc. 
Within this thesis, several models are presented across three individual biological 
scales (macroscopic, mesoscopic and microscopic). These include the description of 
cancer and immune cells interactions (multicellular), the movement of fibroblast cells 
on varying surface structures (cellular) and cell signalling models within the 
cytoplasm and nucleus (subcellular). One of the key strengths of these models is the 
integration with experimentally derived results. This corroboration is important as it 
provides confidence in the results produced, such as dynamical properties and 
parameter estimates. Further benefits of such systems biology approaches include 
the reusability of the algorithms and their versatility in terms of being adapted and 
extended to fit similar biological systems and cell signalling pathways. 
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Chapter 2 describes a continuous macroscopic in-silico model of a highly simplified 
version of the tumour microenvironment of the gut. Specifically, this model was 
developed to characterise the underlying mechanism of reaction between epithelial 
cancer cells and cancer associated stromal immune cells, namely myofibroblasts. Due 
to problems with technical equipment and relocation to a new university, the data 
collection was insufficient for a more complex model of the tumour 
microenvironment. Therefore, this model was purely explorative and was tasked 
with qualitatively identifying the mechanism of interaction. Migration assays 
between these cell types produced data on the diffusion rates of the cells when co-
cultured. Initially, the observed interaction was described through the design of a 
simple diffusion model. This description was found to be inadequate for defining the 
mechanism of interaction observed in the migration experiments. Therefore, the 
model was adapted to simulate density-dependent diffusion. This method produced 
a much more appropriate portrayal of the qualitative dynamics observed on the 
distal side of the epithelial cancer cells. However, this model only provided an 
adequate description of one side of the experiment. This promoted the incorporation 
of a chemotaxis type term into the model, as it has been well documented that 
myofibroblasts release a plethora of chemicals [37,73,311]. Thus, an inhibitory 
chemical was incorporated into the model framework. One such extended model 
depicted the inhibitory profile of the chemotaxis on the proximal side of the epithelial 
cells whereas a second model portrayed the distal side. Each side of the AGS cell 
monolayer (proximal and distal) needed an individual inhibitory profile term due to 
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differences in the distance from the source and direction of migration.  This 
additional refinement of the model provided a better comparison of the 
experimental data than the previous model iterations, suggesting a possible 
chemical/signalling interaction between the two cell types. However, this 
comparison remained insufficient in characterising the exact mechanism of 
interaction present between the cell types. Further experimentation and 
incorporation of controls into this study is clearly needed in order to select 
appropriate model design progression and theories of interaction. Therefore, this 
simplified model of interaction highlights which mechanisms do not describe the 
underlying mechanism which is novel as it rejects previous theories and can inform 
new hypotheses. 
This was the first model investigating the mechanisms of interaction between these 
two cell types in the GI tract. Although the model wasn’t able to provide any 
definitive/quantitative answers on the underlying mechanism driving the interplay 
between the cells, it was clearly able to show which mechanisms were insufficient in 
describing the cellular phenomenon observed in the time-lapse experiments. The 
data derived from these experiments was instrumental in terms of motivating the 
evolution and subsequent iterations of the model. Cumulatively, these iterations 
produced a model capable of replicating several features of the underlying cell 
movements. This is encouraging as there is now potential for further modification 
that can potentially highlight the missing component that would allow for accurate 
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representation of this multicellular interaction. As mentioned above, with more 
substantial data to work with, a more detailed and complex model of these cellular 
interactions can be developed. This more complex model can feature elements 
present in current wound healing models, as the experiment design is similar to a 
scratch wound assay. For example, Dallon et al. [312,313] use force balance 
equations in mechanical models to define the interaction between fibroblast cells 
and newly reforming ECM. This specific feature would be of interest as a possible 
theory in describing the AGS cell migration was whether or not it remodelled ECM 
formed by the 308/1 cells [80]. It would provide insight into the role tissue tension 
plays in the cells migratory behaviour. Another potential theory to investigate was 
the effect of contact inhibition on these cells [314]. This would require switching the 
continuous model to an agent-based model, in which the biological cells are 
represented as individual entities governed by a set of rules. Walker et al. [315] were 
able to successfully show how this method can accurately model wound healing in 
epithelial scratch wound assays. 
Chapter 3 described a discrete cell based in-silico model of fibroblast migration, in 
the mesoscopic scale, utilising cell movement data derived from cell migration 
assays. A novel component of these cell migration assays was the use of engineered 
polyurethane surfaces containing different surface topologies, which have been 
‘nano-scratched’ through abrasive polishing [180]. Initially, the cell motility was 
modelled in terms of a stochastic Ornstein-Uhlenbeck process [291]. Cell velocity, 
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position and random fluctuations were all incorporated into the stochastic model 
through a series of differential equations, resulting in a model producing random cell 
walk migratory paths. Parameterisation of the model with the experimental data 
resulted in the optimisation of the model parameters, yielding an in-silico model 
depicting the cell’s intrinsic motility properties on ‘flat’ surfaces. This approach was 
extended to the ‘linear’ and ‘random’ surfaces, were optimisation of the parameters 
with the experimental metrics resulted in the production of values for the haptotactic 
parameter for each surface. The model was able to replicate the in-vitro experiments 
accurately, while also providing values for the parameters of random motility and 
haptotaxis. 
To the best of my knowledge, there are no other mathematical models of fibroblast 
migration on polyurethane surfaces. However, the model depicts the evolution of 
random walk models that are present in the literature [199]. To begin, the model is 
simply a basic random walk model with no topographical features present to affect 
the migratory behaviour of the cells.  By defining mechanical cues in the design of 
the topographical features of the polyurethane surfaces, it allowed in-vitro 
quantification and real time visualisation of the cell migration paths and upgraded 
the model to a biased random walk. This model confirms the findings by Irving et al. 
[180] that these machine ground polyurethane surfaces enhance cell migration. It 
also reaffirms that grinding technology can be used as an alternative, cost effective 
method to generate functional surfaces that can be used to control fibroblast 
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behaviour.  One improvement that could be made to this model is the inclusion of a 
barrier to confine cell movement to the polyurethane domain i.e., migrating 
fibroblast cells will automatically turn and move away in the opposite direction upon 
reaching the barrier. Although, this isn’t necessary as the model produced 
satisfactory results without this feature. However, it would be beneficial in future 
iterations if longer migration times are needed, particularly on the linear surface as 
cell migration is less tortuous and therefore spreads into space quickly. Mechanistic 
insights derived from this model could now be applied to investigate the possibility 
of controlling cell behaviour on other surfaces i.e., implants, thereby improving 
clinical outcomes [178,290]. 
Chapter 4 describes the development of an in-silico model of Nrf2-Keap1 interaction 
in the subcellular cytoplasmic and nuclear compartments. Key components of the 
pathway incorporating this protein interaction were consolidated into a 
mathematical framework to create an ODE minimal model. This ODE model was 
validated against several experimental data sets. Seven parameters were identified 
to describe all the interactions within the ODE model. Parameter estimates were 
optimised through parameterisation with experimental data. Simulation of the 
model resulted in three optimal parameter sets to describe the Nrf2-Keap1 network. 
This was further reduced to two parameter sets using experimental data to compare 
Nrf2 production rates. Sensitivity analysis revealed that the parameters for nuclear 
influx, efflux and decay were the most sensitive to the model output. The model was 
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able to estimate the relative nuclear influx/efflux rate of Nrf2 and the relative 
cytoplasmic vs nuclear decay of Nrf2 (Table 4-4). Nuclear influx was shown to be 
more than two times greater than nuclear efflux and decay of the Nrf2 protein was 
also greater in the nucleus. 
Although the Nrf2 pathway is widely recognised as an important stress pathway, few 
dynamical models have been developed for it [268,269]. This outcome is a 
consequence of the lack of quantitative data available. Using the Khalil et al. [269] 
model as a starting point for parameterising the minimalist model developed in 
Chapter 4, the model was able to answer key questions proposed by the 
collaborators of this project i.e. relative nuclear influx/efflux rate of Nrf2 and the 
relative cytoplasmic vs nuclear decay of Nrf2. This model was essential to obtaining 
these results, as these rates are experimentally challenging to quantitate due, in part, 
to the short half-life of the Nrf2 protein. The reliability of the model is justified 
through its ability to fit multiple experimental data sets of differing drug incubations. 
However, only normalised datasets were provided for the integration with this 
model. Therefore, the integration with raw datasets would further increase the 
reliability of the model. This integrated in-vitro – in-silico framework offers a novel 
approach for the investigation of the Nrf2 pathway.  
Chapter 5 describes a stochastic Petri net model describing dynamical cross-talk 
between the Nrf2 and NF-κB pathways. A reductionist approach was considered to 
remove dependence on parameterisation as sufficient data was unavailable to 
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parameterise a model of this scale. Nrf2 and NF-κB expression data combined with 
initial in-silico results allowed confirmation that the underlying dynamics in the 
model reflected those in-vitro. This step provided assurance that the model was 
capable of replicating typical dynamical behaviour associated with both pathways, 
namely the oscillations of the Nrf2 and NF-κB proteins [270,309]. Subsequently, the 
model was utilised in a predictive capacity to answer questions about the Nrf2-NF-
κB network. Firstly, the model was tasked with determining the effect of increasing 
Keap1 levels on the network. As expected, the results concluded that there would be 
a marked decrease in Nrf2 protein, as the Nrf2 protein decreased approximately 90% 
for a 2-fold increase in Keap1. Further model predictions were used to explore other 
scenarios, such as increased production of interacting proteins, removal of key 
components and how particular proteins behave when assigned specific roles (i.e. as 
a transporter of decay or exportation). The advantages of the stochastic PN model 
are underlined by its ability to quickly characterise the network dynamics of these 
pathways, without parameterisation, and provide a means for testing hypotheses 
regarding the propagation of signals throughout the network. 
Nrf2 and NF-κB pathways are key for regulating the fine balance of cellular redox 
status in response to stress and inflammation, respectively [217]. Extensive research 
has provided convincing evidence that functional cross-talk exists between these two 
networks [224,227,249,316-318]. However, many aspects of the conditional and 
dynamic nature of this interplay remain unknown. Although, there are many models 
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dedicated to investigating the NF-κB pathway, the limited amount of computational 
Nrf2 models means there are very few models depicting functional cross-talk 
between the two. In particular, there are no PN models describing these pathways. 
This stochastic PN model highlights several points of interaction, providing insight 
into many undefined features of co-regulation, negative feedback loops and post 
transcriptional mechanisms through validation with experimental data. Therefore, 
this novel systematic model provides the capacity to define many important aspects 
of these regulatory pathways as well as driving the development of improved 
strategies to manipulate the balance between the pathway responses, under both 
physiological and disease conditions. 
The results presented in this thesis provide motivation for utilising experimental data 
in the development and validation of mathematical models. In order to obtain 
complex robust models, researchers should seek to obtain high quality quantitative 
data of the system of interest. However, the results of this thesis also demonstrate 
how dynamic qualitative behaviour can be obtained from in-silico models using 
simplistic inputs such as pathway design. There are numerous and variable 
approaches to addressing researchers questions, via in-silico modelling, dependent 
upon on the level of information known about the system of interest and quality of 
data available.  Overall, combination of the experimental and modelling worlds 
allows for key biological questions to be addressed and new hypotheses to be 
theorised. Ideally, a model built with experimental input would yield results that 
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would promote the development of new hypotheses and experimentation which 
would then, in turn, feed back into the model building up multiple iterations and 
increasing the robustness and reliability of its output. A future challenge in the field 
of systems biology is the generation of such large-scale robust models, containing 
the data of multiple signalling networks and protein pathways. The availability of 
data on particular systems can present its own challenge, resulting in models that are 
built upon assumptions. These challenges can be addressed through continued 
collaboration of biologists and mathematicians, as well as improvements in model 
design and computational power. 
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Chapter 7: Appendix 
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7.1 Appendix A – Mark Murphy lab methods 
7.1.1 Preparation of stainless steel moulds 
All patterned surfaces were generated upon a biocompatible polyurethane polymer. 
Patterns were developed on the polymer indirectly, by casting the flat end surface of 
a cylindrical stainless steel mould that had been cut from stainless steel rods (grade 
316, cylinder height 13 mm, diameter 18 mm). To prepare the stainless steel moulds 
for patterning, their flat surfaces were first polished to remove all marks caused by 
the cutting process. This was achieved using a METASERV universal polisher and 
silicon carbide sheets of decreasing grit size (60 to 1200 B) followed by a polishing 
cloth. This resulted in the stainless steel cylinder having a mirrored surface finish 
(mean Ra value of approximately 0.02 μm) which could then be used for processing. 
7.1.2 Abrasive patterned surface development 
Machine grinding was used for this purpose to generate the topographical patterns 
on the polyurethane surfaces. This method involves the micro-patterning of stainless 
steel, which can then be used to cast polymer substrates for observing the migration 
of fibroblasts [180]. An unprocessed plain polymer surface was used as a control and 
was labelled as ‘Flat’. Next, a pattern of parallel lines was cast on the polymer surface 
and was labelled as ‘Linear’. Finally, a pattern of random lines varying in direction 
was etched into the polymer surface and labelled appropriately as ‘Random’. 
Subsequently, a previous study has shown that these machine ground surfaces 
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promote adhesion and migration in fibroblast cells compared to unprocessed, flat 
surfaces [180].  
Once polished to achieve an initial mirrored finish (as described above in Section 
1.2.1) the stainless steel cylinder was then polished to achieve a topographical 
surface patternation through the use of abrasive paper (1200 B). By controlling the 
motion of the stainless steel cylinders relative to the silicon carbide abrasive paper, 
surfaces having either directional, or random, sub-micron abrasive marks could be 
produced, termed here as ‘nano-scratches’. The directional (linear) features are a 
result of the METASEV universal polisher's spinning motion, while the more random 
features are the result of manually rubbing the steel mould across the surface in 
different directions. The surface topography was subsequently characterised by 
white light interferometry and scanning electron microscopy. These stainless steel 
cylinders could then be used as master moulds to cast polymer substrates. In total 
two different patterns were produced; having linear and randomly organised 
features. 
7.1.3 Casting polymer substrates 
Casting the polymer over the stainless steel moulds produces an inverted pattern on 
the polymer surface. Employing this indirect processing method ensures that only 
the surface topography/roughness of the material is altered and not the material 
chemistry. The polymer used here was polyurethane and was provided by Biomer 
Technology Ltd. The polymer substrates were produced using 8% polyurethane in 2:1 
212 
 
 
 
 
Dimethylformamide (DMF) and Tetrehydrofuran (THF). This was poured onto the 
stainless steel moulds and cured at 60°C for 2 h. Following this the mould/cast was 
allowed to cool before peeling off the polymer from the mould following the grain of 
the pattern. Prior to cell culture all polymer surfaces were sterilised by washing with 
70% ethanol then exposed to UV light for 30 min. Finally, the polymers were washed 
with sterilised distilled H2O. 
7.1.4 White light interferometry for surface characterisation 
A Bruker Contour GT-K 3D optical microscope equipped with Vision 64 software 
was used to image the surfaces of the patterned polymers. This enabled feature 
heights/widths and roughness to be determined.  
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7.2 Appendix B – Chris Sanderson lab methods 
7.2.1 Live Cell Imaging 
BACNrf2-Venus were generated by stable integration of bacterial artificial chromosome 
(BAC) encoding Nrf2-Venus fluorescent protein fusion into neuroblastoma SK-N-AS 
cells. The pDendra2-Nrf2 fusion was transiently expressed in SK-N-AS cells. BACNrf2-
Venus were treated with 10μM MG132 and 10μg/ml in separate experiments. To 
silence the expression of the Keap1 protein in the pDendra2-Nrf2 experiments, short 
interfering RNA (siRNA) duplexes targeting human Keap1 (siKeap) (SMART pool ON-
TARGET plus Keap2 siRNA, Darmacon, L-012453-00-000) were transfected at 10nM 
final concentration alongside a scrambled control (siCTR) siGENOME Non-Targeting 
siRNA Pool no 1 (Dharmacon, D-001206-13-05). For real-time imaging of live cells, 
cells were seeded onto the 1 or 4 compartment 35mm glass bottom dishes (Greiner 
Bio-One). The 4 compartments allowed imaging of 4 different experimental 
conditions in parallel. The imaging experiments were performed under humidified 
atmosphere, at 5% CO2 and 37°C on two imaging systems. The primary cells 
expressing plasmid encoded fluorescent protein fusions were imaged on the Zeiss 
Axiovert 5.10 (Zeiss Germany) confocal microscope using 40x oil immersion objective 
with numerical aperture (NA) of 1.4. The image acquisition on this system was 
coupled with autofocus Marco (Ellenberg lab, EMBL), which enabled maintenance of 
stable Z-plane position of the imaged cells, avoiding the problems of focal drifts that 
can occur during the long acquisition times. The LSM 7.80 (Zeiss, Germany) system 
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was used for monitoring low expression of fluorescent proteins, as it has superior 
resolution and sensitivity of detection, using 40xoil immersion objective (1.4 NA) and 
LSM ZEN 2010 image acquisition software (Zeiss). In both systems the image 
acquisition was performed, using 512x512 pixel resolution, 7 scanning speed with the 
pinhole diameter adjusted to the fluorescence intensity of imaged samples. The 
image acquisition of single fluorophore was performed by taking one acquisition 
frame at 8min interval in 1-20 imaging locations, and the time taken to acquire image 
at all selected positions did not exceed the 8min interval. When imaging two separate 
channels (or fluorescent probes) the image acquisition was performed every 7min at 
up to 16 locations. The drug treatment was usually performed following initial three 
frames were acquired, which served as a baseline fluorescence measurement. Both 
imaging protocols were carried out at various lengths of time between 2-14h, and 
the drug of interest was added following 3 initial frames, which were taken to 
establish a signal baseline. 
7.2.2 Lambda Scan 
Lambda Scan imaging mode was used for spectral unmixing of fluorophores with 
overlapping fluorescence emission peaks. This mode was predominantly used to 
image cells exhibiting very low expression of fluorescent protein fusions such as 
BACNrf2-Venus or primary astrocytes transduced with 2kb-Venus-msNrf2. The levels of 
Venus fluorescence in those models was close to autoflourescent signal and 
therefore there was a considerable autofluorescent noise being detected. The 
spectral images were then combined using LSM ZEN 2010 software (Zeiss). 
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7.2.3 pDendra2 Imaging 
The photoswitchable fluorescent protein pDendra2 was isolated from Octocoral 
Dendronephthya. It matures completely at 37°C, its pH stable and monomeric. The 
pDendra2 emits naturally in a green light spectrum, however UV irradiation results 
in irreversible transition in emission to bright and photostable red fluorescent 
protein (RFP) spectrum. The pDendra2-Nrf2 fusion was transiently expressed in SK-
N-AS cells (3μg of plasmid p/35mm dish) 24h before the experiment. To image the 
turnover of Nrf2, four locations were selected with each localization treated with a 
different compound (4 compartment dishes) and the 2 regions of interest (ROIs) were 
selected, each of 13x13 pixel size. The fluorescent signal was collected for the Green 
and the Red channels and following acquisition of three imaging frames, the drug 
was added and one more frame was collected (3min interval between acquisitions). 
Then the photoconversion of pDendra2 was performed by a UV lamp at 75% power 
for 45s. Local pDendra photoconversion was used to monitor nuclear import and 
export rates of pDendra2-Nrf2. The data measurements were performed using ZEN 
2010 and exported and averaged using Microsoft Excel, the averaged data was 
exported to GraphPad Prism 5.  
7.2.4 Image Analysis 
Image analysis post-acquisition was performed using Cell Tracker software Version 
6.0 (www.dbbkgroup.org/celltracker/). The nucleus was drawn manually and 
adjusted on every acquisition image, either manually or automatically by cell tracker 
software. The data was averaged and exported to Excel file format. It was normalized 
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to the initial fluorescence levels and the noise was reduced by averaging the values 
using third order moving average (three frame smoothing).  
7.2.5 Fluorescence Cross Correlation Spectroscopy (FCCS) 
The data collection was performed using LSM 780 with confocor 3 mounted on Axio 
observer Z1 microscope using oil immersion 100x lens (N.A. 1.46) and using ZEN2010 
software (Zeiss). The pinhole was set to 1 airy unit and the laser power was typically 
set to 1% laser power, adjusted to avoid photobleaching and to maximize the count 
per minute (cpm) fluorescent signal to minimum 0.5 kHz value. The data collection 
protocols were carried out 10x for 10s each and the fluorescence signal of channels 
was then compared using first correlation and then cross-correlation logarithms 
using LSM ZEN 2010B FCS function.  
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